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Abstract
Bone is a dynamic tissue that is continuously remodelling itself in response
to the mechanical loading that it is placed under. The cells within the bone
sense the mechanical loads and respond in an appropriate manner. This can be
through increasing bone resorption or increasing bone deposition in response
to decreased or increased loading respectively.
Cells themselves have a number of mechanisms thought to be involved in
sensing mechanical loads and transforming them into biochemical signals in
a process known as mechanotransduction. One such mechanism thought to
be involved is the primary cilium. The primary cilium is a hair-like organelle
that protrudes from the surface of the majority of cells during interphase. It is
theorised that the bending of this organelle in response to fluid shear stress
(FSS) results in the activation of downstream signalling pathways. Primary
cilia have been shown to regulate their mechanosensitivity through altering
their length, becoming shorter and less sensitive in response to continuous
loads. Lithium chloride has been shown to elongate primary cilia and could
therefore have the potential to increase osteogenic responses to FSS. The aim
of this thesis was to examine the effect of lithium chloride on mechanoinduced
osteogenesis.
An in vitro FSS stimulus was optimised to stimulate osteogenic responses in
hES-MP and MLO-A5 cells. The effects of LiCl on primary cilia length and
osteogenesis was than evaluated at a range of concentrations and durations.
Continuous 1mM LiCl was found to increase osteogenesis in both cell lines.
Intermittent treatment with 1mM LiCl was found to increase cilia length
without affecting cilia prevalence or osteogenesis. Cells treated with LiCl were
then stimulated, where they showed increased osteogenic responses to FSS
in both monolayer culture and 3D culture. LiCl was also found to decrease
i
cAMP but increase Ca2+ responses to FSS. These results demonstrate that
LiCl increases mechanically induced osteogenic responses in vitro.
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1. Introduction
Bone is a dynamic tissue widely known to be responsive to mechanical stimu-
lation. The ability of one’s bones to sense and adapt to these stimuli through
bone remodelling is important, not only in maintaining the health and strength
of bones themselves, but also for one’s overall wellbeing. This relationships
between mechanical stimuli, bone formation and resorption are finely tuned to
give bones the required strength to prevent mechanical failure whilst keeping
the use of material, and therefore bone mass, to a minimum. Understanding
the mechanisms behind how bone responds to mechanical stimulation could aid
in the understanding and treatment of bone diseases such as osteoporosis or
even aid in the healing of bone fractures. Furthermore, a better understanding
of the mechanobiology of bone could aid in the design and implementation of
bone tissue engineered constructs with superior ossteointegration. The study
of mechanobiology and mechanotransduction is therefore of high interest in a
number of research fields.
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2. Background
2.1 Bone structure and physiology
2.1.1 Bone function and anatomy
Bone is a highly organised, dynamic tissue that performs several roles within
the body: Bones protect vital organs, provide support, facilitate movement
through acting as levers and providing anchorage for muscles, act as a mineral
reservoir for minerals such as calcium and phosphorus and produce blood cells
and store energy in the form of lipid filled yellow marrow [1,2]. In adults, bone
tissue is comprised of two types of osseous tissue, cortical bone and cancellous
bone (also known as compact bone and trabecular or spongy bone, respectively).
Cortical bone comprises around 80% of an adult skeleton whereas cancellous
bone comprises only 20% [3]. Cortical bone is much denser than cancellous
bone, with a typically porosity lower than 5% compared to 50-90% for cancellous
bone, making its compressive strength around twenty times higher [4]. The
porous structure of cancellous bone is formed of interconnected trabecular
plates and rods which are filled with bone marrow and blood vessels [5].
2.1.2 Bone macrostructure
Bones can vary greatly in shape and size and can be classified by their shape
into five categories; flat, short, long, sesamoid and irregular. From these five
categories flat and long bones can be thought of as the two main categories.
Flat bones such as those found in the skull, scapula and sternum are composed
of a layer of cancellous bone sandwiched between an exterior of cortical bone.
Long bones such as those found in the femur, tibia and humerus consist of
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three regions, the epiphysis, diaphysis and metaphysis. The epiphysis forms
the ends of the bones and is predominantly a core of cancellous bone with
a shell of cortical bone. The diaphysis is the shaft of the bone; it is formed
from a hollow tube of cortical bone with the cavity (known as the medullary
cavity) filled with bone marrow. The metaphysis is the region of bone that
grows during childhood and is otherwise known as the epiphyseal plate. It
sits between the epiphysis and diaphysis of the bone at both the proximal and
distal ends.
Bones also have an exterior sheath of fibrous connective tissue called the
periosteum. The periosteum is formed of two layers; the outer layer is formed
of dense, irregular collagenous tissue and the inner layer is formed of a single
layer of bone cells. The periosteum covers the whole surface of the bone except
at joints where the bones are covered by articular cartilage. The interior
surface of bone is also lined by a membranous sheath termed the endosteum
[6,7].
2.1.3 Bone micro and nano structure
Bone is a composite material composed of one third organic and two thirds
inorganic matter that forms a mineralised matrix containing cells. The organic
matter provides the tensile strength for the bone and allows some degree of
flexibility. The inorganic matter gives bones their compressive strength. The
cells within the bone deposit and resorb the matrix to maintain its health and
strength. The inorganic matter of bone is comprised of around 85% hydroxyap-
atite, 10% carbonated apatite, which can contain ion substitutes of potassium,
fluoride and sodium. The organic matter of bone is comprised of various large
proteins such a type I collagen; which accounts for around 90% of the total
protein within bone [8]. In addition to type I collagen, trace amounts of type
III and type V collagen are also present [9]. Other non-collagenous proteins,
such as proteoglycans, glycosaminoglycans and glycoproteins are also present
in bone and make up around 10% of the total bone. These proteins typically
have a high affinity to calcium ions; which is due to their glutamic and aspartic
acid residues [10].
Osteopontin, osteonectin, osteocalcin and alkaline phosphatase (ALP) are
some examples of the non-collagenous proteins that are present in bone. Osteo-
pontin is a sialoprotein that is involved in bone remodelling and the attachment
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of cells to the bone matrix and has been shown to be an early indicator of
osteoblast differentiation [11, 12]. Osteonectin is a glycoprotein involved in
mineralisation and it has a high binding affinity to calcium, collagen and
hydroxyapatite. Osteocalcin is a matrix gla protein specifically produced by
osteoblasts that also has a high binding affinity to calcium [12,13]. It is thought
that osteocalcin plays a role in bone remodelling and control of mineralisation
through its inhibition [12,13].
There are multiple types of the ALP enzyme present throughout the body.
Within bone tissue non-specific ALP is secreted by osteoblasts and it promotes
the formation of hydroxyapatite crystals within the bone matrix [14]. ALP
activity is also known to increase as cells develop along the osteogenic lineage
and is a specific marker for differentiated bone-forming osteoblasts [15]. It is
therefore commonly used in vitro as an early marker of osteogenic differentia-
tion of stem cells [16]. Despite this the exact mechanisms of its involvement in
bone formation is unknown.
The structural components of bone like many other tissues are arranged
in a hierarchical structure from the nano to the macro scale (Figure 2.1). The
nanostructure consists of the collagen molecules that form mineralised fibrils
and in turn fibers. The microstructure consists of trabeculae and concentric
layers of bone called lamellae which in turn form osteons. The macroscale
consists of the cortical and cancellous bone [17].
Figure 2.1: Hierarchical structure of bone. Figure taken from [15].
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2.1.4 Cell biology of bone
Within bones there are four different types of cells each with a specific func-
tion: osteoblasts, osteocytes, osteoclasts and osteogenic progenitor cells [5].
Osteogenic progenitor cells are a progenitor cell that arise from mesenchymal
stem cells present in the bone marrow. They are able to differentiate into
osteoblasts and therefore give rise to bone formation [18]. However, they can
ultimately also terminally differentiate into osteocytes or some may undergo
apoptosis or become bone lining osteoblasts [19]. Osteogenic progenitor cells
are therefore able to form all bone cells except osteoclasts which are derived
from haematopoietic stem cells.
Osteoclasts are multinucleated cells that resorb bone matrix through ex-
cretion of acids and enzymes. They are formed from monocyte progenitors
derived from haematopoietic stem cells that fuse together to become a multinu-
cleated osteoclast [20]. Osteoclasts have a short lifespan of around 15-20 days
before they undergo apoptosis, which means they must be constantly replaced
from haematopoietic stem cells [21].
Osteogenic differentiation of osteogenic progenitors can occur by two distinct
pathways, either directly via intermembranous ossification or indirectly via
endochondral ossification [22]. In direct differentiation, osteogenic progenitors
will directly differentiate into osteoblasts during intermembranous ossification.
In indirect differentiation, osteogenic progenitors will first differentiate into
chondrocytes where they will initially proliferate before becoming hypertrophic.
When these cells become hypertrophic, osteogenic differentiation is triggered
and the cells differentiate into osteoblasts [5,19].
Osteoblasts are responsible for the deposition of new bone and when com-
pletely encased in deposited bone matrix become osteocytes [2]. Inactive
osteoblasts line the surface of bone and are known as bone lining cells. These
cells form part of an intracellular communication network (along with active
osteoblasts and osteocytes), which is hypothesised to be one mechanism respon-
sible for directing and sensing the need for new bone formation [23]. When
osteoblasts become osteocytes, they undergo many phenotypic changes: They
become smaller and more stellate in shape as more bone is deposited around
them until they are encased in newly deposited bone, where the remaining
space in which they reside becoming known as a lacuna. Osteocytes have a
high number of cytoplasmic processes and they form gap junctions with the
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processes of other osteocytes, osteoblasts or bone lining cells. These processes
also become embedded in newly deposited bone and the resulting channels in
which they lie become known as canaliculi. This interconnectivity is thought
to play a role in the way bone senses and responds to mechanical stimuli [23].
Current theories hypothesise that the interstitial fluid that surrounds the
osteocytes flows from regions of high to low pressure under bone deformation.
This applies a shear stress to the cells, which in turn stimulates osteocytes
to produce signalling molecules that regulate bone formation and resorption.
These fluid shear forces can also occur within the bone marrow itself and can
act upon both bone lining osteoblasts but also the osteogenic progenitors within
the bone marrow [24,25].
2.2 Bone remodelling
Bone continually remodels itself throughout one’s lifetime and it is an essen-
tial physiological process in the maintenance of bone strength and mineral
homoeostasis [26]. Remodelling occurs through the resorption of fractured or
micro-damaged old bone and immature woven bone followed by deposition of
new bone often creating changes in the bone architecture in response to applied
loading forces. In a typical healthy individual approximately 5% of cortical
bone and 20% of trabecular bone is remodelled in this process each year [27].
Throughout childhood bone deposition outweighs bone resorption resulting
in increased bone density. This balance continues until approximately 30
years of age where peak bone density is reached [28,29]. After this point bone
deposition and resorption are balanced maintaining this peak bone mass for
approximately 20 years until bone density begins to decrease through increases
in bone resorption [27].
Old bone is resorbed by osteoclasts and new bone matrix is deposited by
osteoblasts. These cells perform this remodelling process together by assem-
bling into what is known as a basic multicellular unit (BMU). A BMU is
composed of a group of osteoclasts ahead of a group of osteoblasts contained
within supporting connective tissue and accompanied by a blood supply. The
osteoclasts at the front of the BMU resorb bone, this is followed by deposition
of new bone matrix by the trailing osteoblasts. The BMU can advance at up
to 40µmd−1 in cortical bone and up to 11µmd−1 in trabecular bone [30,31].
These differences are due to the way bone is resorbed, in cortical bone the
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BMU forms and fills tunnels whereas in trabecular bone trenches are created
and filled on the surface of the bone (Figure 2.2) [5, 32]. Bone remodelling
Figure 2.2: Basic multicellular units in trabecular (top) and cortical (bottom)
bone. In trabecular bone BMUs initiate underneath a canopy of bone lining
osteoblasts. In cortical bone BMUs initiate within the Haversian canals. Figure
taken from [33].
follows a tightly controlled sequence of phases; quiescence, activation, resorp-
tion, reversal and formation. Quiescence is the inactive state of bone where
no remodelling is occurring. Activation begins with the detachment of bone
lining osteoblasts from the bone surface and the recruitment of mononuclear
osteoclast precursors which are supplied by the local blood supply in the area
of remodelling. These mononuclear cells attach to the bone surface where they
mature and fuse to form multi-nucleated osteoclasts. The maturation of these
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mononuclear cells is controlled by the release of macrophage colony stimulat-
ing factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand
(RANKL) by osteocytes and osteoblasts which initiate osteoclastogenesis. This
formation can also be inhibited by osteoprotegrin (OPG) which can antagonise
the binding of RANKL to receptor activator of nuclear factor kappa-B (RANK).
Once osteoclasts are formed resorption of the bone matrix occurs and can
continue for 2 to 4 weeks. Osteoclasts themselves are short lived, with an
average lifespan of around 10 days. Therefore, a supply of new mononuclear
precursors from the bone marrow are required in order for new osteoclasts to
form and resorption to continue after the apoptosis of old osteoclasts. After the
bone is resorbed the reversal phase occurs. This phase is not well understood
but involves the colonisation of the resorbed bone surface by a population of
mononucleated reversal cells which prepare the degraded bone surface for new
bone deposition. During both bone resorption and the reversal phase many
cytokines are released from the degraded bone matrix including, bone mor-
phogenetic protein 2 (BMP)s, insulin-like growth factor (IGF)s, human basic
fibroblastic growth factor (hFGF)s and transforming growth factor (TGF)-β.
The release of these cytokines promotes the migration of osteogenic progenitor
cells and undifferentiated osteoblasts to the BMU and also stimulates their
proliferation, differentiation and the beginning of new bone matrix deposition
[26,34–38].
After the bone is prepared by the reversal phase osteoblasts begin to re-
place the resorbed bone during this process osteoblast morphology changes
and they become flatter. A cementing substance is initially secreted by the os-
teoblasts after which collagenous matrix is deposited. This collagenous matrix
is then mineralised by the osteoblasts through the secretion of membrane-
bound vesicles which increase the concentration of calcium and phosphorous
ions at the mineralisation front. As deposition progresses some osteoblasts
become embedded in the new matrix, differentiating into new osteocytes, some
osteoblasts will apoptose and others will remain on the bone surface and
become new bone lining osteoblasts. The lifespan of osteoblasts is therefore
much more varied and can be anything from a few days to 100 days (Figure 2.3)
[27,39].
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Figure 2.3: Illustration of the five stages of bone remodelling, quiescence,
activation, resorption, reversal and formation. Formation and activation of os-
teoclasts are controlled through the RANK/RANKL/OPG pathway. Resorption
and the reversal phase release osteogenic cytokines from the bone including
BMPs, IGFs, hFGFs and TGF-β which are involved in controlling proliferation
and differentiation of osteogenic progenitor cells.
2.3 Osteoporosis
Osteoporosis is a bone disorder characterised by reduced bone mineral density
(BMD), impaired microarchitecture and decreased bone mass and strength
resulting in an increase in bone fragility and an increased propensity of fragility
fractures (Figure 2.4) [40]. An estimated 22 million women and 5.5 million men
have osteoporosis in Europe with around 3.5 million people affected within
the UK alone [41]. An individual is classified as having osteoporosis when
their BMD lies more than 2.5 standard deviations below the mean for a typical
young adult i.e. a T score less than -2.5, typically assessed by dual x-ray
absorptiometry of the femoral neck. Osteoporosis can be further classified
into primary or secondary, with primary further divided into type I and type
II [40]. Primary type I, or postmenopausal osteoporosis is the most common
form of osteoporosis and is linked to the decline in oestrogen production in
postmenopausal women. Primary type II, or senile osteoporosis affects both
men and women and is associated with ageing. Secondary osteoporosis can
be caused by several comorbid diseases but can also be caused due to the
adverse effects of medications. Most commonly this can include diseases such
as Cushing’s syndrome, rheumatoid arthritis and hypogonadism and adverse
effects from glucocorticoids [42–44].
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Figure 2.4: Trabecular bone of (A) a 21-year old male and (B) a 65-year old post
menopausal female. Image adapted and reprinted with the kind permission of
Dr. James Weaver and printed in [45].
Osteoporosis manifests itself through fractures, however defining a fracture
as on osteoporotic fracture is not straightforward. For example, although the
incidence of fractures increases with age these may not be due to osteoporosis
since the incidence of falls also rises with age. Therefore, an important aspect
of classifying an osteoporotic fracture is to consider whether a similar trauma
would have caused a fracture in a healthy individual or whether the fracture
site is associated with low BMD. It is estimated that 20% of men and 50% of
women will have an osteoporotic fracture after the age of 50. These fractures
can result in temporary or permanent loss of mobility, greatly reduce the
quality of life and in hip and spinal fractures up to 20% of cases result in
fatality within a year [46]. In addition, these fractures and the subsequent
health and social care costs create a significant economic burden. In the UK
alone the health and social care costs of treating osteoporotic fractures exceeds
£4.5 billion per year and this is forecast to increase by 30.2% by 2030 [47].
As a baseline treatment for osteoporosis patients are recommended to make
lifestyle changes, such as reduction of alcohol consumption, cessation of smok-
ing and increased physical exercise. In addition, vitamin D and calcium
supplements may be given if nutritional intake is inadequate. Therapies
for osteoporosis typically employ bone anabolic drugs that stimulate bone
deposition or anti-resorptive drugs which aim to slow the resorption of bone.
Bisphosphonates are an anti-resorptive drug that promote osteoclast apoptosis
and are typically the first-line therapy employed. Despite their low cost and
long-time success in reducing bone resorption, they can cause gastrointestinal
side effects when taken orally and influenza like side effects when administered
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intravenously. Osteoporosis is asymptomatic until fractures present and this
can mask the importance of medicating especially when it can result in such
side effects. This may account for patient non-compliance or discontinuation
of treatment which occurs in around 30% of patients [48]. Furthermore,
recent research has recognised bisphosphonate-related osteonecrosis of the
jaw (BRONJ) as a potential complication to bisphosphonate treatment [49].
Although this risk is higher in patients treated with bisphosphonates for cancer,
it has been estimated 7.8% of patients treated for osteoporosis may be affected
[50]. Long-term use of bisphosphonates has also been associated with atypical
femur fractures due to suppression of bone remodelling [51].
Hormonal therapies for osteoporosis include hormone replacement therapy
(HRT), selective oestrogen receptor modulators (SERMs) and parathyroid
hormone (PTH). HRT involves the administration of oestrogen alone or in
combination with progesterone and in addition to reducing the risk of fracture,
HRT also reduces the symptoms of menopause. Despite this, HRT is typically
reserved for high-risk postmenopausal women after other treatment therapies
have been ruled out. This is due to the increased risk of stroke, breast cancer,
venous thromboembolism and heart disease associated with the use of this
treatment [52].
SERMs exhibit both antagonistic and agonistic properties on oestrogenic
pathways, decreasing bone resorption and bone turnover rates [53]. Similarly
to HRT, SERMs increase the risk of stroke, cardiovascular disease and venous
thromboembolism [54]. Additionally, there is currently limited clinical data
on the effectiveness of SERMs in reducing fracture risk compared to other
treatment options, therefore SERMs are typically a second-line treatment
option.
PTH treatment is one of the few osteoporosis treatments that are anabolic.
Recombinant PTH is administered via daily injections and stimulates new
bone formation on the bone surface increasing BMD and reducing fracture risk
[55]. Additionally, bone quality is also improved with cortical thickening and
increased trabecular bone connectivity [56]. Due to the high costs and the need
for daily injections, PTH treatment is typically reserved for high-risk patients
and is contraindicated for patients with Paget’s disease, primary or metastatic
bone malignancy, hyperparathyroidism and hypercalcaemic disorders [57].
In comparison to other treatment options PTH shows less severe side effects,
most commonly dizziness, headaches, fatigue nausea and cramps. However,
12
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currently treatment is limited to a maximum of two years due to long term
concerns with the development of osteosarcoma which has been shown to occur
in rats [58].
Bisphosphonates still remain the first-line treatment for osteoporosis. Despite
other treatments showing promise in reducing fracture risk many of the alter-
native treatment options are expensive, increase the risk of developing other
diseases or can only be used for a limited duration. However, there is increasing
concern with the safety of bisphosphonate treatment due to newly associated
risks with BRONJ and atypical femur fractures. Alternative therapies would
therefore be beneficial.
2.4 Mechanical forces in bone
Mechanical forces in bone can be generated by our weight due to gravity,
impacts from movement and also from muscle contractions. These forces result
in deformation of bone which can in turn generate matrix strain and fluid shear
stress.
2.4.1 Strain
When bone deforms due to loading it induces strain within the bone matrix
but also in the cells within the bone. Physiological strains that induce bone
remodelling and deposition were first postulated to range between 0.03% and
0.15% by Frost et al. in 1987 [59]. When strains fall below this range bone
resorption occurs and above this range bone damage and even fracture can
occur. More recently these numbers have been confirmed experimentally in
vivo [60,61]. Although these numbers appear to be correct in vivo, in vitro cells
require much greater strains in the range of 1% and 10% in order to induce
osteogenic responses [62,63]. These strains are of such a high magnitude that
if these strains were to be applied in vivo it would result in bone fracture. This
suggests that bone cells in vitromay not be directly sensing these matrix strains
but instead may be detecting other forces within the bone such as interstitial
fluid flow or may be detecting microstructural strains within the bone such as
strains near lacunae, which are thought to be greater [64].
13
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2.4.2 Fluid shear
The flow of fluid through the extracellular matrix of tissues such as bone is
known as interstitial fluid flow. Interstitial fluid flow forms an integral part
in microcirculation and is important for the transportation of proteins and
other molecules through the inerstitium [65]. In addition to this role, it also
provides mechanical cues, in the form of fluid shear stress, to cells within
the interstitial environment. Within bone interstitial fluid occupies the space
surrounding blood vessels within the Volkmann and Haversian canals and
also within the lacuna-canalicular network. The flow of interstitial fluid can
be driven by a number of factors, including hydrostatic and osmotic pressure
differences between blood vessels, interstitium and the lymphatic system, but
also by blood pressure changes due to movement and the mechanical loading
that movement itself applies [24,65].
Within bone one of the major drivers of interstitial fluid flow is the hydrostatic
pressure drop between the bone marrow and the periosteum [24, 66]. This
pressure drop causes fluid to flow outward radially from the bone marrow
and since bone does not contain a lymphatic system within the bone marrow
the fluid flows through interconnected channels of the bone to the lymphatic
system at the periosteal surface. Interstitial fluid flow can also be induced
through muscle contractions during exercise [67–69]. When muscles contract
the pressure within the bone marrow can be temporarily increased due to
occlusion of the veins that exit the marrow. After the muscle relaxes and
blood can again exit the marrow, it can cause a decrease in marrow pressure
a draw new interstitial fluid into the marrow, creating a pulsatile pressure
wave. In addition to muscle contractions during exercise inducing interstitial
fluid flow, the resultant mechanical loading and deformation of the bone can
also induce flow. Deformation of the bone creates pressure gradients across
the bone causing fluid to flow through the lacuna-canalicular network. Flow
rates of the same magnitude to that caused by hydrostatic pressure drops
between the bone marrow and periosteum can be induced by as little as 75
microstrain [70]. Considering strains due to mechanical loading are typically
in the millistrain magnitude, the fluid flow induced by mechanical loading is
much more substantial and therefore likely to be a more potent mechanical
stimulus [71].
All cells within bone are likely to be subjected to some level of interstitial fluid
flow and therefore fluid shear stress. Osteocytes are likely to be subjected to
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the highest magnitude of fluid shear stress due to the small spaces and narrow
channels of the lacunae and canaliculi in which they reside. Weinbaum et al.,
estimated the fluid shear stress that is applied to osteocytic processes in the
canaliculi during loading to be in the order of 0.8-3Pa [72]. Osteoblasts and
osteogenic progenitor cells are likely to be subjected to lower magnitudes of
fluid shear stress due to the more open porosity environments in which they
reside. Estimation of the fluid shear stress which osteoblasts and osteogenic
progenitors are subjected to are more complicated due to the fact the geometries
in which they reside are continually remodelling and the mechanical properties
of newly deposited osteoid is not definitively known. Despite this, many authors
appear to be in agreement that the fluid shear stress levels osteoblasts and
osteogenic progenitors are subjected to are lower and different to that subjected
to osteocytes [73,74].
2.5 Bone mechanobiology
Mechanical loading is essential for bone health and plays an active role in
directing bone deposition and resorption. This is evident when loading of bone
is removed, for example through extended periods of bed rest or limb paralysis,
but also when loading levels are increased, for example in the playing arm
of a tennis player where bone density is greater than in the non-playing arm
[75–77]. In order for bone to remodel in response to mechanical loading, there
must be a shift in the current resorption and deposition levels. Since new
bone is deposited predominantly along the loading stress lines, this suggest
there must be some local sensing and regulation, due to mechanical stimuli,
that regulates bone formation and resorption [78]. The mechanism by which
cells detect and convert mechanical forces into biochemical signals is called
mechanotransduction [79].
As previously discussed, the intracellular communication network formed
by osteogenic progenitors, osteoblasts and osteocytes is thought to play a role
in the control of bone homeostasis and adaptation. However, it is unclear
what role each cell type plays in this network. Experimental evidence has
shown that all three cell types can be sensitive to mechanical stimuli and that
each cell type can respond differently to different mechanical stimuli [80–82].
For example, 15 minutes of pulsating fluid flow has been shown to increase
prostaglandin G/H synthase-2 messenger ribonucleic acid (mRNA) expression
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in osteocytes but not in osteoblasts, whereas 6 hours of intermittent hydrostatic
compression has been shown to stimulate prostaglandin E2 (PGE2) production
in both osteoblasts and osteocytes [80,81]. In addition to their ability to sense
mechanical stimuli, the distribution and abundance of osteocytes within the
bone matrix (around 90% of all bone cells), places them in an ideal location
to sense any local mechanical loading throughout the bone. This has resulted
in the consensus that osteocytes are the primary mechanosensor within bone.
Despite this, primary osteocytes are not widely studied due to difficulties
extracting them from within the lacunae of bone and culturing them for long
periods. Therefore, osteocyte-like cell lines such as murine long bone osteocyte
Y4 (MLO-Y4) and murine long bone osteocyte A5 (MLO-A5) are typically used
[62].
There are many physical triggers that could provide the stimuli to the
mechanosensitive cells, such as matrix strain, interstitial fluid flow and
hydraulic pressure. It is unclear if one of these mechanisms or an interplay
between them all is the physical stimulus that triggers a response. However
fluid flow induced shear stress has become the most studied mechanism. Ex-
perimental evidence has confirmed the idea that interstitial fluid flows in
response to local bone deformation through the following of tracers through
the lacuna-canalicular network during bone loading [83]. In addition, bone
cells in culture have been shown to be responsive to fluid shear within a range
of shear values and loading frequencies expected to occur in vivo (1-3 Pa at 1-3
Hz) [84,85]. Fluid flow both in vitro and in vivo not only induces a shear stress
on cells but also creates streaming potentials and increased chemotransport.
By altering flow rate while also altering fluid viscosity, fluid transport and
therefore chemotransport can be altered without also changing the applied
fluid shear. This has shown that streaming potentials and chemotransport
have little to no effect as a stimulus in comparison to fluid shear [86].
The exact mechanisms behind how bone cells translate these mechanical
stimuli into biochemical responses are also not fully understood. However,
force induced changes in structures such as integrin complexes, mechanosen-
sitive ion channels, cell-cell adhesions, glycocalyx and primary cilia are all
potential sensory elements (Figure 2.5). As in other mechanosensitive cells,
the cytoskeleton is thought to play a role in the mechanotransduction and
biochemical response. This is through the interaction of the cytoskeleton and
extracellular matrix (ECM), through transmembrane cell surface receptors,
known as integrins [87]. In osteoblasts, actin disruption and mutant adhesion
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proteins have been shown to inhibit various signal pathways induced by fluid
shear, highlighting the importance of the cytoskeleton and integrins in mechan-
otransduction [88]. In addition, gene expression of cytoskeletal and integrin
related molecules have been shown to be upregulated by the application of fluid
shear [89]. These results suggest the cytoskeleton rearranges its structure
to increase cell adhesion with the ECM, increasing the expression of integrin
related molecules that aid in the transfer of mechanical stimuli into the cells.
Figure 2.5: Mechanosensory structures in bone cells. (1) Cytoskeleton, in-
tegrins and cell-cell adhesion complexes. (2) Mechanosensitive sensitive ion
channels. (3) The primary cilium. (4) The glycocalyx.
A second mechanism theorised involves the activation of mechanosensitive
ion channels resulting in an influx/efflux of ions into or out of the cell [90].
Mechanosensitive ion channels can be activated or inactivated by mechanical
forces and can respond to stretch, curvature or other deformation that causes
tension in the cell membrane [91]. There are large number of mechanosensitive
ion channels with the most commonly studied falling into the TREK, TRAAK
or TRP families. These channels are known to be present in osteogenic cells
[92,93]. These mechanosensitive ion channels can be located throughout the
cell membrane but have also been found to be localised to the primary cilium
membrane [94].
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The primary cilium is another popular cellular feature thought to play a
role in mechanotransduction. It was once believed that primary cilia were
a vestigial organelle that no longer play any role in the cell. However, more
recently the primary cilium has been implicated in a number of biological
responses such as sonic hedgehog signalling, an important signalling pathway
in embryonic development [95], control of left-right axis determination during
embryonic development [96] and polycystic kidney disease [97] and will be
discussed further later in this chapter.
Absence or damage to any of these key functional or structural components
can have major clinical implications. Duchenne muscular dystrophy is caused
by mutations in the dystrophin gene causing disruption in force transmission
between the cytoskeleton and ECM resulting in muscle degeneration [98].
Abnormalities in mechanosensitive ion channels can result in neuronal and
muscular degeneration, cardiac arrhythmias, hypertension and polycystic
kidney disease [99–103]. Previous research on the role primary cilia play in
these diseases have found both chemosensory and mechanosensory roles in
response to fluid flow.
2.6 Primary cilia
Primary cilia are solitary, immotile, hair-like protrusions that emanate from
the cell surface of most mammalian cells [104], including bone cells [105],
during arrested cell growth. The length of a typical cilium can range in length
from 1-10µm, varying between cell types and culture conditions [106]. Not
all cells that are known to express primary cilia generate one and spatial
confinement, one key regulator of cilia genesis, is thought to control this [107].
Primary cilia themselves have been linked to a number of signalling pathways
and cellular processes such as polycystin, hedgehog and wingless/integrated
(Wnt) signalling [108–110]. Defects of primary cilia can therefore cause a wide
range of diseases termed ciliopathies.
2.6.1 Primary cilia structure
The ciliary skeleton or axoneme, extends from the basal body and consists of
nine microtubule doublets. In contrast to motile cilia, primary cilia do not
contain a central doublet and have hence been termed 9+0 cilia (Figure 2.6)
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[111]. Primary cilia also lack elements of motile cilia involved in cilia motility
such as the outer and inner dynein arms [110]. The axoneme of the primary
cilia is surrounded by the ciliary membrane which is an extension of the cell
membrane. The ciliary membrane is separated from the cell membrane by the
ciliary necklace and in some cells also the ciliary pocket. These regions form
a barrier to the movement of proteins and lipids into and out of the primary
cilia, allowing the primary cilia to have a unique membrane composition [89].
The membranes of primary cilia contain a high density of receptor proteins
and calcium channel proteins, with many of these proteins being specific to
the primary cilia itself [112, 113]. The localisation of these proteins further
supports the sensory role of primary cilia.
Figure 2.6: A Schematic illustration of a primary cilium including transverse
sections of the cilium at different points along its axis.
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Primary cilia do not contain the necessary machinery to synthesise these
proteins, thus they must be transported from the cell cytoplasm into the cilia.
This role is performed by the intraflagellar transport (IFT) system, which is
itself formed from many proteins that aid in the trafficking of proteins towards
the distal ends of the cilia and back again [114]. The IFT system is formed of
protein modules, known as IFT trains, particles or rafts which travel along the
axoneme of the cilium. IFT particles are assembled at the base of the cilium in
the transition zone [115]. The IFT particles carry the protein cargoes in the
anterograde direction, from the base to the distal end of the cilium powered by
the kinesin-2 motor-complex [116]. At the cilium tip kinesin-2 is inactivated
and protein cargoes are released. The IFT particles return to the cilium base
by retrograde IFT powered by dynein-2 [117]. These retrograde particles may
also contain protein cargoes; however, proteins can also be transported out of
the cilium by ectosomes and vesicle shedding [118].
2.6.2 Ciliogenesis
Primary cilia form from the mother centriole in a process termed ciliogenesis.
Due to this, ciliogenesis is intrinsically linked to the cell cycle as centriole
duplication requires resorption of the primary cilia [119]. Cilium formation
occurs several hours after mitosis in vitro and typically occurs in G1/G0 phase
[120,121]. Once cilia form it can take several days before they reach their full
length, after which if cells do not remain quiescent primary cilia are resorbed
upon the cells entering either S-phase or G2/M-phase [104,120,121].
After mitosis the mother centriole migrates from the mitotic spindle and
docks at the actin-rich cell cortex. During migration to the cell cortex the
centriole associates with membrane vesicles and upon docking these vesicles
subsequently fuse to the cell membrane establishing the primary cilia mem-
brane and the basal body [122,123]. The axoneme is formed by nucleation of
axonemal microtubules from the basal body that begin to protrude beneath the
primary cilia membrane extension. The transition zone is the most proximal
region of the cilium and contains the ciliary necklace, which along with the
transition fibres form a functional barrier that separates the ciliary membrane
from the plasma membrane [124]. Protein synthesis does not occur within the
primary cilium itself so all proteins required for elongation of the cilium must
be actively imported and transported to the tip of the cilium [125,126]. This
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process is known as intraflagellar transport (IFT), is bidirectional and involves
the movement of protein complexes along the axoneme via a molecular motor-
driven process. Once the primary cilium is formed there is still continuous
turnover of tubulin at the ciliary tip, with disassembly of microtubules and
new tubulin being incorporated [127]. This continuous turnover is balanced
such that the cilium does not elongate further or shorten.
2.6.3 Primary cilia mediated mechanotransduction
Primary cilia were first noted for their mechanosensitivity in kidney epithelial
cells, where they are thought to act as urine flow sensors [128]. The degree of
cilium bending correlates with the applied fluid shear magnitude similar to a
cantilever beam [128]. This has been mathematically modelled by Schwartz et
al. where it was shown that cilium bending increases strain on the convex side
of the cilium [129]. In renal tubules primary cilia are bent by the flow of urine
and it is theorised that this deflection is detected by a heterodimeric complex
containing polycystin (PC)-1 and PC-2 [114]. However, this is not universally
accepted and others have suggested that PC-1/2 are not activated by cilia de-
flection. Upon deflection the membrane strain causes these mechanosensitive
ion channels to undergo a conformation change allowing the passage of Ca2+
into the cell triggering a local increase in Ca2+ concentration and subsequent
activation of downstream signalling cascades [114,130]. Direct stimulation of
primary cilia by micropipette to induce primary cilia bending has also resulted
in increases in intracellular calcium. This direct stimulation of primary cilia
rather than applying fluid flow to the whole cell removed the influence other
cellular mechanotransducers may have played and verified the role of the
primary cilia.
In addition to their role in kidneys primary cilia have been shown to play
an important role in bone mechanotransduction as well as other tissues. Pri-
mary cilia are present on bone cells both in vivo and in vitro. Furthermore,
primary cilia have been shown to bend in response to sub-physiological flow
in a similar manor to that of kidney cells. Primary cilia are required for
many osteogenic mechanoresponses to occur. When primary cilia are removed
through chloral hydrate treatment, fluid flow induced increases in osteopontin
(OPN) no longer occur. However, these cells are still able to upregulate OPN
expression in response to vitamin D administration. This demonstrated that
removal of primary cilia did not itself inhibit OPN gene expression. Removal
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of primary cilia through either chloral hydrate treatment or small interfering
ribonucleic acid (siRNA) targeting of IFT88 (an IFT protein required for cilio-
genesis) has been shown to abrogate other fluid flow induced responses in bone
cells, including PGE2, matrix mineralisation, cyclooxygenase-2 (COX-2) and
3’,5’-cyclic adenosine monophosphate (cAMP) signalling further demonstrating
the role primary cilia play as a mechanotransducer in bone [131–133].
Although primary cilia act as mechanosensors in multiple tissues, the mecha-
nism by which this occurs has been shown to differ. In kidney cells, primary
cilia bending has been shown to be responsible for Ca2+ signalling responses
[114,130]. In addition to kidney cells this calcium dependent mechanism also
occurs in cholangiocytes in the liver [134]. The influx of extracellular Ca2+
across the cell membrane has been shown to be required for whole cell calcium
signalling to occur. The bending force induced by fluid flow is theorised to
induce conformational changes in PC1, which in turn activates PC2, a Ca2+
channel that forms a complex with PC1 in the primary cilia membrane. The
resulting influx of Ca2+ then triggers intracellular Ca2+ release and subse-
quently various cellular functions, including cell growth, apoptosis and gene
expression. Additionally, after fluid flow is ceased the intracellular tail of PC1
is proteolytically cleaved, where it translocates to the nucleus to function as a
transcription factor [135]. Another Ca2+ channel, transient receptor potential
(TRP)V4 has also been found to be essential in regulating responses to fluid
flow in kidney cells where it co-localizes and interacts with PC2 [136]. However,
a recent paper by Delling et al. found that Ca2+ signalling does not originate
in the primary cilia and that the mechanosensory role primary cilia play, if
any, must be through some other pathway [137]. This has been refuted by
others, where it has been suggested that the contrasting results may be due
to Delling et al. not subjected the cells to long enough stimuli durations that
other groups have required to detect peak calcium flux [138].
Although bone cells show a similar increase in intracellular Ca2+ in response
to fluid flow, this response still occurs in the absence of primary cilia [131].
Furthermore, when Ca2+ channels are inhibited by gadolinium chloride intra-
cellular Ca2+ still increases in response to fluid flow. This demonstrates that
calcium signalling in bone cells is not dependant on the influx of extracellular
Ca2+ as in kidney cells. Other studies have also shown primary cilia mediated
mechanosensing in bone cells is Ca2+ independent [131,139]. An alternative
signalling pathway that has been shown to occur in bone cells upon fluid
flow stimuli is cAMP. Kwon et al. found osteocytes subjected to fluid flow
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showed a decrease in cAMP after 2 min which led to an increase in COX-2
gene expression. This cAMP response to fluid flow has also been shown to be
abrogated through removal of primary cilia, demonstrating cAMP to be cilia
mediated [140]. Furthermore, upon downregulation of adenylyl cyclase (AC)6,
an andenylyl cyclase isoform that has been shown to be specific to primary
cilia, flow mediated cAMP responses have been shown to be disrupted similarly
to if primary cilia are removed altogether [140]. After the initial decrease
in cAMP in response to fluid flow, intracellular cAMP levels then increase [133].
AC is the sole enzyme that synthesizes cAMP from adenosine triphosphate
(ATP) and there are numerous isoforms, many of which have been shown to
localize to the primary cilia microdomain [133,140,141]. Different AC isoforms
can be either inhibited by (AC5 and AC6), stimulated by (AC1, AC3 and AC8) or
insensitive to (AC2, AC4, and AC7) Ca2+ [142]. Most notably, both AC3 - a Ca2+
stimulated isoform and AC6 - a Ca2+ inhibited isoform, localise to the primary
cilia membrane and this may explain the initial decrease and subsequent
increase in cAMP in response to fluid flow. This interplay between Ca2+ and
cAMP signalling in response to fluid flow has been shown to be required for the
initial decrease in cAMP. When Ca2+ channels were blocked with gadolinium
chloride in osteocytes the cAMP decrease was no longer observed. Further-
more, the decrease was shown to be independent of intracellular Ca2+ release,
indicating Ca2+ influx was required to trigger the decrease. The importance of
this interplay between Ca2+ and ACs was further highlighted by Moore et al.
where osteocytes were transfected with AC3/6 and TRPV4 plasmids that do
not interact with Ca2+. Adverse cAMP responses were observed in response to
fluid flow and expression of COX-2 was downregulated [143].
2.6.4 Primary cilia mediated signalling
In addition to their role in mechanotransduction, primary cilia also play an
important role in a number of extracellular signalling pathways. Wnt, hedgehog
and IGF signalling have all been shown to utilise mechanisms involving the
primary cilium.
Insulin like growth factor signalling
IGF-1 is a hormone similar in structure to insulin and has anabolic effects in a
number of tissues including bone [144]. The link between IGF-1 and primary
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cilia was first demonstrated by Zhu et al, in preadipocyte cells, where IGF-1 was
found to play an important role in the induction of adipogenic differentiation
[145]. When primary cilia were removed, cells had reduced sensitivity to
insulin and reduced expression of adipogenic genes. It was also found that a
small fraction of the cellular IGF-1R localised to the primary cilia and it was
proposed that this compartmentalisation enhanced the receptor sensitivity to
insulin. This was similarly found to occur in bone marrow derived stem cells
undergoing adipogenic differentiation [146]. Further research by Wang et al.
suggested IGF-1R signalling relies on the formation of a protein complex at the
base of the cilium [147]. In addition to adipogenic differentiation primary cilia
mediated IGF signalling has been implicated in cell cycle progression [148].
Activation of IGF-1R localised to primary cilia in retinal pigment epithelium
and in fibroblasts accelerates primary cilia resorption and cell cycle progression
from G1 phase to S phase [148].
Hedgehog signalling
The importance of primary cilia in hedgehog signalling was first discovered
through genetic screening in mice that identified genes required for both
primary cilia formation and normal hedgehog signalling [149]. The hedgehog
family of proteins, consisting of Sonic, Desert and Indian in mammals, play
roles in controlling cell growth, survival and fate and in embryonic development
are responsible for patterning tissues [150]. Since the discovery of this link
numerous mutations that result in primary cilia and hedgehog signalling
disruption have been discovered [151]. In the absence of hedgehog, patched-1
is localised to the primary cilium membrane where it suppresses smoothened
activity and excludes it from the cilium (Figure 2.7) [152]. In this inacti-
vated state, Gli is sequestered and suppressed by suppressor of fused (SuFu).
Upon binding of hedgehog patched-1 is internalised and degraded resulting in
translocation of smoothened into the primary cilium and its activation. The
activation of smoothened represses SuFu halting suppression of Gli resulting
in the formation of Gli activator which is transported out of the cilium to the
nucleus where it modifies target gene transcription [153–156]. IFT plays an
important role in the trafficking of these signalling intermediaries into and
out of the cilium [157,158]. Therefore, IFT protein function is also essential
for the correct functioning of hedgehog signalling.
The Primary cilium can act as a positive or negative regulator of the hedgehog
signalling pathway [158,159]. Ciliary defects can have wide ranging effects
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Figure 2.7: A Schematic illustration of Hedgehog signalling. (Left) In
the unstimulated state, patched-1 is localised to the cilium and suppresses
smoothened activity. In this inactive state Gli is sequestered and suppressed by
SuFu. (Right) In the stimulated state, patched-1 is internalised and degraded
resulting in the transolcation of smoothened which in turn suppresses SuFu
halting the suppression of Gli. This results in the formation of Gli activator
which is transported out of the cilium to the nucleus where it can modify target
gene transcription.
including defects in neural tube formation, structural heart defects, polydactyl,
coloboma and lung hypoplasia [149,160–163]. In addition, there is increasing
evidence that cilia-mediated hedgehog signalling may play a role in cancer
progression. In some forms of cancer where hedgehog signalling is upregulated
a large proportion of the cells lack primary cilia compared to the surrounding
normal tissue cells [164]. This can either inhibit or promote cancer progres-
sion dependent upon whether the tumours are driven by activation of Gli or
activation of smoothened [165,166].
Wnt signalling
Wnt signalling consists of two pathways, canonical and non-canonical. Canon-
ical Wnt signalling involves β-catenin and is therefore also referred to as
β-catenin dependant Wnt signalling. Non-canonical Wnt signalling functions
independently of β-catenin and is functionally more complex. It is largely
accepted that the primary cilium plays a role in both of these pathways. How-
ever, some studies have disputed this role in canonical Wnt signalling [164,167].
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The activation of both pathways begins with Wnt binding to Fused (Fzd)
and a co-receptor of Fzd (Figure 2.8) [168,169]. In the case of non-canonical
Wnt signalling this co-receptor is not well-defined, in canonical Wnt signalling
this co-receptor is low-density lipoprotein receptor-related protein (LRP)5/6
[170]. The activation of the Wnt receptor complex leads to interaction of Fzd
with dishevelled (Dsh) in the cytoplasm [171]. It is at this point that Wnt
signalling branches into the distinct canonical or non-canonical pathways.
Figure 2.8: A Schematic illustration of canonical Wnt signalling. (Left) In the
unstimulated state, cytoplasmic β-catenin is targeted for ubiquitination by a
destruction complex. (Right) In the activated state Wnt binds to its receptor
complex, activating Dsh. Axin translocates to the tail of LRP5/6 disrupting
the β-catenin destruction complex through the inhibition of glycogen synthase
kinase 3 β (GSK3-β). This results in the accumulation of stabilised β-catenin
in the cytoplasm, which subsequently translocates to the nucleus where it
functions as a transcriptional co-activator.
In the absence of Wnt signalling, cytoplasmic β-catenin is targeted for ubiqui-
tination by a destruction complex formed of axin, adenomatous polyposis coli
(APC), protein phosphatase 2A (PP2a), GSK3-β and casein kinase 1A (CK1A)
through phosphorylation by GSK3-β and CK1A [172,173]. Upon Wnt binding
to its receptor complex, the activation of Dsh results in the translocation of axin
to the tail of LRP5/6 disrupting the β-catenin destruction complex through
the inhibition of GSK3-β [174, 175]. Due to the inactivation of this complex
β-catenin is no longer targeted for ubiquitination. This results in the accumula-
tion of stabilised β-catenin in the cytoplasm, which subsequently translocates
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to the nucleus where it functions as a transcriptional co-activator [176]. Many
osteogenic genes are targets of β-catenin transcriptional co-activation including
OPG, BMP, COX-2 and activation of canonical Wnt has been reported to result
in increased bone formation [177–180]. In addition, canonical Wnt signalling
suppresses RANKL expression in osteoblasts, this in combination with the
upregulation of OPG can result in decreased osteoclastogenesis and bone
resorption [181].
In non-canonical Wnt signalling the binding of Wnt and recruitment of Dsh
activates Rho and Rac (Figure 2.9). Activation of Rho occurs through com-
plex formation of Dsh with disheveled-associated activator of morphogenesis
(DAAM)1, which subsequently leads to activation of Rho-associated protein
kinase (ROCK), a key regulator of the actin cytoskeleton and its arrangement
[182,183]. Activation of Rac is independent of DAAM1 and results in the acti-
vation of c-Jun N-terminal kinase (JNK) [184]. The activity of Wnt signalling
downstream of JNK is poorly understood but it is thought to also play roles in
cytoskeleton regulation [185].
Figure 2.9: A Schematic illustration of non-canonical Wnt signalling. (Left)
DAAM1 independent non-canonical Wnt signalling through Rac. (Right)
DAAM1 dependent non-canonical Wnt signalling through Rho.
The primary cilium plays an essential role in non-canonical Wnt signalling,
specifically in planar cell polarity as the process is dependent upon migration
of the basal body to the apical surface of the cell [186]. Defects in proteins
regulating the migration of the basal body and ciliogenesis can therefore lead
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to neural tube, inner ear and gastrulation defects. The ciliary protein, inversin
acts as a switch between the two different Wnt signalling cascades [187]. In
the canonical Wnt pathway inversin targets Dsh for degradation, resulting
in reduced disruption of the β-catenin destruction complex, preventing β-
catenin accumulation. The primary cilium can further control Wnt signalling
through jouberin [188]. Jouberin facilitates the translocation of β-catenin into
the nucleus, however upon sequestration of jouberin in the primary cilium
translocation of β-catenin is disrupted and Wnt signalling is inhibited.
2.6.5 Primary cilia length regulation
Primary cilia have a highly conserved basic morphology. However, in vivo
distinct cell types bear cilia with different mean lengths suggesting there is
some biological control of their length [189]. Primary cilia length regulation
has primarily been determined through genetic and human disease studies
that have focused on the molecular components that are required for their
correct formation. These studies have identified the involvement of molecules
that play a role in the levels of soluble tubulin and the organization of the actin
cytoskeleton [190,191]. Regulation of primary cilia length is one mechanism
by which cells can modulate mechanosensitivity and cilia-mediated signalling.
Regulation of cilia length is a dynamic process that is balanced through
the continuous assembly and disassembly of ciliary axonemal subunits at the
ciliary tip [127]. The regulation of cilia length via assembly and disassembly
forms the basis of the "balance-point" model. IFT proteins transport the
required axonemal subunits to the ciliary tip and if this process is "switched
off", it results in a constant rate of resorption of the primary cilia [192]. This
rate of resorption suggests that the disassembly rate of cilia is independent of
their length [127]. In order for cilia to maintain a constant length, the rates
of assembly and disassembly must therefore be equal if the amount of IFT
does not alter [193]. Furthermore, if cilia disassembly is independent of its
length then this suggests the mechanisms involved must act upon the assembly
process of the primary cilium. The actual mechanism by which cilium length is
regulated remains elusive, despite the large and growing list of involved genes
and potential signalling pathways.
The "balance-point" model is likely to be an oversimplification of a more
complex regulation mechanism. In some instances, primary cilia have been
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shown to decrease in length with increases in both anteroegrade and ret-
rograde IFT [194]. This is due to disrupted cargo loading of anterograde
IFT particles resulting in the transportation of cargo-less IFT particles. The
increase in cargo-less particles reaching the ciliary tip results in increased
ciliary disassembly due to greater availability of empty cargo binding sites
for disassembly products. There are therefore at least two mechanisms able
to regulate primary cilia length, IFT velocity and cargo loading of IFT particles.
In addition to genetic defects an increasing amount of evidence has shown
that both chemical and mechanical stimuli can affect the architecture and
length of cilia. Several studies have shown that mechanical stimulation can
cause cilia length to decrease in a variety of different cell types from kidney
cells to osteoblasts [104, 195]. Besschetnova et al. demonstrated that this
decrease in cilia length due to mechanical loading may be due to decreases
in cAMP levels and increases in intracellular Ca2+ acting through a protein
kinase A (PKA))-dependant increase in anterograde IFT [195]. This response
was also shown to be dependent upon PC1 and PC2, two mechanosensitive
proteins present in the ciliary membrane that have been shown to play a
role in mechanosensitivity of many cell types [196–198]. Additionally, it was
also found that cilia elongation could be induced through activation of AC
with forskolin: which subsequently increases cAMP, or inhibition of Ca2+ by
treatment with Gd3+. This response of cilium to cAMP and Ca2+ creates a
negative feedback loop where decreases in cAMP and increases in Ca2+, due
to mechanical stimulation, causes a decrease in cilia length. This decrease
in length has been shown to result in reduced mechanosensitivity, thought
to be due to the decreased lever length [199]. This reduction causes a larger
force to be required to bend the cilia and activate signalling cascades. With the
removal of the stimuli and the return of the pre-stimulated Ca2+ and cAMP
levels, cilia length and mechanosensivity is restored. The theory that cilia
length is regulated by its assembly rate was also supported by the study by
Besschetnova et al, where the anterograde IFT velocity was shown to increase
when the cells were treated with forskolin or Gd3+ treatment without effecting
the retrograde IFT rate [195].
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2.6.6 Chemical and biological manipulation of primary
cilia
Several chemical agents have been shown to alter cilia length which may be
useful in studying the role of cilia, both modelling ciliopathies and studying
their treatments and in beneficially altering mechanoresponses in vivo and in
vitro. Primary cilia can be removed, shortened or lengthened with a variety of
both chemical and biological methods.
For complete cilia removal chloral hydrate is commonly used which acts
by disrupting the cilium-basal body junction and causing microtubule disas-
sembly [200]. However, this chemical has fallen out of use due to its unspecific
effects on the cell cytoskeleton and the introduction of siRNA techniques [131].
siRNA techniques prevent primary cilia from forming through knocking down
genes essential in ciliogenesis. Cells are typically transfected with plasmids
containing siRNA sequences against IFT88 or IFT20 [201,202].
Cilia length can be reduced with the CDK5 inhibitors R-roscovitine or S-
CR8. Both of these chemicals have been shown to result in sustained cilia
length reductions even after their withdrawal in jck mice [203]. The chemicals
were not shown to affect the velocities of either anterograde or retrograde
IFT suggesting CDK5 and its direct target CRMP2 may play a role in cilia
length regulation by altering microtubule dynamics. CRMP2 has been shown
by recent studies to be a critical protein in microtubule assembly, axon and
ultimately primary cilia formation [204].
For cilia elongation, many chemical agents have been shown to be effective.
Fenoldopam, a dopamine D1-like receptor agonist has recently been shown to
elongate primary cilia through an AC-cAMP mechanism [205–207]. Similarly,
forskolin, a commonly used drug used to directly activate AC increasing cAMP,
has also been shown to increase the length of primary cilia. This supports
the previous studies suggesting cAMP levels regulate cilia length. Lithium,
through the use of lithium chloride (LiCl) and other lithium salts, has also
been shown to induce cilia elongation both in vivo and in vitro [208–211]. The
mechanism by which lithium induces cilia elongation is unclear. Nakakura et
al proposed lithium induces cilia elongation through an increase in acetylated
α-tubulin triggered by inhibition of GSK3-β by LiCl [208]. Another study
also showed LiCl inhibition of GSK3-β was involved in cilia elongation and
additionally showed two other GSK3-β inhibitors also induced cilia elongation
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[212]. However, other studies have shown that cilia elongation induced by LiCl
is not dependent on GSK3-β inhibition and that other GSK3-β inhibitors do
not effect cilia length, instead suggesting the increase in cilia length is due
to an inhibition of AC and a reduction of cAMP [209, 210]. This contradicts
the previously mentioned research that increases in cAMP results in cilia
elongation. The interaction between AC, cAMP and cilia length is clearly
complex and these conflicting results highlight the potential of other feedback
mechanisms that may play a role in cilia length regulation. Clearly further
research in this area is required to pinpoint the mechanisms behind cilium
length regulation.
2.6.7 Lithium
Lithium salts including lithium chloride have been used to treat bipolar disor-
der since the 1970s where they have been shown to reduce suicidal tendencies
[213]. The therapeutic range of lithium has been shown to be narrow with
therapeutic serum concentrations typically between 0.8-1.2mM, with mild
toxicity presenting in humans at levels between 1.5-2.5mM and moderate to
severe symptoms presenting at serum concentrations greater than 2.5mM
with continuous treatment [214,215].
Lithium’s pharmacological actions are caused by the inhibition of magne-
sium dependent enzymes due to competition from lithium ions [216]. Lithium
and magnesium have similar ionic radii and ionic potentials allowing them
to compete for the same binding sites on biomolecules. Due to this lithium
affects the activity of many enzymes and therefore pathways within cells. This
includes muscarinic and β-adrenergic receptor coupling to G proteins, inositol
monophosphatase (IMPase), AC, bisphosphate 3-prime-nucleotidase and GSK3-
β [217–221]. Many of these enzymes are themselves involved in a large range of
biological processes and pathways, for example GSK3-β alone has a predicted
256 proteins that it directly interacts with [222]. The three main enzymes that
have been studied with regards to lithium’s affects are IMPase, GSK3-β and AC.
GSK3-β can be inhibited by lithium in a number of ways, the first is through
direct inhibition through competing with magnesium, secondly through in-
creasing its inhibitory phosphorylation and finally through inhibiting its
transcription (Figure 2.10) [223,224]. The exact mechanism by which lithium
promotes the phosphorylation of GSK3-β is not fully understood. However,
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activation of phosphoinositide 3-kinase (PI3K) and inhibition of PP2a, an
enzyme that dephosphorylates both GSK3-β and protein kinase B (Akt) (which
in turn phosphorylates GSK3-β), are known to be involved. Inhibition of
GSK3-β by lithium activates pathways that would be inhibited by its activity.
One major pathway that GSK3-β is involved in is Wnt signalling, where it
marks β-catenin for ubiquitination. Lithium inhibits this activity resulting in
the accumulation of β-catenin, effectively mimicking Wnt signalling [225].
Lithium directly inhibits IMPase through competing with magnesium for
at least two binding sites. In addition to IMPase, lithium inhibits another
enzyme involved in the inositol phosphate signalling pathway, inositol polyphos-
phate 1-phosphatase (IPP) by direct competition with magnesium (Figure 2.10).
The inhibition of these enzymes results in the depletion of inositol and subse-
quent reduction in Phosphatidylinositol 4,5-bisphosphate (PIP2) and inositol
1,4,5-trisphosphate (IP3) [226]. IP3 is a second messenger that binds to re-
ceptors on the endoplasmic reticulum, inducing the release of internal Ca2+
stores which activates downstream Ca2+ dependent kinases, such as protein
kinase (PK)C. In osteoblasts PKC can enhance proliferation and suppress
differentiation, although this pathway is also regulated by Wnt signalling [227].
The effect lithium has on proliferation and differentiation in bone cells may
therefore depend on the degree of IP3 inhibition and Wnt signalling activation.
Lithium directly inhibits AC through competing with magnesium on the
magnesium binding site on AC itself or on the G-protein which activates it
(Figure 2.10) [219]. cAMP is a ubiquitous second messenger that is synthesised
by AC, the inhibition of AC by lithium therefore reduces cAMP levels. cAMP
activates PKA which regulates the activity of a multitude of enzymes through
phosphorylation [228]. In addition, PKA regulates gene transcription through
phosphorylation of the transcription factor cAMP response element-binding
protein (CREB) [229]. Genes that are upregulated by CREB contain a cAMP
response element (CRE) in the promoter region of the gene. In bone BMP2,
a gene which is important in osteoblast differentiation and bone formation,
contains a CRE in its promoter region and is known to be stimulated by CREB
[230].
Lithium’s effects on osteogenesis and mechanosensitivity
As previously mentioned, lithium treatment has been shown to increase cilium
length in tissues in vivo, but it has also been shown to increase bone mineral
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Figure 2.10: ASchematic illustration of lithium responsive signal transduction
pathways.
density in patients treated with lithium for psychiatric disorders [231]. In
vivo studies have shown GSK3-β inhibition causes increases in osteogenesis
and reduced bone turnover [232–234]. Since inhibition of GSK3-β upregulates
Wnt/β-catenin signalling, which is a well-known regulator of bone metabolism,
it is not surprising that lithium treatment increases bone formation [225].
However, it is not known if this is the whole story, if cilia elongation is linked
to GSK3-β inhibition, this increase in osteogenesis may also be linked to the
increase in cilia length and a subsequent increase in mechanosensitivity in
bone cells. Cilia length has been shown to effect mechanosensitivity with
increases in length showing increases in mechanosensitivity and vice versa.
A study by Spasic et al has shown increases in osteogenic gene expression in
mechanically stimulated, LiCl treated cells compared to only mechanically
stimulated cells [205]. Therefore, it is possible the increase in bone production
found with lithium treatment may be due to both direct inhibition of GSK3-β
and an increase in mechanosensitivity due to cilia elongation.
2.7 In vitro mechanical stimulation
Bone cells have been shown to be responsive to a number of different mechanical
stimuli in vitro. A great deal of research has looked at various loading durations,
magnitudes and frequencies yet an optimum loading stimulus is still unknown.
In in vitro culture the use of fluid flow induced shear stress is a popular method
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and more recently the use of magnetic particles attached to various elements
of the cell have seen increased use. Both of these methods can be used to
apply stimuli to cells in a controlled manner. Fluid flow induced shear stress is
thought to be a major influencing stimulus experienced by bone cells in vivo,
caused by the interstitial fluid flow through the lacunocanalicular network.
To apply shear stress to cells in vitro a number of methods can be employed.
The simplest systems include orbital shakers and rocking "see-saw" platforms
with slightly more complex systems such as parallel plate flow chambers also
being commonly used. For three-dimensional (3D) culture a range of different
bioreactors can be employed to apply fluid shear.
2.7.1 Parallel-plate flow chamber
Parallel plate flow chambers can be built in-house out of glass slides and
polydimethylsiloxane (PDMS) or can be obtained from a range of manufactur-
ers. Parallel plate flow chambers apply well-defined, uniform and predictable
laminar flow allowing modelling of the shear forces experienced by the cells.
This flow can also be oscillatory, pulsatile or unidirectional [235–237]. Oscil-
latory flow is often used as it is thought to be more representative of the in
vitro environment. Shear stress can be applied at a physiologically relevant
range of 0.001-3Pa [238]. Due to the pump driven nature of parallel plate flow
chambers, in addition to fluid shear hydrostatic pressure is also applied to the
cells within the chamber. This can be reduced through the use of "push-pull"
pump systems to reduce the pressure build-up within the device.
The culture surface of the chamber can be modified with micro-patterning to
modify cell attachment and alter their morphology. For example, an osteocyte
network in a parallel plate flow chamber was built by Lu et al. through modify-
ing the surface chemistry of the chamber and applying micro-contact printing
[237]. This technique could therefore be useful for investigating signalling in
osteocyte networks in response to various fluid flow regimes.
Imaging of cells within parallel plate flow chambers can be performed in
situ during the application of flow. This has made them a popular choice
for studying cell signalling in response to fluid flow applications. Typically,
other short term responses can also be analysed, such as gene expression and
cytokine release. However, parallel plate flow chambers are rarely used in
longer term experiments that may look at matrix deposition. This is due to
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common problems such as bubble formation in the channels and blocking of
the channels with deposited extracellular matrix.
2.7.2 Rocking platforms and orbital shakers
Orbital shakers and rocking platforms produce a less well-defined fluid flow
which can be unidirectional or oscillatory for orbital shakers and only oscillatory
for rocker platforms. The simplicity, high throughput of samples and ability to
culture for longer time periods compared to parallel plate flow chambers makes
them a favourable method for long-term responses to fluid flow stimulation.
Although the fluid flow is less well-defined in rocker platforms the shear stress
induced by rocking has been modelled through the use of a lubrication-based
model [83]. This has been further characterised with a finite element model
which was validated with PIV measurements [239]. Both see-saw and orbital
shakers are only able to create low magnitudes of fluid shear stress (FSS)
(<1Pa). The FSS magnitude is also not even throughout the surface of the well
plate. In both systems FSS is higher at the edge of the well plate compared to
the centre.
Despite the low magnitude FSS that can be applied, studies implement-
ing these methods have found osteogenic cells do respond to these low levels.
Delaine-Smith et al. found osteogenic progenitor cells subjected to rocking
increased ALP activity and matrix mineralisation [240]. Lim et al. found
osteogenic progenitor cells subjected to orbital shaking increased matrix min-
eralisation [241]. Well plate stimulation methods have also been used to create
conditioned media from stimulated cells which can be applied to separate cells
to investigate the osteogenic effects of factors released in response to loading
[242].
2.7.3 Magnetic bead stimulation
Techniques that allow forces to be directly transmitted to cells and even di-
rectly to specific regions of individual cells are another method used for the
stimulation of cells. One such method to achieve this direct manipulation of
cells is through the use of magnetic particles and magnetic field bioreactors.
The magnetic particles can be attached to regions of cells and by altering a
magnetic field the particles can be manipulated to stimulate the cells. Previous
studies have shown that using magnetic particles to directly manipulate inte-
35
Chapter 2. Background
grin receptors results in a range of responses in osteoblasts, including changes
in MAP kinase activity and increases in intracellular calcium [243,244]. Typi-
cally, these studies have focused on short term culture due to internalisation
of particles. However, this internalisation of particles does not produce any
measurable toxicity with the use of coated particles [245]. Magnetite (iron
oxide) is typically used as the base for magnetic particles and it is known to
naturally occur in a number of regions within the human body [246]. Com-
monly coatings of dextran or polyethylene glycol (PEG) are also applied as they
have been shown to reduce possible cytotoxic effects of nano sized particles
[247]. This biocompatibility of coated magnetic particles has resulted in their
approval for human clinical use. Therefore, it is clear that magnetic particles
can be used for longer culture periods. Indeed, a study conducted by Cartmell
et al. has shown that mechanical stimulation of osteoblasts with RGD coated
magnetic particles is possible for extended periods of time and that this stimu-
lation increases mineralisation [248]. In addition to dextran and PEG coatings
magnetic particles can also be functionalised with proteins or peptides to allow
specific targeting of the particles to regions of the cell such as integrins or ion
channels, where this targeted stimulation has been shown to stimulate bone
cells [249].
2.7.4 Perfusion flow bioreactors
For applying FSS to cells in a 3D environment basic apparatus such as placing
scaffolds in a well plate on an orbital shaker or rocking platform or placing
scaffolds inside a spinner flask are commonly used. However, the FSS that this
applies is not defined and may only be applied to the surface of the scaffold [250].
Therefore, perfusion flow bioreactors are more commonly used. Perfusion flow
bioreactors force fluid through the entire scaffold giving a more homogeneous
microenvironment throughout the scaffold. Approximations of shear stress
magnitude within the scaffold can be made through the use of cylindrical
pore models. For this porosity of the scaffold must be known and all pores
are assumed to be the same size and cylindrical. This model is therefore an
oversimplification for the majority of scaffold designs and alternative methods
of estimate FSS should be employed such as through computational modelling.
Similarly to parallel plate flow chambers, perfusion flow bioreactors also
apply hydrostatic pressure to the cells, which again can be reduced through,
push-pull designs. The fluid flow within the scaffold also causes it to deform,
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resulting in scaffold strain which can be detected by cells on the scaffold. In
addition, FSS forces can also be transmitted to deposited matrix within the
scaffold resulting in matrix stain. Furthermore, the deformation of the scaffold
itself can also cause fluid flow itself. This is similar to how interstitial fluid
flow is caused by bone deformation in vivo. Clearly the mechanical microenvi-
ronment within scaffolds is more complex than the mechanical environment in
monolayer culture.
2.8 Bone tissue engineering
Large bone defects that will not heal without interventions are known as
critical-sized bone defects. Critical-sized bone defects can be caused by com-
minuted fractures and bone tumour resection and require bone grafts to fill
the defects and facilitate bone healing. Bone is the second most transplanted
tissue after blood with an estimated 2.2 million grafts performed each year
[251]. Autologous bone grafts can be taken from the metaphysis adjacent to
the reconstruction site or when larger grafts are required, from the iliac crest.
Autologous bone grafts contain native cells and growth factors and therefore
result in osteogenic, osteoinductive and angiogenic grafts that promote bone
healing upon implantation [252,253]. However autologous grafts can result in
donor site morbidity and prolonged pain for the patient and are also limited
by the amount of tissue that can be harvested. Alternatively, allogeneic bone
can be used from other human donors after decellularisation of the donor
bone. Allografts allow larger defects to be filled and tissue is more readily
available. However, due to the decellularisation, homologous bone grafts do
not vascularise as well as autologous grafts and therefore the bone defect often
takes longer to heal [254]. Additionally, disease transmission and immune
rejection are also a concern. Another alternative is the use of xenogeneic grafts
from bone harvested from another species. Xenografts are processed similarly
to allografts and therefore have the same advantages and disadvantages,
although immune responses can be more severe in xenografts [255].
None of the currently used bone grafts are ideal and have drawbacks in
terms of osteogenic and angiogenic potentials, donor site morbidity, size and
shape restrictions, patient safety, availability, shelf life and cost. Bone tissue
engineering is an emerging field that aims to create bone grafts with more
beneficial characteristics that address these limitations. The basic concept of
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bone tissue engineering involves the harvest of cells from a patient which are
then expanded, seeded onto a scaffold and implanted into the defect site where
they are resorbed over time [256].
Scaffolds used in bone tissue engineering can be formed of biological ma-
terials such as collagen or chitosan or synthetic materials such as ceramics,
metals and polymers [257]. Ceramics and metals have high mechanical
strength and both have been shown to be osteoinductive through their use in
dental and orthopaedic applications. However, ceramics can be vulnerable to
fracture and neither material is biodegradable. Furthermore, due to their
higher stiffness compared to bone they can result in poor osseointegration
with the surrounding bone. Polymers used in bone tissue engineering can
be synthetic or natural and biodegradable or non-biodegradable. Synthetic
polymers typically used include polylactic acid (PLA), polycaprolactone (PCL),
polyurethane (PU) and polyglycolide (PGA) [257]. Natural polymers include
proteins such as collagen, silk and keratin and polysaccharides such as chitin
and cellulose. Collagen scaffolds tend to have excellent osseoinduction and
osseointegration due to being a natural component of bone matrix. Despite this,
collagen scaffolds provide poor structural support and this typically applies
to other polymers that can be employed. To tailor mechanical properties and
biological activity these materials can be combined into composites of different
polymers or polymer/ceramic/metal.
Different cell types can be used for bone tissue engineering. Bone marrow
or adipose derived stem cells are one option. These stem cells are able to
differentiate into osteogenic, chondrogenic or adipogenic lineage cells [258].
The lineage to which the cells differentiate can be controlled through biochem-
ical or physical cues or a combination of the two [259–261]. Since the cells
are derived from the patient’s own cells there are no issues with immune
rejection as with autografts. Additionally, the harvest of bone marrow or
adipose derived stem cells results in less donor site morbidity than the harvest
of bone for an autograft. Despite these positives, currently this approach would
necessitate two operations, one to harvest the cells and one to implant the
tissue engineered construct. Additionally, the cell expansion process is time
consuming and expensive. This may improve in the future with cell banks and
improvements in culture methods and automated cell culture.
Scaffolds can be seeded with cells and directly implanted or can be initially
cultured in vitro to allow time for cells to deposit matrix onto the scaffold before
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implantation. In monolayer culture cells are typically cultured statically with
no issues of nutrient or oxygen availability. However, in tissue engineered
constructs nutrient and oxygen availability can become an issue in larger
scaffolds and can result in necrosis at the core of the scaffold [262]. To overcome
this, bioreactors that introduce some form of fluid flow can be employed. Biore-
actors can range in complexity from a basic culture vessel placed on an orbital
shaker, to bespoke perfusion flow systems and even bioreactors that apply
mechanical loading to the scaffolds [263]. In addition to the increased mass
transport provided by dynamic culture the fluid flow itself can be implemented
in other useful ways. Cell seeding can be improved through dynamic seeding,
improving the distribution of cells throughout the scaffold. Additionally, the
fluid shear stress created can mechanically stimulate the cells in a similar
manner to the interstitial fluid flow within bone itself. The combination of fluid
shear and increased mass transport can therefore improve cell distribution,
proliferation, differentiation and matrix deposition [264–266]. Perfusion flow
systems typically perform better than other bioreactor systems in terms of cell
distribution, growth and matrix deposition [263]. However, there is currently
no consensus on the optimal culture and flow regime to be employed, for exam-
ple flow duration and magnitude. To optimise bioreactor culture for bone tissue
engineering, bioreactor designs that allow for higher throughput and evenly
distribute flow throughout scaffolds are needed. Additionally, knowledge in
the area of bone mechanotransduction may help to design and improve flow
regimes and subsequent cellular responses in bioreactors used for bone tissue
engineering.
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3. Project aims and objectives
The overall aim of the work presented in this thesis was to investigate the
effects of lithium chloride on primary cilia length and prevalence, osteogenesis
and mechanostimulated osteogenic responses in osteogenic progenitor and
osteoblast cells. It was hypothesised that lithium chloride would enhance
mechanosensitivity and therefore result in enhanced osteogenic responses to
fluid shear stress. In order to achieve this aim, the project was divided into the
following objectives:
1. Investigate the effects of lithium chloride on osteogenesis and primary
cilia length and prevalence.
2. Develop a protocol to mechanically stimulate cells with fluid shear stress
that induces osteogenic responses.
3. Measure the osteogenic responses to fluid shear stress when cells have
been treated with lithium chloride compared to untreated controls.
4. Measure cAMP and Ca2+ responses to fluid shear when cells have been
treated with lithium chloride.
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4. Materials and methods
4.1 Materials
All reagents were purchased from Sigma-Aldrich (UK) unless otherwise stated.
Tissue culture plastic was purchased from Thermo Fischer Scientific (UK).
4.2 Methods
The plate reader used in all measurements was a Tecan Infinite® 200 PRO
4.2.1 Cell lines
hES-MP 002.5
Human embryonic stem-cell derived mesenchymal progenitors 002.5 (hES-
MP) cells were purchased from Cellartis (Sweden). They are a multi-potent
mesenchymal progenitor cell line derived from Cellartis’ SA002.5 embryonic
stem cell line. They are able to differentiate into several mesodermal lineages
including osteogenic lineages. They have a high resemblance to adult human
mesenchymal stem cells.
MC3T3-E1
Mouse calvaria 3T3 clone-E1 (MC3T3-E1) cells are a clonal osteoblast pre-
cursor cell line established from new-born C57BL/6 mice using standard 3T3
passaging [267]. However, although originally established as a clonal cell line,
prolonged passaging resulted in a phenotypically heterogeneous population.
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In 1999 Wang et al. isolated 52 subclones from this heterogeneous population
and selected 10 of these based on their ability to produce or not produce min-
eralised matrix [268]. Although having been used extensively, the subclone
used in studies is commonly not reported giving no indication of whether a
phenotypically heterogeneous population was used or a subclone. Differences
between findings using MC3T3-E1s may therefore, be due to differences in the
populations used. The MC3T3-E1s used here were subclone 4, which exhibit
high levels of mineralised matrix production.
MLO-A5
Murine long bone osteocyte A5 (MLO-A5) cells are a post-osteoblast/pre-
osteocyte cell line established from osteocalcin promotor-driven immortalizing
T-antigen transgenic mice [269]. They rapidly produce sheets of mineralised
extracellular matrix and express high levels of alkaline phosphatase (ALP),
osteocain (OCN) and bone sialoprotein (BSP), typical of the post-osteoblast
phenotype [270].
4.2.2 Culture media preparation
The media composition used for each cell line is presented in Section 4.1. All me-
dia used were based on basal media (BM) which was the simplest formulation
used. BM consisted of α-minimum essential medium (α-MEM) (Lonza, UK)
with 10 vol/vol% fetal bovine serum (FBS), 100Uml−1 penicillin, 100µgml−1
and 2mM L-glutamine. Cells were passaged in their respective expansion me-
dia (EM), which was BM supplemented with human basic fibroblastic growth
factor (hFGF) for hES-MPs and BM for all other cell lines used. Media used to
promote osteogenic matrix formation is referred to as either supplemented me-
dia (SM) or osteogenesis induction media (OIM). Both of these media contained
ascorbic acid 2-phosphate (AA-2P) and β-glycerophosphate (BGP), however,
OIM contained dexamethasone (Dex), a corticosteroid, to stimulate osteogenic
differentiation.
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Table 4.1: Media compositions used for each cell line
Cell Line Media Type hFGF AA-2P BGP Dex
hES-MP
MLO-A5
MC3T3-E1
BM 0 0 0 0
hES-MP EM 4 0 0 0
MLO-A5
MC3T3-E1
EM 0 0 0 0
hES-MP OIM 0 50 5 100
MC3T3-E1 OIM 0 50 5 10
hES-MP
MLO-A5
SM 0 50 5 0
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4.2.3 General cell culture
All cells were cultured following aseptic technique and incubated in a humidified
5% carbon dioxide (CO2) environment at 37 ◦C.
Passaging of cells
Cells were rinsed with Dulbeco’s phosphate buffered saline (PBS) twice before
adding 1ml of trypsin-ethylenediaminetetraacetic acid (EDTA) per 25 cm3 of
flask area. Flasks were then incubated for 5min at 37 ◦C to detach the cells.
The flasks were checked under the microscope to ensure the cells had detached
and the trypsin was inhibited by adding 2ml of BM per 1ml of trypsin-EDTA.
This solution was then centrifuged for 5min at 200 × g. The supernatant was
removed and the cell pellet re-suspended in a known volume of BM. A known
volume of the cell suspension was mixed with a known volume of Trypan Blue®,
placed in a haemocytometer and live cells counted. At this point cells were
either cryopreserved, passaged into new flasks at a density of 6,600 cells cm−3
or used in experiments.
Cryopreservation of cells
After cells were detached and counted, they were adjusted to 1× 106 cellsml−1
in freezing medium (10 vol/vol% dimethyl sulfoxide (DMSO) in FBS). The cells
were aliquoted into 1ml cryo vials and frozen at a rate of −1 ◦Cmin−1 in an
isopropanol jacketed freezing container in a −80 ◦C freezer. Once frozen the
cells were transferred to liquid nitrogen for long term storage.
Cells were thawed by warming briefly in a water bath before immediately
transferring the defrosted cells into 10ml of BM and centrifuging at 200 × g
for 5min. The supernatant was removed and the cells re-suspended in BM and
transferred into new flasks at 6,600 cells cm−3.
4.2.4 3D Culture
Polyurethane scaffold preparation
Polyurethane (PU) foam (Caligen Foam Ltd) was cut into 4 mm × 5 mm (di-
ameter × height) cylinders using a biopsy punch to create a long cylinder and
cutting to the correct length with a scalpel. The cut scaffolds were submerged in
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a 0.1 w/v% gelatin solution and autoclaved at 121◦C for 30 minutes to sterilise
the scaffolds and coat the surface with gelatin.
Polyurethane scaffold seeding
Prior to seeding, the gelatin was aspirated from the polyurethane (PU) scaffolds
before soaking them in BM for 1 hour. To seed the scaffolds, the BM was
aspirated and 20µL of seeding suspension was distributed throughout the
scaffold. 1,200 cellsmm−3 and 600 cellsmm−3 were seeded per scaffold for hES-
MPs and MLO-A5s respectively. Cells were left to attach for 1 hour before
submerging in BM. The following day, scaffolds were transferred to new well
plates with serum free media with the relevant supplements for or each cell
type. Media was changed every 2-3 days.
4.2.5 Resazurin reduction assay
Cell viability was assessed by measuring the metabolic activity of cells through
the use of resazurin reduction (RR) assays. Metabolically active cells reduce
the weakly fluorescent resazurin sodium salt to the highly orange fluorescent
resorufin. The intensity of the fluorescence therefore correlates with metabolic
activity [271].
The stock solution (1mM resazurin sodium salt in deionized water (diH2O))
was diluted to make a 0.1mM working solutions (10 vol/vol% resazurin stock
solution in BM). Media was removed from the wells and replaced with a known
volume of the resazurin working solution and incubated for 4 h. When perform-
ing a RR on scaffolds the scaffolds were first transferred to new well plates
to ensure only the metabolic activity of cells attached to the scaffolds were
measured. After 4 h, 200µl was transferred in triplicate to a 96-well plate and
read on a plate reader at λex: 540nm and λem: 590nm. Wells or scaffolds were
then washed twice with PBS and fresh media added.
4.2.6 Prostaglandin E2 quantification
Prostaglandin E2 (PGE2) is a lipid metabolite derived from arachidonic acid
through cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) activity. It
plays an important role in regulating bone metabolism, although its mode of
action and whether it is primarily an anabolic or catabolic stimulant of bone
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metabolism is still widely debated. However, PGE2 has been shown to be essen-
tial in early responses to mechanical stimulation in vivo, where its inhibition
at the time of mechanical stimulation prevents osteogenic responses [272].
in vitro, PGE2 is released into the culture medium in response to mechanical
stimulation. Therefore, to measure the amount of PGE2 released in response
to mechanical stimulation an enzyme-linked immunosorbent assay (ELISA)
was performed on cell culture supernatants. Media was changed 1h before me-
chanical stimulation and 2h after stimulation the culture media supernatant
was taken and centrifuged at 200 × g to remove particulates. A commercially
available PGE2 ELISA kit (R&D systems, UK) was used following the man-
ufacturer’s instructions. The optical density of each well was measured at
λabs: 450nm. The absorbance at 570nm was subtracted from the absorbance
at 450nm to correct for optical aberrations in the plate. To determine the
concentration of PGE2 in the samples, a four-parameter logistic curve, fit to
the absorbance of the known standards was used.
4.2.7 Cell digestion
Cells were digested to produce lysates for ALP activity and deoxyribonucleic acid
(DNA) assays. Media was removed from wells and washed twice with PBS. Cell
digestion buffer (CDB) was made by diluting cell assay buffer (CAB) (1.5M Tris-
HCL, 1mM ZnCl2 and 1mM MgCl2 in diH2O) in diH2O (10 vol/vol%) and
adding 1 vol/vol% Triton-X100. In two-dimensional (2D) culture 1ml CDB
was added to each well followed by 30min incubation. In three-dimensional
(3D) culture the scaffolds were transferred to 1.5ml tubes and 1ml of CDB
added followed by 30min incubation. The well plates or tubes were then freeze-
thawed three times (−80 ◦C 10min, 37 ◦C 15min). After the last thaw, wells
were scraped and the lysates transferred to 1.5ml tubes. All samples were
vortexed and then centrifuged at 6700 × g for 5 minutes to remove cell debris.
If not used immediately, samples were stored at −80 ◦C.
4.2.8 Alkaline phosphatase activity
ALP is an enzyme synthesised by a range of cells within the body including
those of an osteogenic lineage. ALP catalyses the hydrolysis of phosphomo-
noesters, releasing inorganic phosphate [273]. Although its precise function
in bone formation is unknown, it is thought to be involved in the early stages
of osteogenesis. Due to this, it is widely used as an early marker of osteogene-
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sis. To measure ALP activity a Pierce™ para-nitrophenol phosphate (pNPP)
substrate kit (Thermo Scientific, UK) was used. One 5mg pNPP tablet was
dissolved per 5mL of diethanolamine buffer (20 vol/vol% in diH2O) to form the
substrate solution. 20µl of cell lysate (Section 4.2.7) was added to a 96-well
plate in triplicate. 180µl of the substrate solution was added and the optical
density of each well was measured at λabs: 405nm once a minute for 30min at
25 ◦C. The molar absorption coefficient was calculated from a standard curve
of known concentrations of para-nitrophenol (pNP) using the Lambert-Beer
law. ALP activity, expressed as nmol pNP min–1 was calculated from the molar
absorption coefficient.
4.2.9 DNA quantification
DNAwas quantified from the same cell lysates as used in the ALP activity assay.
This allowed the ALP activity to be normalised to the amount of DNA in each
sample. A Quant-iT® high sensitivity double-stranded deoxyribonucleic acid
(dsDNA) assay kit was used to quantify the amount of DNA in each cell lysate.
10µL of the cell lysate was added in triplicate to a 96-well plate. The Quant-iT®
reagent was diluted in the Quant-iT® assay buffer (0.5 vol/vol%) and 90µl of
this solution was then added to each well. The plate was incubated for 10min at
room temperature to allow the reagent and DNA to conjugate. The fluorescence
was measured using a plate reader at λex: 485nm and λem: 535nm.
4.2.10 Cell fixation
To fix samples for antibody, alizarin red S (ARS) and direct red 80 (DR80)
staining media was removed from each well followed by two washes in PBS.
The samples were then submerged in 3.7 vol/vol% formaldehyde for 20min in
2D and 30min in 3D. The formaldehyde was removed and the samples washed
twice in PBS and used immediately or submerged in PBS for short term storage
at 5 ◦C.
4.2.11 Alizarin red S staining
ARS is commonly used to stain calcium in biological samples by forming a
non-water-soluble ARS-calcium complex salt [274, 275]. ARS staining was
therefore used to measure the amount of mineralised matrix produced by the
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cells. ARS was dissolved in diH2O at 1 weight/vol% and buffered to pH 4.1
with 0.1M ammonium hydroxide. The buffered ARS solution was then filtered
through a 0.45µm filter to remove any undissolved particles. The PBS was
removed from the fixed samples followed by two washes in diH2O. The samples
were submerged in ARS solution and left for 30min for the ARS to form water
insoluble ARS-calcium complex. The stain was removed and the samples
washed with gently running diH2O until the water remained clear to remove
excess ARS that had not formed complexes. 1mL of 5 vol/vol% perchloric acid
was then added followed by 15min of orbital shaking at 100 revolutions per
minute (RPM) to destain the ARS from the ARS-calcium complexes. 150µL
of the destained sample solution was added in triplicate to a 96-well plate
and the optical density was measured at λ(abs): 405nm in a plate reader. The
concentration of ARS was calculated from a standard curve fit to the absorbance
of known concentrations of serially diluted ARS in destain solution.
4.2.12 Direct red 80 staining
Direct red 80 (DR80), commonly referred to as Sirius Red, is a sulphonated
strongly acidic azo dye. It binds to collagen through strong interactions of
its acidic sulphonic groups with the basic amino acids of collagen molecules
[276,277]. DR80 staining was therefore performed to measure the amount of
collagen produced by the cells. DR80 was dissolved in saturated picric acid
(1 weight/vol%) and filtered through a 0.45µm filter to remove any undissolved
particles. The PBS was removed from the previously fixed samples followed by
two washes in diH2O. The samples were submerged in DR80 solution and left
for 30min. The stain was removed and the samples rinsed with gently running
diH2O until the water remained clear to remove any remaining unbound DR80.
A destain solution was made by mixing 0.2M sodium hydroxide and methanol
in equal volumes. 1ml of the destain solution was then added followed by
15min of orbital shaking at 100 RPM. 150µL of the destained sample solution
was added in triplicate to a 96-well plate and the optical density was measured
at λ(abs): 405nm in a plate reader. The concentration of DR80 was calculated
from a standard curve fit to the absorbance of known concentrations of serially
diluted DR80 in destain solution.
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4.2.13 Fluorescence microscopy staining
To image primary cilia and cell nuclei, antibody staining and 4’, 6-diamidino-2-
phenylindole dihydrochloride (DAPI) stainingwas performed. PBSwas removed
from previously fixed samples and samples were submerged in 0.1 vol/vol%
Triton X-100 for 10min to permeabilise the cells. The samples were washed
twice with PBS and a blocking solution of 5 vol/vol% goat serum in dulbeco’s
phosphate buffered saline with 0.1 vol/vol% TWEEN® 20 (PBST) applied for 1 h
at room temperature to block non-specific binding of the antibodies, followed by
two washes in PBS. Between each of the following steps 3 PBS washes of 5min
each were performed. All antibodies were diluted in PBST with 5 vol/vol% goat
serum to reduce non-specific protein-protein interactions. 1µgmL−1 of anti-
acetylated α-tubulin clone 6-11B-1 produced in mouse (Sigma Aldrich - T7451,
UK) was applied for 24h at 5 ◦C. Goat anti-mouse immunogloblin G (IgG) heavy
and light chain (H&L) conjugated to Alexa Fluor® 488(Abcam - ab150113, UK)
was applied for 1h at room temperature. Finally, DAPI (1µgmL−1 in PBST
only) was applied for 15min at room temperature. Once stained samples were
imaged using either a Nikon Eclipse Ti microscope (Nikon Instruments Europe
BV, Netherlands) a Zeiss LSM510 Meta confocal microscope (Carl Zeiss AG,
Germany) or a Zeiss Z.1 light-sheet microscope (Carl Zeiss AG, Germany).
4.2.14 Light-sheet microscopy
Light-sheet imaging was performed using a Zeiss Z.1 light-sheet microscope
(Carl Zeiss AG, Germany). Samples were mounted in 0.8 vol/vol% agarose in
diH2O inside a 1mL syringe. To mount the samples, agarose was heated to
70◦C in a heating block to melt it. The end of a syringe was removed by cutting
it with a scalpel. The melted agarose was aspirated into the syringe and the
sample to be mounted placed within the syringe in the agarose. Once the
agarose had cooled the syringe was placed in the accompanied syringe holder
and inserted into the sample chamber filled with diH2O. The samples were
positioned and focused using the infra-red camera. Samples were illuminated
via two 10×/0.2 objectives (Carl Zeiss AG, Germany) positioned perpendicu-
lar to a W Plan-Apochromat 20×/1.0 UV-VIS detection objective (Carl Zeiss
AG, Germany) as shown in Figure 4.1. 405nm (20mW), 488nm (50mW) and
561nm (20mW) lasers were used to excite the samples for fluorescence imaging
at blue, green and red wavelengths respectively. Samples could be moved in
the x, y and z-axis and rotated around the centre of the field of view or around
the central drive axis. For the 20×/1.0 objective images were acquired at a
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pixel resolution of 92 × 92nm and a z step-size of 385nm.
4.2.15 Statistical analysis
All statistical analysis was performed using Graphpad Prism v7.0. Datasets
were tested for normality (D’Agostini-Pearson omnibus normality test) and
normally distributed datasets were analysed with either a student’s t-test for
comparing two populations, or for comparing more than two populations, by
a one or two-way analysis of variance (ANOVA) followed by Tukey’s post-hoc
multiple comparisons, depending on whether a response was affected by one
or two factors. Datasets that were not normally distributed were analysed by
a Mann-Whitney test for the comparison of two populations, or by a Kruskal-
Wallis test followed by Dunn’s multiple comparison test for the comparison
of more than two populations. Differences were considered significant when
p<0.05 with notable significant differences indicated on graphs by *. Unless
otherwise stated in the figure legend graphs are presented as mean ± standard
deviation (SD). Experiments were repeated three times in triplicate for each
condition unless stated otherwise in the figure legend where the total number
of replicates (n) is stated.
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A
B
Figure 4.1: (A) Illustration of light-sheet microscope set-up showing the illumi-
nation objectives, detection objective and a PU scaffold embedded in an agarose
gel held in a 1mL syringe. (B) Top view of the planar illumination light-sheet
illustrating the most tightly focused midpoint thickness of the light-sheet which
becomes less tightly focused moving away from this central point.
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5. Lithium accelerates osteogene-
sis and elongates primary cilia
5.1 Introduction
Lithium is most commonly used in the treatment of psychiatric disorders such
as bipolar disorder, due to its mood stabilising and neuroprotective effects
[278–280]. It is commonly administered as a salt such as lithium carbonate
lithium orotate or lithium chloride. A number of case-control studies have
reported a reduction in fracture risk with lithium use in psychiatric patients,
including reduced risk of osteoporotic fractures [281–283]. However, psychiatric
disorders are often themselves associated with increased fracture risk and
these studies do not fully account for the association between the treatment of
the underlying mental disorder on the risk of fractures and the reduction in
fracture risk due to lithium itself [284]. This is complicated by the fact that
pharmacological alternatives to lithium, such as selective serotonin reuptake
inhibitors, may actually increase fracture risk [284–286]. This led to studies
directly investigating the effects of lithium on osteogenesis or bone mineral
density itself, with conflicting results reported in the literature [287–291].
Specifically, studies involving mice found increased osteogenesis and bone
mineral density with lithium treatment [289, 290] and a study in chickens
found lower bone stiffness without affecting bone volume or trabecular number
and thickness [288]. In humans, Cohen et al. found no differences in bone
mineral density between short-term and long-term lithium treatment groups
[287]. However, Zamani et al. found lithium treatment increased bone mineral
density, although this was only significant in women, with the authors con-
cluding the increase in bone mineral density may be due to a decrease in bone
turnover. In addition, in vitro, Satija et al. found lithium treatment upreg-
ulated osteogenic gene expression in mesenchymal stem cells (MSC)s [231,291].
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Lithium’s pharmacological actions are complex and multifaceted, affecting
a number of different biological pathways, as discussed in detail in chapter
2.6.7. Lithium typically exerts its effects through competing with Mg2+ for
metal-binding sites on enzymes resulting in their subsequent inhibition and
subsequent alteration of complex and interconnected signalling cascades. The
main pathways affected by lithium are wingless/integrated (Wnt)/β-catenin,
through glycogen synthase kinase 3 β (GSK3-β) inhibition, 3’,5’-cyclic adeno-
sine monophosphate (cAMP), through adenylyl cyclase (AC) inhibition and Ca2+
signalling through inositol depletion. These pathways have all been implicated
in osteogenic differentiation of stem cells, stimulation of osteogenesis itself and
mechanotransduction pathways including length regulation of the primary
cilium. It is therefore possible that lithium’s effects on osteogenesis in vivo
could be a result of its actions on osteogenesis itself, mechanotransduction or a
combination of the two. Activation of Wnt/β-catenin signalling has been shown
to result in increased osteogenesis and play an important role in mechanotrans-
duction in osteocytes [180,292–297]. However, Ca2+ and cAMP signalling play
an important role in both osteogenesis and mechanotransduction, therefore,
lithium’s inhibitory effects on these pathways may be detrimental.
Primary cilia are thought to play an important role in mechanotransduc-
tion in bone. Through regulating their sensitivity, primary cilia can control
osteogenic responses to mechanical loading. One way primary cilia may alter
their sensitivity to mechanical stimuli is through regulation of their length,
shortening in response to a continuous or high magnitude stimulus and elon-
gating after the stimulus is removed [195]. This results in a negative feedback
loop, where a decrease in length results in a decrease in sensitivity requiring a
greater magnitude of stimulus to generate the same biological response. This
suggests that increasing primary cilia length may increase mechanosensitiv-
ity and therefore, also increase osteogenic responses to the current level of
mechanical loading. Lithium has been shown to elongate primary cilia in a
range of different cell types [208–211]. This elongatory effect may therefore be
another potential mechanism behind how lithium could increase osteogenesis.
Due to the conflicting results in studies assessing the effects of lithium on
osteogenesis clearly further investigation is required. This chapter therefore
explores the effects of lithium on osteogenic differentiation, matrix production
and its effects on primary cilia length and prevalence.
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5.2 Aims and objectives
The aim of this chapter was to explore the osteogenic response of progenitor
and osteoblast cells to lithium chloride (LiCl) and the effects of LiCl on pri-
mary cilia length and prevalence. This was performed in order to develop
a relevant protocol for investigating the effects of lithium on mechanotrans-
duction. The experiments were performed in monolayer initially in order to
establish a smaller range of concentrations to apply to a 3D culture system.
Since monolayer culture can provide misleading data that is not representative
of in vivo cell behaviour, 3D culture was performed to evaluate LiCl’s effects in
an environment that more closely reflects the in vivo environment. In addition,
one hypothesis was that LiCl would stimulate matrix formation for bone tissue
engineering applications. An industrially sourced PU foam was chosen due to
its previous use in bone tissue engineering studies [298,299]. In this chapter
the following objectives were addressed:
• Assess the effect of LiCl on the indicators of osteogenesis, ALP and colla-
gen and mineralised matrix production in monolayer culture.
• Assess the effect of LiCl in a 3D culture system on indicators of osteoge-
nesis, ALP and collagen and mineralised matrix production in order to
evaluate LiCl’s effects in a culture environment more reflective of the in
vivo environment and its potential for use in bone tissue engineering.
• Examine the response of primary cilia prevalence and length to LiCl
treatment in monolayer culture and PU scaffolds.
5.3 Methods
The following materials and methods are specific to the work presented in this
chapter. General details can be found in chapter 4.
5.3.1 Application of lithium chloride
Serum-free and serum-containing stock solutions were made by dissolving LiCl
salt directly in serum-free BM and sterile filtering. For the serum containing
stock solution, 10 vol/vol% FBS was added. The final concentration of both
stock solutions was 100mM once the appropriate supplements had been added.
To create working solutions the stock solution was serially diluted in serum-
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free or serum-containing BM as appropriate giving final concentrations of 100,
50, 20, 10, 1 and 0.1mM once the appropriate supplements had been added.
Three LiCl treatment regimens were used, continuous, intermittent and single
(Figure 5.1). For assessing the effects of LiCl on cilia prevalence and length a
single treatment of 10, 1 or 0.1mM LiCl was applied for 24 hours before fixing
and staining the samples (Figure 5.2).
Figure 5.1: LiCl treatment regime timelines used in assessing LiCl’s os-
teogenic effects in monolayer culture. (A) Continuous treatment, (B) inter-
mittent treatment and (C) single treatment.
Figure 5.2: LiCl treatment regime timelines used to asses LiCl’s effects on
primary cilia prevalence and length.
5.3.2 Primary cilia measurement
After samples were fixed and stained following the protocols in Section 4.2.10
"Cell fixation" and section 4.2.13 "Fluorescence microscopy staining" the sam-
ples were imaged using a fluorescent, confocal or light-sheet microscope. A
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Nikon Eclipse Ti microscope (Nikon Instruments, Netherlands) in conjunc-
tion with a Nikon Intensilight CHGFI fluorescence unit was used to count
the number of ciliated cells in monolayer. An Upright LSM510 Meta confocal
microscope (Carl Zeiss AG, Germany) was used to measure primary cilia length
in monolayer. A Zeiss Z.1 light-sheet microscope (Carl Zeiss AG, Germany)
was used for both primary cilia prevalence and length measurements. To
measure the number of cells with primary cilia, three fields of view (838µm x
707µm) per sample were imaged and analysed. The number of ciliated cells
was determined by counting the number of nuclei and the number of those
nuclei with primary cilia present. The length of primary cilia in monolayer
was determined by measuring the length of each primary cilium in a maximum
intensity projection and the number of z-stack slices over which the primary
cilium appears and applying Pythagoras theorem (Figure 5.3). When imaging
scaffolds, as the plane of illumination within the light-sheet microscope is not
an even width within the whole field of view, the axial resolution is greatest
in the centre. Due to this and the greater lateral resolution, primary cilia
length was measured by positioning each cilium centrally within the field of
view and orientating it so as to position the cilia longitudinally in the x-y axis.
ImageJ was used for all measurements except primary cilia length in 3D which
was measured using the ZEN 2 (Blue Edition) software packaged with the
light-sheet microscope.
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Figure 5.3: Primary cilia length measurement with confocal microscopy. (A) A
maximum intensity projection of cell nucleus and primary cilium. The primary
cilium is measured from its base to its tip as shown in the cropped image
(2.7µm). (B) Sequential optical sections of 0.4µm thickness. The primary cil-
ium is not visible in the first or last optical sections, and is therefore only visible
in 4 sections, giving a height of 1.6µm (0.4µm×4 = 1.6µm). (C) Illustration of
primary cilium protruding from a cell. Red dashed boxes indicate an optical
section. a is the maximum intensity projection measurement, b the number of
optical sections multiplied by their thickness and c the actual cilium length,
which here is 3.13µm (
p
2.72 + 1.62 = 3.13 ).
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5.4 Results
5.4.1 Continuous lithium chloride exposure is cytotoxic
at 10 mM and above
Lithium chloride cytotoxicity in hES-MP cells
When used therapeutically lithium is administered daily to keep blood serum
levels within a tight range, around 1mM. Above this level cytotoxic effects
become apparent rapidly. However, in vitro, lithium has been used at concentra-
tions up to 100mM with no reported cytotoxicity in some instances. Therefore,
the cytotoxicity of lithium was first evaluated in both hES-MP and MLO-A5
cells in monolayer and 3D culture to evaluate if there were any differences in
cytotoxicity between osteogenic progenitors and post-osteoblasts/pre-osteocytes
in monolayer or 3D culture.
In hES-MP cells, at concentrations at or below the therapeutic concentration of
1mM, no significant differences in metabolic activity compared to the untreated
control were found over the 21 days of culture in monolayer or 3D (Figures 5.4 -
5.5). Cytotoxicity was observed at all concentrations evaluated above 1mM. In
monolayer culture, at 10mM and above, cytotoxicity was observed after only
24 hours of LiCl treatment (day 7), with significantly lower metabolic activity
found compared to the untreated control. However, on day 7 in 3D culture
metabolic activity was only lower in 50mM LiCl treated cells. Metabolic activ-
ity reduced significantly between day 7 and 21 in 10mM and above LiCl treated
cells in both monolayer and 3D culture. There was no change in metabolic
activity in 10mM LiCl treated cells in monolayer between day 7 and 14, but
there was a significant reduction between day 14 and 21.
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Figure 5.4: Effect of continuous LiCl exposure applied from day 6 on hES-
MP metabolic activity over 21 days of monolayer culture. Cytotoxicity was
observed at concentrations of 10 mM and above. Data represents mean ± SD
n=9. Fluorescence was measured at λex: 540nm and λem: 590nm.
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Figure 5.5: Effect of continuous LiCl exposures applied from day 6 on hES-MP
metabolic activity over 21 days of 3D culture. Cytotoxicity was observed at con-
centrations of 10 mM and above. Data represents mean ±SD n=9. Fluorescence
was measured at λex: 540nm and λem: 590nm.
63
Chapter 5. Lithium accelerates osteogenesis and elongates primary cilia
Lithium chloride cytotoxicity in MLO-A5 cells
One replicate of the following results were performed by Ingvar Kiricenko
during his INSIGNEO summer project under my guidance.
Similarly to hES-MP cells, in MLO-A5 cells no significant differences in
metabolic activity were observed in 0.1 or 1mM LiCl treated cells over the
14 day culture period in monolayer or 3D culture (Figures 5.6 - 5.7). However,
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Figure 5.6: Effect of continuous LiCl exposure applied from day 2 on MLO-A5
metabolic activity over 14 days of monolayer culture. Cytotoxicity was observed
at concentrations of 20 mM and above. Data represents mean ± SD n=9.
Fluorescence was measured at λex: 540nm and λem: 590nm.
in monolayer culture 10mM LiCl treatment also had no significant effect over
14 days. At 50mM LiCl and above, metabolic activity significantly reduced
over 14 day in both monolayer and 3D culture. In 3D culture, after an initial
increase in metabolic activity between day 1 and 5, 10mM LiCl treated cell’s
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Figure 5.7: Effect of continuous LiCl exposure applied from day 2 on MLO-A5
metabolic activity over 14 days of 3D culture. Cytotoxicity was observed at con-
centrations of 10 mM and above. Data represents mean ±SD n=9. Fluorescence
was measured at λex: 540nm and λem: 590nm.
metabolic activity decreased back to day 1 levels.
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5.4.2 Continuous lithium chloride treatment stimulates
osteogenesis
Osteogenic effects of lithium chloride in hES-MP cells
ALP activity, an early marker of osteogenesis, was higher with continuous
1mM LiCl treatment in both monolayer and 3D culture of hES-MP cells com-
pared to the untreated control (Figures 5.8 - 5.9). This was found for both
total ALP activity and normalised ALP activity. Total DNA showed similar
results to the day 14 RR results. 20, 50 and 100mM LiCl treated groups had
significantly lower DNA levels compared to the untreated control. However,
10mM LiCl treated cells were not significantly different to the untreated con-
trol, as was found in the RR assay. 0.1mM LiCl treatment did not affect ALP
activity or total DNA in monolayer or 3D culture. In addition to increasing
early markers of osteogenesis, 1mM LiCl treatment also resulted in an in-
crease in matrix mineralisation, as shown by ARS in both monolayer and 3D
culture (Figures 5.10 - 5.11). Despite the increase in matrix mineralisation
at 1mM LiCl, there was no increase found in collagen production in either
monolayer or 3D culture. In fact, in monolayer culture there was a significant
reduction in the amount of collagen produced after 21 days compared to the
untreated control and although not statistically significant, the amount of
collagen produced in 3D culture was also found to be lower. Both total matrix
mineralisation and collagen production were found to be significantly lower
compared to the untreated control in monolayer and 3D culture at 10mM and
above, except for matrix mineralisation in 3D culture, which although lower
was not statistically different. 0.1mM LiCl treatment did not affect matrix
mineralisation or collagen production in monolayer or 3D culture.
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Figure 5.8: Effect of continuous LiCl exposure applied from day 6 on hES-MP
day 14 cell number and ALP activity in monolayer culture. (A) Total DNA. (B)
ALP activity. (C) ALP activity normalised to total DNA. Data represents mean
±SD n=9.
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Figure 5.9: Effect of continuous LiCl exposure applied from day 6 on hES-MP
day 14 cell number and ALP activity in 3D culture. (A) Total DNA. (B) ALP
activity. (C) ALP activity normalised to total DNA. Data represents mean ±SD
n=9.
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Figure 5.10: Effect of continuous LiCl exposure applied from day 6 on hES-MP
matrix formation in monolayer culture. (A) Day 21 matrix calcium quantified
by ARS. (B) Day 21 matrix collagen quantified by DR80. Data represents mean
±SD n=9.
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Figure 5.11: Effect of continuous LiCl exposure applied from day 6 on hES-
MP matrix formation in 3D culture. (A) Day 21 matrix calcium quantified by
ARS. Matrix calcium formation was higher in the 1 mM LiCl treated cells and
lower in the 50 mM and above LiCl treated cells. (B) Day 21 matrix collagen
quantified by DR80. Collagen matrix formation was lower in the 10 mM and
above LiCl treated cells compared to the control. Data represents mean ±SD
n=9.
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Osteogenic effects of lithium chloride in MLO-A5 cells
One replicate of the following 3D culture results were performed by Ingvar
Kiricenko during his INSIGNEO summer project under my guidance.
In MLO-A5 cells, ALP activity and total DNA was not affected by 0.1 or 10mM
LiCl treatment in monolayer or 3D culture (Figures 5.12 - 5.13). 1mM LiCl
treatment resulted in a significant increase in total ALP activity and nor-
malised ALP activity in both monolayer and 3D culture. LiCl treatment with
10mM and above resulted in a significant decrease in ALP activity and total
DNA in both monolayer and 3D culture. Similarly to ALP activity mineralised
matrix production was also significantly increased compared to the untreated
control with 1mM LiCl treatment in both monolayer and 3D culture (Fig-
ures 5.14 - 5.15) . In monolayer culture, both 0.1 and 1mM LiCl treatment
increased collagen production compared to the untreated control. At 50mM
and above, LiCl treatment resulted in no matrix mineralisation and very little
collagen production in both monolayer and 3D culture. In 3D culture 10mM
LiCl treatment also resulted in a decrease in matrix mineralisation and total
collagen production. However, in monolayer culture there was no significant
effect.
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Figure 5.12: Effect of continuous LiCl exposure on MLO-A5 day 7 cell number
andALP activity inmonolayer culture. (A) Total DNA. (B) ALP activity. (C) ALP
activity normalised to total DNA. Data represents mean ±SD, n=9, * = p<0.05
compared to the untreated control.
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Figure 5.13: Effect of continuous LiCl exposure on MLO-A5 day 7 cell number
and ALP activity in 3D culture. (A) Total DNA. (B) ALP activity. (C) ALP
activity normalised to total DNA. Data represents mean ±SD n=9, * = p<0.05
compared to the untreated control.
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Figure 5.14: Effect of continuous LiCl exposure on MLO-A5 matrix formation
in monolayer culture. (A) Day 14 matrix calcium quantified by ARS. (B) Day 14
matrix collagen quantified byDR80. Data representsmean±SDn=9, * = p<0.05
compared to the untreated control.
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Figure 5.15: Effect of continuous LiCl exposure on MLO-A5 matrix formation
in 3D culture. (A) Day 14 matrix calcium quantified by ARS. (B) Day 14 matrix
collagen quantified by DR80. Data represents mean ±SD n=9, * = p<0.05
compared to the untreated control.
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5.4.3 Short term lithium treatment does not stimulate os-
teogenesis
In order to assess if lithium treatment alters mechanoinduced osteogenic re-
sponses, a LiCl treatment regime that did not affect osteogenesis in static
conditions was required. Therefore, shorter term LiCl treatments were as-
sessed for their osteogenic effects.
Short term lithium chloride treatment in hES-MP cells cultured in 2D
In monolayer culture of hES-MP cells were treated with LiCl for 24h on day 6
(single treatment) only or day 6 and day 13 (intermittent treatment) of culture.
50mM LiCl treatment resulted in minimally detectable metabolic activity
indicating cell death. However, the reduction in metabolic activity over the
21 day culture period occurred at a slower rate, taking 21 days compared to
14 days formetabolic activity to reduce to near zero levels with both a single dose
(Figure 5.16) and double dose (Figure 5.17). 20mM LiCl treatment resulted in
lower metabolic activity by day 21 in both single and double dose treatment
regimens compared to the untreated control. In addition, both single and
double dose 20mM LiCl treatments had significantly lower metabolic activity
on day 21 of culture compared to the untreated control.
With both single dose and intermittent treatment regimens 1mM LiCl or lower
had no effect on ALP activity or total DNA (Figure 5.18). Although day 14
metabolic activity was only significantly lower with intermittent treatment
in 20mM LiCl treated cells, total DNA was significantly lower in both single
dose and intermittent treatment regimens compared to the untreated control.
20mM LiCl treatment decreased total DNA and ALP activity compared to the
untreated control with both single dose and intermittent treatment. Matrix
mineralisation and total collagen production was decreased in both single dose
and intermittent treatment groups when treated with 20mM LiCl and above
(Figure 5.19). At 10mM, only intermittent LiCl treatment significantly reduced
matrix mineralisation compared to the untreated control. However, both single
dose and intermittent treatment at 10mM LiCl significantly reduced collagen
production. At 1mM or below, LiCl treatment did not affect either matrix
mineralisation or total collagen production in either single dose or intermittent
treatment.
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Figure 5.16: Effect of a single LiCl exposure on hES-MP metabolic activity
over 21 days of culture monolayer culture. Data represents mean ±SD n=9.
Fluorescence was measured at λex: 540nm and λem: 590nm.
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Figure 5.17: Effect of intermittent LiCl exposure on hES-MP metabolic ac-
tivity over 21 days of monolayer culture. Data represents mean ±SD n=9.
Fluorescence was measured at λex: 540nm and λem: 590nm.
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Figure 5.18: Effects of a single and intermittent LiCl exposure on hES-MP
day 14 cell number and ALP activity. (A) Total DNA. (B) ALP activity. (C) ALP
activity normalised to total DNA. Data represents mean ±SD n=9, * = p<0.05
compared to the untreated control.
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Figure 5.19: Effects of a single and intermittent LiCl exposure on hES-MP
matrix formation. (A) Day 21 matrix calcium quantified by ARS. (B) Day 21 ma-
trix collagen quantified by DR80. Data represents mean ±SD n=9. * = p<0.05
compared to the untreated control. # = p<0.05 compared to the single treatment
regime.
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Short term lithium chloride treatment in hES-MP cells cultured in 3D
In 3D culture of hES-MP cells 24h treatments of LiCl were applied on day 4,
12 and 17. Intermittent LiCl treatment had no significant effects on metabolic
activity at any time point compared to the untreated control (Figure 5.20).
However, 10mM was the only concentration to show no significant increase in
metabolic activity between day 7 and 21. There were no significant differences
in total DNA or ALP activity on day 14 (Figure 5.21). There were also no signif-
icant differences in day 21 matrix mineralisation or total collagen production
(Figure 5.22).
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Figure 5.20: Effect of three 24 hour LiCl exposures on hES-MP metabolic
activity over 21 days of culture. Data represents mean ±SD n=9. Fluorescence
was measured at λex: 540nm and λem: 590nm.
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Figure 5.21: Effect of three 24 hour LiCl exposures on hES-MP day 14 cell
number and ALP activity. (A) Total DNA. (B) ALP activity. (C) ALP activity
normalised to total DNA. Data represents mean ±SD n=9.
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Figure 5.22: Effect of three 24 hour LiCl exposures on hES-MP matrix forma-
tion. (A) Day 21 matrix calcium quantified by ARS. (B) Day 21 matrix collagen
quantified by DR80. Data represents mean ±SD n=9.
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Short term lithium chloride treatment inMLO-A5 cells cultured in 2D
Repeats of the following results were performed by Ingvar Kiricenko during
his INSIGNEO summer project under my guidance.
LiCl was applied for 24h on day 2 and 7 for intermittent treatment of MLO-A5
cells. On day 7 only 100mM LiCl treatment resulted in a decrease in metabolic
activity compared to day 1, which remained at near zero levels on day 14
(Figure 5.23). Although metabolic activity increased from day 1 to 7 in both 20
and 50mM LiCl treated cells, their metabolic activity was significantly lower
than the untreated control.
Although day 7 metabolic activity was lower in 50mM LiCl treated cells, day 14
total DNA was not significantly different to the untreated control (Figure 5.24).
At concentrations below 50mM there were also no significant effects on total
DNA. Both 50 and 100mM LiCl treatment significantly decreased total DNA
levels and ALP activity. Although, 10 and 50mM LiCl treatment significantly
decreased total ALP activity, when normalised to total DNA this was no longer
significant. 1mM LiCl treatment and below had no significant effect on ALP
activity. Interestingly, although both 10 and 50mM LiCl treatment decreased
total ALP activity, they both increased matrix mineralisation compared to the
untreated control (Figure 5.25). Additionally, although 50mM LiCl treatment
decreased ALP activity, matrix mineralisation and total collagen production
were not affected. Treatment with 1mM LiCl and below had no effect on matrix
mineralisation or total collagen production.
83
Chapter 5. Lithium accelerates osteogenesis and elongates primary cilia
1 7 14
Day
0
5
10
15
20
25
Fl
uo
re
sc
en
ce
(A
U
)
×103
LiCl Concentration
0.0 mM
0.1 mM
1.0 mM
10.0 mM
50.0 mM
100.0 mM
200.0 mM
Figure 5.23: Effect of intermittent LiCl exposure on MLO-A5 metabolic ac-
tivity over 14 days of monolayer culture. Cytotoxicity was observed at concen-
trations of 100 mM and above. Data represents mean ±SD n=9. Fluorescence
was measured at λex: 540nm and λem: 590nm.
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Figure 5.24: Effect of intermittent LiCl exposure onMLO-A5 day 7 cell number
andALP activity inmonolayer culture. (A) Total DNA. (B) ALP activity. (C) ALP
activity normalised to total DNA. Data represents mean ±SD n=9. * = p<0.05
compared to the untreated control.
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Figure 5.25: Effect of intermittent LiCl exposure on MLO-A5 matrix forma-
tion in monolayer culture. (A) Day 14 matrix calcium quantified by ARS. (B)
Day 14 matrix collagen quantified by DR80. Data represents mean ±SD n=9.
* = p<0.05 compared to the untreated control..
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Short term lithium chloride treatment inMLO-A5 cells cultured in 3D
Repeats of the following results were performed by Ingvar Kiricenko during
his INSIGNEO summer project under my guidance.
In 3D culture intermittent LiCl treatment was applied for 24h on day 2 and
7 of culture. 0.1 and 1mM LiCl treatment had no effect on metabolic activity
over the 14 day culture period (Figure 5.26). 10mM LiCl treatment resulted
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Figure 5.26: Effect of intermittent LiCl exposure on MLO-A5 metabolic activ-
ity over 14 days of 3D culture. Cytotoxicity was observed at concentrations of 10
mM and above. Data represents mean ±SD n=9. Fluorescence was measured
at λex: 540nm and λem: 590nm.
in significantly lower metabolic activity on day 14 of culture compared to the
untreated control. 10mM LiCl treatment decreased day 7 total DNA and total
ALP activity (Figure 5.27). However, when ALP activity was normalised to
total DNA this was no longer significant. No other concentration tested had
an effect on ALP activity or total DNA. Intermittent LiCl did not affect matrix
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mineralisation at any of the concentrations tested (Figure 5.28). Only 10mM
LiCl treatment had a significant effect on total collagen production, causing a
decrease in collagen compared to the untreated control.
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Figure 5.27: Effect of intermittent LiCl exposure onMLO-A5 day 7 cell number
and ALP activity in 3D culture. (A) Total DNA. (B) ALP activity. (C) ALP
activity normalised to total DNA. Data represents mean ±SD n=9. * = p<0.05
compared to the untreated control.
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Figure 5.28: Effect of intermittent LiCl exposure onMLO-A5matrix formation
in 3D culture. (A) Day 14 matrix calcium quantified by ARS. (B) Day 14 matrix
collagen quantified by DR80. Data represents mean ±SD n=9. * = p<0.05
compared to the untreated control.
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5.4.4 1 mM lithium chloride does not induce osteogenic
differentiation
The previously reported experiments using hES-MP cells have all been per-
formed with media containing Dex for the first 5 days of culture. Dex itself
stimulates osteogenic differentiation, therefore, to assess the effects of lithium
on osteogenic differentiation 1mM LiCl was applied either continuously or
intermittently in hES-MP cells cultured without Dex (SM) and compared with
culture with Dex to day 5 (dexamethasone withdrawn media (DW)). hES-MP
cells cultured in SM showed a significantly greater increase inmetabolic activity
over 21 days compared to hES-MP cells cultured in DW (p≤0.05) (Figure 5.29).
On day 7 of culture cells cultured in SM media and continuously treated with
LiCl had significantly higher metabolic activity compared to the untreated
control cultured in SM (p≤0.05). There were no other significant differences
between groups in SM cultured cells at any other time point. In DW cultured
cells, there were no significant differences between treatment groups on any
day except day 21, where continuous LiCl treated cells had a higher metabolic
activity compared to the untreated control (p≤0.05). Similarly to the RR results
LiCl had no effect on day 14 total DNA levels in either media type (Figure 5.30).
ALP activity was significantly lower in hES-MP cells cultured in SM compared
to DW. In hES-MP cells cultured in SM LiCl had no effect on ALP activity. How-
ever, as previously shown continuous LiCl treatment significantly increased
ALP activity in DW cultured cells. Total collagen production was not signifi-
cantly different between SM and DW culture. Continuous, but not intermittent
LiCl treatment significantly reduced total collagen production compared to the
untreated control (Figure 5.31). In SM cultured hES-MP cells LiCl had no effect
on total collagen production with either continuous or intermittent treatment.
Matrix mineralisation was significantly lower in hES-MP cells cultured in SM
compared to DW. In DW cultured hES-MP cells continuous, but not intermit-
tent LiCl treatment significantly increased matrix mineralisation compared
to the control. In SM cultured hES-MP cells LiCl treatment had no effect on
matrix mineralisation with either continuous or intermittent treatment.
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Figure 5.29: Comparison of the effects of intermittent and continuous LiCl
exposure on hES-MP metabolic activity in SM or DW monolayer culture. Data
represents mean ±SD n=9. Fluorescence was measured at λex: 540nm and
λem: 590nm.
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Figure 5.30: Comparison of the effects of intermittent and continuous LiCl
exposure on hES-MP ALP activity in SM and DW monolayer culture. (A)
Total DNA. (B) ALP activity. (C) ALP activity normalised to total DNA. Data
represents mean ±SD n=9. * = p<0.05 compared to the untreated control.
# = p<0.05 compared to the continuous treatment regime.
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Figure 5.31: Comparison of the effects of intermittent and continuous LiCl
exposure on hES-MP matrix formation in SM and DW monolayer culture.
(A) Day 14 matrix calcium quantified by ARS. (B) Day 14 matrix collagen
quantified by DR80. Data represents mean ±SD n=9. * = p<0.05 compared
to the untreated control. # = p<0.05 compared to the continuous treatment
regime.
94
Chapter 5. Lithium accelerates osteogenesis and elongates primary cilia
5.4.5 1 mM lithium chloride induces primary cilia elon-
gation
In addition to lithium’s direct effects on osteogenesis, lithium treatment has
also been shown to elongate primary cilia. Since primary cilia are thought to
be mechanosensitive with their length regulating their sensitivity, Lithium
induced primary cilia elongation could also affect osteogenesis by altering
mechanosensitivity. Therefore, the effects of lithium treatment on primary
cilia length and prevalence was evaluated. Cells were cultured in LiCl or vehicle
control for 24h and immunocytochemistry used to image primary cilia in order
to assess the number of ciliated cells and any changes in primary cilia length.
hES-MP primary cilia length and prevalence in monolayer culture
In hES-MP cells in monolayer culture, only 10mM LiCl treatment had an effect
on the number of ciliated cells, showing a reduction of 33 % compared to the
untreated control (Figures 5.34A & 5.32). Both 1 and 10mM LiCl treatment
significantly increased primary cilia length by 42 % and 53 % respectively,
compared to the untreated control (Figures 5.34B & 5.33).
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Figure 5.32: Fluorescent images representative of ciliated hES-MP cells after
LiCl treatment in monolayer. hES-MP cells cultured for 7 days were labelled
with anti-acetylated a-tubulin antibody (green) and DAPI (blue) to view the
primary cilia and nuclei respectively. (A) untreated control, (B) 0.1 mM LiCl,
(C) 1 mM LiCl and (D) 10 mM LiCl.
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Figure 5.33: Fluorescent images representative of hES-MP primary cilia after
LiCl treatment in monolayer. hES-MP cells cultured for 7 days were labelled
with anti-acetylated a-tubulin antibody (green) and DAPI (blue) to view the
primary cilia and nuclei respectively. (A) untreated control, (B) 0.1 mM LiCl,
(C) 1 mM LiCl and (D) 10 mM LiCl.
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Figure 5.34: Effect of LiCl exposure on hES-MP primary cilia prevalence
and length in monolayer. (A) Percentage of hES-MPs that bear a primary
cilium. Data represents mean ±SD n≥450.(B) Box and whisker plot of primary
cilia length. The central line indicates the median, the box the 25th to 75th
percentile and the whiskers the upper/lower quartile ±1.5×interquartile range
(IQR). + indicates outliers n ≥100. Statistical significance was assessed using
Mann Whitney U test. * = p<0.05 compared to the untreated control.
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hES-MP primary cilia length and prevalence in 3D culture
In 3D culture only the effects of 1mM LiCl treatment on primary cilia preva-
lence and length was evaluated, as this concentration was found to increase
length without affecting prevalence in monolayer culture. As in monolayer
culture primary cilia prevalence was not affected by 1mM LiCl treatment (Fig-
ures 5.37A & 5.35). Primary cilia prevalence was also similar at 55 % ± 8.8 %
in monolayer culture and 53 % ± 12.4 % in 3D culture in the untreated control
groups. Primary cilia length was 63 % shorter in 3D culture compared to
monolayer culture, at a median length of 1.3µm and 3.5µm respectively for
the untreated control groups. 1mM LiCl treatment significantly increased
primary cilia length by 66 % (Figures 5.37B & 5.36).
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Figure 5.35: Fluorescent images representative of ciliated hES-MP cells after
LiCl treatment in 3D. hES-MP cells cultured for 5 days were labelled with
anti-acetylated a-tubulin antibody (green) and DAPI (blue) to view the primary
cilia and nuclei respectively. (A) untreated control and (B) 1 mM LiCl.
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Figure 5.36: Fluorescent images representative of untreated (A) and 1 mM
(B) LiCl treated hES-MP cell’s primary cilium in 3D. hES-MP cells cultured
for 7 days were labelled with anti-acetylated a-tubulin antibody (green) and
DAPI (blue) to view the primary cilia and nuclei respectively.
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Figure 5.37: Effect of LiCl exposure on hES-MP primary cilia prevalence and
length in 3D. (A) Percentage of hES-MPs that bear a primary cilium. Data
represents mean ±SD n≥500. (B) Box and whisker plot of primary cilia length.
The central line indicates the median, the box the 25th to 75th percentile and
the whiskers the upper/lower quartile ±1.5×IQR. + indicates outliers n ≥100.
Statistical significance was assessed using Mann Whitney U test. * = p<0.05
compared to the untreated control.
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MLO-A5 primary cilia length and prevalence in monolayer culture
In MLO-A5 cells in monolayer culture, 1mM LiCl treatment did not affect
primary cilia prevalence (Figures 5.40A & 5.38). Primary cilia prevalence was
similar to that found in hES-MP cells at 61 % ± 15 % compared to 55 % ± 8.8 %
in hES-MP cells in the untreated controls. Primary cilia of the untreated control
were 52 % shorter in MLO-A5 cells compared to hES-MP cells. 1mM LiCl
treatment increased primary cilia length by 96 % compared to the untreated
control (Figures 5.40B & 5.39).
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Figure 5.38: Fluorescent images representative of ciliated MLO-A5 cells after
LiCl treatment in monolayer. MLO-A5 cells cultured for 3 days were labelled
with anti-acetylated a-tubulin antibody (green) and DAPI (blue) to view the
primary cilia and nuclei respectively. (A) untreated control and (B) 1 mM LiCl.
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A
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B
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Figure 5.39: Fluorescent images representative of untreated (A) and 1 mM (B)
LiCl treatedMLO-A5 cell’s primary cilium inmonolayer. MLO-A5 cells cultured
for 3 days were labelled with anti-acetylated α-tubulin antibody (green) and
DAPI (blue) to view the primary cilia and nuclei respectively.
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Figure 5.40: Effect of LiCl exposure on MLO-A5 primary cilia prevalence
and length. (A) Percentage of MLO-A5s that bear a primary cilium. Data
represents mean ±SD n≥500. (B) Box and whisker plot of primary cilia length.
The central line indicates the median, the box the 25th to 75th percentile and
the whiskers the upper/lower quartile ±1.5×IQR. + indicates outliers n ≥100.
Statistical significance was assessed using Mann Whitney U test. * = p<0.05
compared to the untreated control.
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MLO-A5 primary cilia length and prevalence in 3D culture
In MLO-A5 cells in 3D culture, 1mMLiCl treatment did not affect primary cilia
prevalence (Figures 5.43A & 5.41). Primary cilia prevalence was significantly
lower to that found in MLO-A5 cells in monolayer culture at 27 % ± 8.3 %
compared to 61 % ± 15 % in monolayer culture in the untreated controls.
Primary cilia of the untreated control were 37 % shorter in 3D culture compared
to monolayer culture. 1mM LiCl treatment had a less pronounced effect on
primary cilia length in MLO-A5 3D culture only increasing primary cilia length
by 12 % compared to the untreated control (Figures 5.43B & 5.42).
A
25μm
B
25μm
Figure 5.41: Fluorescent images representative of ciliated MLO-A5 cells after
LiCl treatment in 3D. MLO-A5 cells cultured for 3 days were labelled with
anti-acetylated a-tubulin antibody (green) and DAPI (blue) to view the primary
cilia and nuclei respectively. (A) untreated control and (B) 1 mM LiCl.
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Figure 5.42: Fluorescent images representative of untreated (A) and 1 mM
(B) LiCl treated MLO-A5 cell’s primary cilium in 3D. MLO-A5 cells cultured
for 3 days were labelled with anti-acetylated α-tubulin antibody (green) and
DAPI (blue) to view the primary cilia and nuclei respectively.
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Figure 5.43: Effect of LiCl exposure on MLO-A5 primary cilia prevalence
and length. (A) Percentage of MLO-A5s that bear a primary cilium. Data
represents mean ±SD n≥400. (B) Box and whisker plot of primary cilia length.
The central line indicates the median, the box the 25th to 75th percentile and
the whiskers the upper/lower quartile ±1.5×IQR. + indicates outliers n ≥100.
Statistical significance was assessed using Mann Whitney U test. * = p<0.05
compared to the untreated control.
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5.5 Discussion
This chapter investigated the response of osteogenic progenitors (hES-MP)
and post-osteoblast/pre-osteocyte (MLO-A5) cell lines to LiCl treatment. The
reported osteogenic effects of lithium have been conflicting, therefore a range
of concentrations, including the therapeutically relevant concentration 1mM,
were tested for cytotoxicity and osteogenic effects. Lithium has also been
reported to elongate primary cilia in a number of different cell types. The
length of primary cilia has been shown to regulate the sensitivity of cells to
mechanical stimulation. Therefore, since bone is a mechanically sensitive organ
that upregulates bone deposition in response to increases in load, enhanced
sensitivity to mechanical stimulation through elongation of primary cilia may
be one mechanism behind any positive effect lithium has on osteogenesis. In
order to assess if primary cilia elongation could be involved in any increased
osteogenesic response to mechanical stimulation, LiCl treatment regimens
were evaluated in conjunction with assessing LiCl’s effects on primary cilia
prevalence and length. This was performed in order to assess whether primary
cilia were elongated at the same concentrations that would be used to assess
the effects of lithium mechanoinduced osteogenesis.
Lithium, administered as lithium carbonate, lithium orotate or lithium chlo-
ride, is most commonly used in the treatment of psychiatric disorders such
as bipolar disorder [278–280]. In the treatment of psychiatric disorders, the
blood serum concentration of lithium is tightly controlled, with therapeutic
effects typically seen at concentrations between 0.8-1.2mM [214, 215]. The
tight control of serum concentrations is due to mild toxicity presenting at levels
between 1.5-2.5mM and chronic toxicity presenting at serum concentrations
greater than 2.5mM with continuous treatment [300]. Here in both monolayer
and 3D culture of hES-MP cells, continuous LiCl treatment showed cytotoxicity
at concentrations of 10mM and above in both monolayer and 3D culture. In
MLO-A5 cells, cytotoxicity was observed at 50mM LiCl and above in mono-
layer culture and 10mM LiCl and above in 3D culture. These concentrations
are higher than the toxicity levels reported in vivo [300]. However, they are
comparable to the toxicity levels found in vitro, which have been reported to
range between 20mM and 50mM [301–303]. Although, Ou et al used 100mM
LiCl with no cytotoxicity reported when applied for between 7 and 12h in
synoviocytes [209]. This reduced exposure time may explain the tolerance of
the cells to this higher concentration. Similarly, hES-MP and MLO-A5 cells
cultured in monolayer had a greater tolerance to higher LiCl concentrations
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with shorter exposures in intermittent treatments. MLO-A5 cells were also
more tolerant to higher LiCl concentrations in monolayer culture compared to
hES-MP cells, with toxicity presenting at 50mM and 10mM respectively with
continuous treatment. Since lithium does not passively transport into or out of
cells, these differences may be due to different transport rates into and out of
the cells between hES-MP and MLO-A5 cells. A higher transport of lithium
out of, or lower transport into MLO-A5 cells would result in lithium being less
toxic [304]. Alternatively, as lithium affects multiple pathways, the differences
observed may be due to differences in these pathways between stem cells and
mature bone cells or even between human and mouse cells.
Activation of the Wnt/β-catenin signalling pathway through inhibition of
GSK3-β is one of the mechanisms by which lithium affects cells [305]. Wnt/β-
catenin signalling, known as canonical Wnt signalling, plays an important role
in the development and maintenance of a number of tissues and is known to be
involved in stem cell self-renewal, osteogenic differentiation and osteogenesis
itself [180, 306, 307]. Lithium treatment is therefore likely to affect these
cellular functions. Wnt/β-catenin signalling occurs through Wnt binding to
frizzled inducing complex formation with the co-receptor low-density lipoprotein
receptor-related protein (LRP)5/6 [308]. This leads to intracellular dishevelled
(Dsh) binding and activation which in turn inhibits the axin, adenomatous
polyposis coli (APC), GSK3-β complex [309]. The inhibition of the axin, APC,
GSK3-β complex prevents GSK3-β phosphorylating β-catenin resulting in
β-catenin accumulation in the cytosol and its subsequent translocation into
the nucleus where it can mediate transcriptional activity through binding with
transcription factors, altering gene expression [310].
In haematopoietic and mesenchymal stem cells, lithium has been shown
to promote proliferation [303,311,312]. This increase in proliferation with LiCl
treatment was not seen here in the dose response studies where hES-MP cells
were cultured in DW media. However, when comparing the effects of LiCl on
osteogenesis in SM and DW media, a greater increase in metabolic activity
between day 1 and day 7 was observed in cells cultured in SM and continuously
treated with 1mM LiCl compared to the untreated control. This greater
increase in metabolic activity indicates a greater increase in cell number and
therefore greater proliferation. However, this increase in proliferation was
not observed in hES-MP cells cultured intermittently in LiCl. Zhang et al.
demonstrated that the pathway through which lithium promoted stem cell
proliferation was through its inhibitory effects on GSK3-β and the subsequent
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accumulation of β-catenin and Wnt pathway activation [303]. Interestingly,
Dex has also been shown to affect proliferation through GSK3-β, where Smith
et al. showed Dex inhibited cell cycle progression, reducing proliferation
through GSK3-β activation and direct degradation of c-Myc [313].
This inhibitory effect of Dex on proliferation was also observed here, with
reduced cell metabolic activity over the 21 day culture of hES-MP cells in DW
compared to SM. Since Dex was withdrawn on day 5 of culture and metabolic
activity was not significantly lower until day 21, this suggests the inhibitory
effects of Dex either persist or take an extended culture period to become ap-
parent. LiCl inhibition of GSK3-β has been shown to counteract the inhibitory
effects of Dex on cell proliferation [313,314]. This was observed here where
continuous 1mM LiCl treatment of DW cultured hES-MP cells resulted in a
greater metabolic activity on day 21 compared to the untreated DW control,
indicating an increase in proliferation over the 21 days of culture. Continuous
1mM LiCl treatment in DW cultured cells also partially counteracted the
inhibitory effects of Dex on cell proliferation. Day 21 metabolic activity of both
intermittent and untreated controls were significantly lower compared to all
SM cultured groups but the continuous treatment group was not significantly
different. It should be noted that LiCl was not applied to cells until after Dex
withdrawal, unlike the studies by Smith, et al. and Ohnaka, et al. where
LiCl was applied in combination with Dex to counteract its inhibitory effects
on cell proliferation. Therefore, the LiCl applied here may not be directly
counteracting the activity of Dex.
In addition to promoting proliferation, LiCl has also been shown to pro-
mote osteogenic markers in vitro and in vivo [231,287–291,315]. In order to
evaluate if lithium may promote osteogenesis in stem cells or mature bone cells,
the effects of continuous LiCl treatment at 1mM were evaluated. In addition,
concentrations above and below this concentration were evaluated for their
potential use in promoting osteogenesis in a tissue engineering capacity. These
higher LiCl concentrations were tested as with in vitro use the LiCl concentra-
tion is not limited by toxicity on different cells within the body. In vitro, studies
investigating LiCl’s effects on osteogenic differentiation or osteogenesis have
typically been performed in monolayer culture and focused on osteogenic gene
expression. The extended culture periods performed here, allowed evaluation
of matrix formation further building on these previous studies. Furthermore,
the inclusion of 3D culture was used to assess its suitability in stimulating
osteogenesis for tissue engineering applications.
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Unsurprisingly, at the concentrations that were found to be cytotoxic, all
osteogenic markers were reduced compared to the untreated controls in both
hES-MP and MLO-A5 cells and in both monolayer and 3D culture. In other
studies, these higher concentrations have been shown to stimulate osteogenic
differentiation [315,316]. Li et al. reported both 50 and 100mM LiCl promoted
proliferation and stimulated increases in osteogenic gene expression [316].
However, Bain et al. reported 100mM LiCl to be cytotoxic, but both 10 and
25mM promoted osteogenic gene expression with no negative effects on cell
viability or proliferation [315].
Although higher concentrations were cytotoxic and therefore did not pro-
mote osteogenic differentiation, continuous 1mM LiCl consistently promoted
osteogenesis here. ALP activity was up-regulated in hES-MP cells in both
monolayer and 3D culture and MLO-A5 cells in 3D culture. Matrix mineralisa-
tion in both hES-MP and MLO-A5 cells in monolayer and 3D culture was also
up-regulated. Similarly, Satija et al. also reported higher concentrations to be
cytotoxic and detrimental to osteogenic markers but found 5mM LiCl promoted
ALP activity and osteogenic gene expression in MSCs [291]. In contrast, De
Boer et al. found that although 4mM LiCl treatment enhanced proliferation, it
actually had no effect on ALP activity in MSCs [312]. The difference between
these two studies may be due to the duration of LiCl exposure. Satija et al.
cultured MSCs in LiCl for 7 days before ALP levels were measured, compared
to 4 days for De Boer et al. Although MSCs were not used here, hES-MP cells
have similar characteristics and would therefore likely behave in a similar
manner. The duration of LiCl exposure used here was slightly longer at 8 days
and an increase in day 14 ALP activity was observed. This suggests that the
short duration of culture used by De Boer et al. may not have been long enough
for osteogenic differentiation to have progressed sufficiently for ALP levels to be
affected. Although theMLO-A5 cells were only cultured in LiCl for 5 days before
ALP levels were evaluated, they are a mature post-osteoblast/pre-osteocyte cell
line with inherently high levels of ALP activity and do not need to undergo
osteogenic differentiation for ALP activity levels to increase. After exposure
times of up to 48h and 72h for hES-MP and MLO-A5 cells respectively, no
increases in any of the osteogenic markers were observed. This gives further
evidence that prolonged LiCl exposure may be needed to increase osteogenesis.
The results presented here also suggest 1mM LiCl itself may not induce
osteogenic differentiation and requires the use of Dex. To investigate LiCl
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induced osteogenic differentiation hES-MP cells were cultured without Dex,
since Dex itself induces differentiation [317]. Without Dex no changes in
ALP activity or matrix production were observed with continuous 1mM LiCl
treatment. LiCl itself therefore did not induce osteogenic induction but did
synergistically increase osteogenic markers when used on stem cells stimulated
by Dex to differentiate. Additionally, since this same treatment regime (contin-
uous 1mM LiCl in SM) promoted increases in matrix production in MLO-A5s,
which are mature bone cells, these results suggest 1mM LiCl treatment alone
only promotes osteogenic responses in osteogenically differentiating cells or
in mature bone cells and does not induce osteogenic differentiation itself. In
contrast Tang et al. investigated LiCl effects on osteogenic differentiation,
concluding that LiCl does induce osteogenic differentiation. However, the
MSCs were cultured with Dex and therefore, their conclusion that LiCl induces
osteogenic differentiation may be inaccurate [318].
A number of case-control studies investigating fracture risk in osteoporotic
psychiatric patients have shown lithium treatment can reduce fracture risk
[281–283]. A study by Zamani et al. found lithium treatment in patients
increased bone mineral density in the spine, femoral neck and trochanter
[231]. Additionally, an in vivo study of mice fed lithium rich diets by Clement-
Lacroix et al. also found increases in bone mineral density due to lithium [289].
Similarly to the in vivo studies, continuous lithium treatment applied at a
therapeutically relevant concentration (1mM) increased osteogenesis. One
mechanism by which lithium acts is though inhibition of GSK3-β. The Ki for
lithium on GSK3-β has been shown to be 2mM in isolated GSK3-β, which
would suggest that the increase in osteogenic markers with continuous 1mM
lithium exposure would not be due to inhibition of GSK3-β [319]. Other in
vitro studies investigating the osteogenic effects of lithium have typically used
5mM LiCl or above and would therefore be above this threshold [291,315,318].
However, the Ki has been shown to be greatly dependent upon the free Mg2+
concentration and at Mg2+ levels found within cells; the Ki is reduced to
0.8mM LiCl [320,321]. As the 1mM LiCl concentration used here is above this
threshold, GSK3-β inhibition could be a mechanism behind the increase in
osteogenic markers and proliferation and would also be relevant to the anabolic
actions on bone seen in vivo. Together this suggests lithium, or alternative
drugs that target GSK3-β or the canonical Wnt signalling pathway could be
used therapeutically as an anabolic agent for bone.
Although continuous LiCl treatment increased osteogenic markers in hES-MP
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cells at a therapeutically relevant concentration, it also required the use of
Dex to have this effect. When used therapeutically LiCl is not typically used
in combination with steroids. Therefore, the observation of other studies that
bone mineral density increases with lithium treatment may not be due to
increased bone stem cell differentiation. Increased stem cell proliferation
may however play a part, since this was observed without the use of Dex.
Continuous 1mM LiCl treatment did however increase matrix production
in MLO-A5 cells which were not cultured with Dex. Therefore, the increase
in bone mineral density observed with LiCl treatment in vivo could be due
to increased matrix production from osteoblasts and not from any increased
osteogenic differentiation of stem cells. However, both increased stem cell
proliferation and increased matrix production from osteoblasts would be ben-
eficial in increasing bone health in osteoporotic patients, improving fracture
healing and in bone tissue engineering. Studies have highlighted the poten-
tial benefits of short-term systemic lithium administration to improve bone
fracture healing through increased stem cell proliferation and matrix produc-
tion. In an in vivo study by Vachhani et al., ovariectomised rats subjected to
femoral diaphyseal fracture were administered lithium [322]. This resulted
in a 50% higher maximum yield torque compared to the control and better
periosteal and mineralized callus bridging. Another similar study by Wang et
al. found that rats subjected to an osteotomy and distraction showed greater
bone mineral density and better continuity in the regenerated bone mass in
the distraction gaps in rats administered lithium compared to the controls [323].
In addition to lithium’s systemic administration, lithium could also be admin-
istered locally, potentially avoiding or reducing side effects. Administration of
lithium to enhance matrix production locally would be beneficial in fracture
treatment, hip implants and other bone tissue engineering applications. Fur-
thermore, although the LiCl concentrations above 1mM applied here were
not found to be osteogenic, other studies have found higher concentrations
up to 20mM to be more osteogenic than lower concentrations [318,324]. Al-
though it would not be possible to apply these concentrations systemically, local
application of concentrations at this higher range could be possible without
inducing toxicity or severe side effects. Lithium could be administered locally
through injection or through incorporating lithium into implantable materials
that subsequently elute it into the local area. Li et al. for example, incorpo-
rated lithium into porous gelatin/hydroxyapatite nanospheres and implanted
them into rabbit femoral heads where they were found to improve new bone
formation at the defect site [325]. However, the study did not evaluate the
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concentration of lithium eluted. A similar study by Khan et al. incorporated
lithium into bioactive glass scaffolds and implanted them into rabbit femoral
head defects [326]. Scaffolds incorporating lithium also showed increased
new bone formation and better scaffold integration compared to the control
bioactive glass scaffolds.
To avoid administration of lithium and introducing it into the body, lithium
could be used in the pre-treatment of bone tissue engineered scaffolds to
promote matrix production in scaffolds before implantation. This would take
advantage of the positive effects of lithium on matrix production whilst avoid-
ing any potential toxicity of lithium within the body. The increases in matrix
production with continuous 1mM LiCl found here highlight this potential
use. For implant use, an alternative stem cell source to hES-MP cells would
be required, such as the patient’s own MSCs. Additionally, the PU scaffold
used here would also not be suitable for implantation and would therefore also
require an alternative scaffold. However, these results do demonstrate a proof
of concept for using lithium in vitro to improve matrix production in tissue
engineered bone constructs.
Although continuous LiCl treatment was found to be osteogenic, intermittent
0.1 and 1mM LiCl treatment in hES-MP and MLO-A5 cells and 10mM in
hES-MP cells was not found to be osteogenic in static conditions and did
not affect cell viability. Intermittent 0.1, 1 and 10mM LiCl treatment could
therefore be used in hES-MP cells and 1mM in MLO-A5 cells to investigate
the mechanoinduced osteogenic effects of LiCl.
To investigate whether primary cilia elongation could be a potential method
by which lithium treatment increases osteogenesis in vivo, primary cilia
length and prevelance was also evaluated. In vitro studies utilising osteogenic
cell types have shown primary cilia elongation at physiological (≤1mM)and
supraphysiological (>1mM) concentrations of lithium [205,327,328]. At the
physiologically relevant concentrations, primary cilia elongation varies between
46% (0.5mM LiCl [205]) and 80% (1mM LiCl [328]). At the physiologically
relevant concentrations tested here, 0.1mM had no effect on primary cilia
length in hES-MP cells cultured in monolayer. 1mM LiCl increased primary
cilia length by 42% in hES-MP cells and 96% in MLO-A5 cells. The lack
of primary cilia elongation with 0.1mM LiCl treatment is likely due to the
concentration being below the threshold at which it has an effect. Since Spasic
et al. found 0.5mM LiCl did elongate primary cilia, this threshold is likely to
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be somewhere between 0.1 and 0.5mM. Due to having no effect on primary
cilia length in hES-MP cells in monolayer culture, 0.1mM LiCl treatment was
not used in any further primary cilia elongation experiments. At 1mM LiCl,
the increases observed in hES-MP (42%) and MLO-A5 cells (96%) are similar to
the 46% and 80% elongation found at physiologically relevant concentrations by
Spasic et al. and Oliazadeh et al. Although there have been no in vivo studies
investigating the effects of lithium on primary cilia length in bone cells, there
have been studies in other cell types that have shown lithium can increase
primary cilia length in vivo. One such study by Thompson et al. found Wistar
rats administered dietary lithium resulted in a 19% increase in primary cilia
length in chondrocytes [210]. The lack of in vivo studies investigating cilia
elongation in osteogenic cells is likely due to the difficulties in imaging the
organelle in vivo. Taken with the fact primary cilia elongation does occur in
vivo in other cells and that hES-MP and MLO-A5 cells were elongated with
the physiologically relevant concentrations of LiCl used here, it is certainly
possible that primary cilia of osteogenic cells would also elongate in vivo with
lithium treatment.
At supraphysiological concentrations of LiCl, Oliazadeh et al. and Shi et
al. observed primary cilia elongation of 166% (10mM) and 139% (5mM) respec-
tively. Although 10mM LiCl also elongated hES-MP primary cilia to a greater
extent than 1mM LiCl, it was only a modest increase (53%) in elongation
compared to that found by Oliazadeh et al. and Shi et al. Although elongation
did not increase as much with higher concentrations as was found by Oliazadeh
et al., primary cilia elongation still increased in a dose dependant manner. The
differences in elongation may be due to different sensitivities of the cells used in
each of the experiments. This is supported by the fact that 1mM LiCl increased
hES-MP and MLO-A5 cell primary cilia by different extents (42% compared
to 96% respectively). Alternatively, the difference may be due to 10mM LiCl
being cytotoxic to hES-MP cells. As although with short-term treatment (as
was used when elongating primary cilia), 10mM LiCl was not found to affect
cell viability, but with continuous treatment it did and could therefore, still be
having a negative effect on the cells. This may prevent primary cilia elongation
to the extent seen by Oliazadeh et al. Further evidence was seen with the
reduction in the number of ciliated cells. LiCl treatment did not affect the
number of ciliated cells at any other concentration used and was not reduced
by the 10mM LiCl treatment used by Oliazadeg et al. The reduction in the
number of ciliated cells is therefore likely due to the toxicity of LiCl rather
than it having a specific effect on ciliogenesis.
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The previously discussed studies were all performed in monolayer culture
and to the authors knowledge no 3D in vitro studies have been performed
assessing the effects of LiCl on primary cilia length in osteogenic cells. Inter-
estingly, in 3D culture the primary cilia of both hES-MP and MLO-A5 cells
were shorter, by 63% and 37% respectively. The greater reduction in length
with 3D culture in hES-MP cells compared to MLO-A5 cells is likely due to the
primary cilia being longer in monolayer hES-MP culture and therefore, could
have a greater decrease in length. Primary cilia have also been shown to be
shorter in 3D culture compared to monolayer culture in a study by Zhang et
al., where MSCs were roughly 39% shorter when cultured on a 3D structured
surface compared to when cultured on glass coverslips [329]. Similarly to the
results presented here, the materials of the monolayer and 3D surfaces used
by Zhang et al. were different. It is therefore possible that instead of, or in
addition to the change to a 3D environment having an effect on cilia length, the
actual material itself may be affecting primary cilia length. Interestingly, the
study by Zhang et al. went further and evaluated the effects of different surface
topographies of the same material on primary cilia length and found primary
cilia were longer on surfaces with a submicron topography compared to a
micron topography. In addition to primary cilia length, the number of ciliated
cells were also found to be lower in micron topography scaffolds compared to
submicron and glass coverslips. Primary cilia prevalence was only found to
be lower in MLO-A5 cells cultured in 3D compared to monolayer and not in
hES-MP cells. From this it is clear that surface topography and therefore
3D culture compared to monolayer culture can alter primary cilia length and
prevalence. These changes could be caused by a variety of factors known to be
different in 3D culture compared to monolayer culture.
One of the major differences in 3D culture compared to monolayer culture is cell
attachment, which regulates many fundamental cellular behaviours such as,
differentiation and proliferation [330,331]. Since primary cilia are only present
during G1 and G0 phases of the cell-cycle, changes in cell proliferation can
have an effect on primary cilia prevalence [332]. It would therefore be logical
that a decrease in proliferation rate would result in an increase in primary
cilia prevalence. However, counter-intuitively the opposite was found here and
3D culture of MLO-A5 cells resulted in a decrease in proliferation rate and
a decrease in primary cilia prevalence. Additionally, although hES-MP cell
proliferation was also lower in 3D compared to monolayer culture, primary
cilia prevalence was not affected. These results suggest proliferation rate does
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not have an effect on primary cilia prevalence. Since not all cells that have
exited the cell division cycle generate a primary cilium, cilia prevalence must
be affected by more than just the rate of proliferation [333].
In relation to proliferation, the level of confluence is also known to influ-
ence primary cilia prevalence [334]. It is difficult to compare confluence levels
between monolayer and 3D cultures and the idea of "confluence" may not
be relevant to 3D culture. However, in monolayer at "confluence" cell-cell
contact and spatial confinement of cells is at its maximum. Of these, spatial
confinement has been shown to play a role in ciliogenesis and could therefore
be a mechanism behind why "confluence" results in a higher cilia prevalence
[333]. In MLO-A5 cells in 3D culture primary cilia prevalence was measured
on day 3 of culture compared to day 7 of culture in hES-MP cells. Although
MLO-A5 cells both grow and deposit matrix faster than hES-MP cells, due
to the earlier timepoint of the measurement the MLO-A5 cells would have
proliferated less and deposited little matrix. This would likely result in a lower
level of spatial confinement compared to the hES-MP cells and may explain
the lower primary cilia prevalence observed.
Interestingly, the lengths of primary cilia in 3D culture were closer to the
lengths found in bone in vivo compared to those of monolayer culture [335].
Shorter primary cilia in vivo compared to monolayer culture have also been
observed in other cell types such as chondrocytes [210]. In a study by Coughlin
et al. primary cilia were measured in cells within the trabeculae and within
bone marrow, where primary cilia were found to be longer in both osteoblasts
and osteocytes (1.65µm) within the bone compared to the cells within the
marrow (1.46µm). The pericellular space between osteocytes and the lacunar
wall has been reported to be between 0.1µm-2.7µm with a typical space of
1µm which suggests that this spatial constraint is what limits primary cilia
length in osteocytes [335–338]. However, the cells within bone marrow have no
such spatial constraint. Additionally, the 3D cultured hES-MP and MLO-A5
cells would not be under these same spatial constraints and they also had
similarly short primary cilia lengths of 1.1µm and 1.3µm for MLO-A5 and
hES-MP cells respectively. It is therefore likely that primary cilia lengths are
not shorter in vivo and in 3D culture compared to monolayer culture due to
spatial constraints but instead may be due to differences between the "2D" and
3D environment.
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5.6 Summary
To summarise, a LiCl treatment regime that did not alter osteogenesis in static
conditions was developed in monolayer and in 3D culture. Continuous doses of
1mMLiCl was found to promote osteogenic markers and was therefore excluded
from use. However, when used intermittently 1mM LiCl did not alter osteoge-
nesis. This same treatment regime was also found to increase primary cilia
length without affecting primary cilia prevelance. Since primary cilia length is
thought to be one mechanism by which cells regulate their mechanosensitivity.
This LiCl induced primary cilia elongation could be one mechanism behind any
LiCl induced changes in mechanotransduction.
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6. Response of bone andbonepre-
cursor cells to fluid shear
6.1 Introduction
Mechanical loading is well known to stimulate osteogenic responses in os-
teogenic cells both in vivo and in vitro. In vivo this functions to stimulate bone
remodelling to ensure the demands of its mechanical environment are met.
Within bone itself, osteogenic cells such as osteoblasts, osteocytes and bone
precursor cells are all subjected to mechanical stimuli. Mature osteocytes are
thought to mainly have a mechanosensory role within bone and do not actively
produce bone matrix. Osteoblasts are produced from bone precursor cells and
although their main role is the production of bone matrix, osteoblasts and their
precursors have also been shown to be mechanosensitive. It is therefore likely
that all three of these cell types play an important part in mechanosensation
and adaptation within bone.
Bone cells are subjected to a number of different mechanical stimuli from
compression to fluid shear stress (FSS). In vitro FSS is a commonly used
mechanical stimulus used to study the response of osteogenic cells to me-
chanical stimuli. However, these studies are typically short-term studies that
evaluate cell signalling, such as calcium signalling or upregulation of genes
such as runt-related transcription factor 2 (RUNX2), ALP and COX-2. These
short-term studies are suitable for evaluating osteocyte responses to FSS, since
they themselves do not actively produce bone matrix. However, since these
studies only evaluate initial responses, it is not always clear whether these
would translate into long-term osteogenic responses such as osteogenesis in
osteoblasts or their precursors. Osteogenesis itself takes multiple weeks to
occur and therefore requires longer term studies.
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Assessment of osteogenesis in response to mechanical stimuli in vitro requires
a device that allows application of fluid flow in combination with long-term
culture of cells. This excludes parallel plate flow chambers, one of the most
commonly used methods to apply FSS, as they become blocked with long-term
matrix production. Two devices that can be used to apply FSS and allow
long term culture are rocking platforms and orbital shakers. Both of these
devices allow the use of standard well plates, are high throughput. However,
only rocking platforms can apply oscillatory fluid flow which is thought to
more closely replicate that of the FSS stimulus that occurs in vivo. The FSS
produced by rocking platforms (<0.1Pa) is likely lower than that which bone
cells are subjected to in vivo, which has been theorised to range between
0.3-25Pa [339,340]. Despite this, previous studies have shown bone cells to be
sensitive to this low-level stimulus [132,240]. Furthermore, since the use of
low-level stimuli is unlikely to saturate mechanoresponses, rocking platforms
may be useful when assessing the effects of treatments aimed at increasing
mechanosensitivity.
6.2 Aims and objectives
The aim of this chapter was to explore the mechanoresponse of osteogenic
progenitor and osteoblast cells to low-level FSS. This was performed in order
to develop an optimised mechanical loading regime that could be used to inves-
tigate the effects of lithium on mechanotransduction. The following objectives
were addressed in order to achieve this:
• Evaluate the effect of rocking frequency on three cell lines (MLO-
A5, MC3T3-E1 and hES-MP) that have previously been shown to be
mechanosensitive.
• Evaluate the effect seeding density has on osteogenic responses to FSS.
• Evaluate the effects culture conditions, in particular temperature and
CO2 concentrations have on osteogenic responses to FSS.
• Evaluate the effect the duration of Dex exposure has on osteogenic re-
sponses to FSS in hES-MP cells.
• Evaluate the effect of serum batch variability on osteogenic responses to
FSS in hES-MP cells.
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6.3 Methods
6.3.1 Application of fluid shear stress
Oscillatory FSS was generated in circular 6-well plates through the use of
either a Stuart SSL4 see-saw rocker (Stuart, UK) or an IKA 2D digital see-saw
rocker (IKA, UK). The use of a see-saw rocker and circular wells has previously
been implemented by Delaine-Smith et al. to stimulate osteogenic responses
in hES-MP and MLO-A5 cells [132,240]. The choice of circular wells compared
to square wells is not optimum as the shear stress on the bottom surface in
circular wells is not evenly distributed as it would be in square wells. However,
as previous studies utilised circular wells, circular wells were also used here to
allow cross-comparison. Initially a Stuart SSL4 rocker was utilised following
the same method used by Delaine-Smith et al. Well plates with 2ml of media
were placed on the rocking platform and subjected to either 0.75Hz or 1Hz.
Since the Stuart rocking platform was not suitable for use in an incubator
an IKA rocking platform was also used to stimulate cells. The IKA rocking
platform had a lower maximum tilt angle of 5° compared to the 7° of the Stuart
rocking platform. Therefore instead of 1Hz a higher frequency of 1.33Hz was
chosen to match the FSS generated by the rocking platform used by Delaine-
Smith et al. (0.05Pa. The characteristic FSS magnitude (τ), defined as the
FSS at the centre of the well when the plate is horizontal, was calculated using
a model developed by Zhou et al. (Equation 6.1) where μ is the fluid viscosity
(1× 10−3 Pa s, θmax is the maximum tilt angle of the platform (radians), sigma
is the ratio of the fluid depth (2.08mm) to diameter (35mm) in the well and T
is the time for one cycle (seconds). The manufacturers stated maximum angle
of 7° (0.122 rad) was used for the Stuart rocker and the IKA rocker was set at
its maximum 5° (0.087 rad) tilt angle. The characteristic FSS was calculated
using these manufacturer stated tilt angles for each rocker frequency used
(Table 6.1).
|τ| =
piμθmax
2δ2T
(6.1)
MLO-A5 rocking
MLO-A5 cells are a fast-growing post-osteoblast/pre-osteocyte cell line. The
doubling rate of the batch of cells initially used was greater than the doubling
rate reported by Kato et al. and also appeared greater compared to the growth
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Table 6.1: Theoretical characteristic FSS (τ) generated by see-saw rockers
Rocker Frequency (Hz) |τ| (Pa)
Stuart SSL4 0.75 0.041 0.05
IKA 2D Digital 0.75 0.031.33 0.05
rate of the MLO-A5 cell used by Delaine-Smith et al. [269]. This resulted in cell
detachment and death during long term experiments when cells were seeded at
1,000 cells cm−2, as used by Delaine-Smith et al. Therefore, the seeding density
was lowered to 50 cells cm−2 which prevented this. Additionally, a new batch
of cells was purchased from Kerafast (Boston, USA) and experiments were
repeated at 1,000 cells cm−2. Cells were cultured in 6-well plates in 2mL of
media and subjected to rocking at room temperature on a Stuart rocker or in an
incubator on an IKA rocker, static cells were also placed at room temperature
for 1 hour for room temperature experiments. Cells were rocked for 1 hour
per day, 5 days per week, from day 3 at 0.75Hz or 1Hz on a Stuart rocker and
0.75Hz or 1.33Hz on an IKA rocker.
hES-MP rocking
hES-MP cells were seeded at 1,000 or 10,000 cells cm−2 in a 6well plate to assess
the effect of seeding density on mechanically induced osteogenic responses.
Cells were cultured in one of three different batches of FBS and BMwas changed
to OIM on day 1 of culture. On day 5 of culture Dex was either withdrawn
from the media for the remainder of culture (DW) or Dex was not withdrawn.
Rocking was performed for 1, 2 or 3 hours per day, 5 days per week, from day 7
at 1Hz or 1.33Hz on an IKA rocker at room temperature or in an incubator.
MC3T3-E1 rocking
MC3T3-E1 cells are another osteogenic cell line that have previously been
shown to be sensitive to mechanical stimuli [86,341,342]. Cells were seeded
at 200,000 cells per well in a 6 well plate in 2mL of media and subjected to
rocking in an incubator on an IKA rocker. Rocking was performed for 1 hour
per day 5 days per week from day 7 at 0.75Hz or 1.33Hz.
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6.3.2 Rocker characterisation
An inertial measurement unit (OPAL, APDM Inc., Portland, Oregon USA)
was used to measure rocking platform movement to characterise the rocking
platform’s cycle frequency. The inertial measurement unit was located in
the same position as where well plates were placed for rocking experiments
and firmly secured to the platform. The signals were recorded for 5 cycles
once the rocker had been running for 30 seconds at a sampling frequency of
128 samples s–1. The acquired acceleration data was low pass filtered using
a 4th order Butterworth filter with a cut-off frequency of 5Hz and any DC
offset was removed. The tilt angle of the rocker was calculated using Equation
6.2 where a is the acceleration and g is acceleration due to gravity taken as
9.807ms−2. The tilt angle was plotted and the mean frequency of the rocker
was calculated using the built in Matlab function “meanfreq”. Mean peak tilt
angle was calculated by averaging peak tilt angle from each half cycle.
θ = sin–1
a
g

(6.2)
The calculated angles over the rocking period were then used to calculate the
characteristic wall shear stress and the wall shear stress at three points in the
well plate over the rocking cycle using another model developed by Zhou et al.
(Equation 6.1, 6.3) [83].
|τ| =
2piμθmaxx(2R – x)
T(h0cotθ +R – x)2sin2θ
cos
2pit
T
(6.3)
6.4 Results
6.4.1 Rocker platform cycle characterisation
The Stuart rocking platform cycle did not conform with the set frequency,
with measurements showing a mean frequency of 0.89Hz (14% higher) and
1.21Hz (21% higher) when set at 0.75Hz and 1Hz respectively (Figure 6.1).
Additionally, the mean peak tilt angle was also found to be higher at 9.13° and
10.2° respectively. This resulted in 1.2% (0.051Pa) and 2.4% (0.077Pa) higher
characteristic FSS than that calculated using the set values for "0.75Hz" and
"1Hz" respectively. The IKA rocking platform showed more reliable values,
with measurements showing a mean frequency of 0.79Hz (3.4% higher) and
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1.38Hz (4.9% higher) when set at 0.75Hz and 1.33Hz respectively. The mean
peak angles also deviated less from the set values at 5.5° and 5.9° when set
at 5° for 0.75Hz and 1.33Hz respectively. These deviations resulted in 0.2%
(0.03Pa) and 1% (0.077Pa) higher characteristic FSS than that calculated
using the set values for "0.75Hz" and "1.33Hz" respectively.
The FSS at 3 points parallel to the fluid movement along the centre of the base
of the well were calculated ( xR = 1, 0.75, 0.5, where x is the distance from the
well edge and R is the diameter). The FSS varied between points in the well
becoming higher the nearer to the edge of the well (Figure 6.2). The FSS varied
in a sinusoidal manner at the centre of the well ( xR = 1) but deviated from a
typical sinusoidal wave at xR = 0.75 and 0.5. This was particularly evident with
the Stuart rocking platform at xR = 0.5 where the FSS had an initial peak of
0.07Pa or 0.2Pa followed by a second peak of 0.05Pa or 0.12Pa for 0.75Hz
and 1Hz cycles respectively. Peak FSS levels with the IKA rocking platform
only varied slightly between positions in the well and between each peak.
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6.4.2 Rocker culture of MLO-A5
Initial rocking experiments were performed with a Stuart rocking platform.
However, after its rocking cycle was shown to be unreliable further experiments
were performed with an IKA rocking platform that had the added benefit of
being rated for use in an incubator.
Influence of seeding density on osteogenic responses to FSS
Seeding density had no significant effect on cell growth rate at room tem-
perature or when stimulated in an incubator. Both low and high seeding
densities had similar increases in metabolic activity over 14 days at each
temperature (Figure 6.3, 6.4). There were also no significant differences in
metabolic activity between static and rocked groups at either seeding density
at either temperature. Both metabolic activity and total DNA levels were
higher when cells were seeded at a higher seeding density compared to the
lower seeding density.
Both static and rocked groups had similar levels of ALP activity suggest-
ing FSS had no effect on ALP activity (Figure 6.5, 6.6).
Both DR80 and ARS staining showed patchy staining spread across the bottom
surface of the wells at low seeding density at both temperatures (Figure 6.7,
6.8). ARS staining was more intense and covered a greater area in the cells
stimulated in an incubator compared to at room temperature. Areas of staining
corresponded with colonies of confluent cells. There were no visual differences
between staining of rocked groups compared to static groups in terms of stain-
ing intensity or staining distribution in cells seeded at low-density. This was
further confirmed quantitatively, with no differences between groups when
samples were destained. At high seeding density, both ARS and DR80 staining
was more evenly distributed on the bottom surface of the wells. There were no
visual differences in terms of distribution and staining intensity between static
and rocked groups in cells stimulated at room temperature. However, when
stimulated in an incubator ARS staining was more intense in cells subjected to
1.33Hz and when destained was also quantitatively higher than the statically
cultured cells. There were no consistently observable differences in staining
distribution between static or rocked cells or between each rocking frequency.
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Figure 6.3: Effect of FSS on MLO-A5 metabolic activity over 14 days of mono-
layer culture at a high and low seeding density. Cells were mechanically
stimulated on a Stuart rocking platform for 1h, 5 days per week from day 3 at
room temperature. Metabolic activity was assessed with RR. Data represents
mean ± SD n=9.
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Figure 6.4: Effect of FSS on MLO-A5 metabolic activity over 14 days of mono-
layer culture at a high and low seeding density. Cells were mechanically
stimulated on a IKA rocking platform for 1h, 5 days per week from day 3 in
an incubator. Metabolic activity was assessed with RR. Data represents mean
± SD n=9. Fluorescence was measured at λex: 540nm and λem: 590nm.
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Figure 6.5: Effect of FSS on MLO-A5 day 7 cell number and ALP activity in
monolayer culture at a high and low seeding density. Cells were mechanically
stimulated on a Stuart rocking platform for 1h, 5 days per week from day
3 at room temperature. (A) Total DNA. (B) ALP activity. (C) ALP activity
normalised to total DNA. Data representsmean± SD n=9. # = p<0.05 compared
to the high seeding density.
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Figure 6.6: Effect of FSS on MLO-A5 day 7 cell number and ALP activity in
monolayer culture at a high and low seeding density. Cells were mechanically
stimulated on an IKA rocking platform for 1h, 5 days per week from day 3 in
an incubator. (A) Total DNA. (B) ALP activity. (C) ALP activity normalised to
total DNA. Data represents mean ± SD n=9. # = p<0.05 compared to the high
seeding density.
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Figure 6.7: Effect of FSS onMLO-A5matrix formation in monolayer culture at
a high and low seeding density. Cells were mechanically stimulated on a Stuart
rocking platform for 1h, 5 days per week from day 3 at room temperature. (A)
Day 14matrix calcium quantified by ARS. (B) Day 14matrix collagen quantified
by DR80. Data represents mean ± SD n=9. # = p<0.05 compared to the high
seeding density. Representative photographs of stained wells are shown below
their corresponding graphs.
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Figure 6.8: Effect of FSS onMLO-A5matrix formation in monolayer culture at
a high and low seeding density. Cells were mechanically stimulated on an IKA
rocking platform for 1h, 5 days per week from day 3 in an incubator. (A) Day 14
matrix calcium quantified by ARS. (B) Day 14 matrix collagen quantified by
DR80. Data represents mean ± SD n=9. # = p<0.05 compared to the high
seeding density. Representative photographs of stained wells are shown below
their corresponding graphs.
131
Chapter 6. Response of bone and bone precursor cells to fluid shear
6.4.3 Rocker culture of MC-3T3 cells
Metabolic activity significantly increased from day 1 to day 21 of culture
increasing between each day except between day 14 and day 21 (Figure 6.9).
No significant differences were found between static and rocked samples at any
time point over the 21 day culture period. Similarly, day 14 DNA levels also
showed no differences between groups (Figure 6.10).
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Figure 6.9: Effect of FSS on MC3T3-E1 metabolic activity over 21 days of
monolayer culture. Cells were mechanically stimulated on an IKA rocking
platform for 1h, 5 days per week from day 7 in an incubator. Metabolic activity
was assessed with RR. Data represents mean ± SD n=9. Fluorescence was
measured at λex: 540nm and λem: 590nm.
There were no significant differences between total ALP activity of stati-
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cally cultured or rocked groups (Figure 6.10). This remained true when ALP
activity was normalised to total DNA content in each well. Normalised ALP
activity levels of MC3T3-E1 cells were similar to that of MLO-A5 cells.
ARS staining was evenly distributed over the surface of the well plate (Fig-
ure 6.11). ARS staining was significantly less intense than in MLO-A5 cells
and unlike in MLO-A5 cells, mineralised matrix was not nodular in appearance.
ARS levels in samples subjected to rocking did not differ from the statically
cultured samples. Collagen staining was found to be uniformly spread across
the majority of the well surface and when assessed quantitatively there were
no significant differences in collagen production found in cells subjected to
rocking, although 1.33Hz levels were lower.
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Figure 6.10: Effect of FSS on MC3T3-E1 day 14 cell number and ALP activity
in monolayer culture. Cells were mechanically stimulated on an IKA rocking
platform for 1h, 5 days per week from day 7 in an incubator. (A) Total DNA.
(B) ALP activity. (C) ALP activity normalised to total DNA. Data represents
mean ± SD n=9.
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Figure 6.11: Effect of FSS on MC3T3-E1 matrix formation in monolayer
culture. Cells were mechanically stimulated on an IKA rocking platform for
1h, 5 days per week from day 7 in an incubator. (A) Day 21 matrix calcium
quantified by ARS. (B) Day 21 matrix collagen quantified by DR80. Data
represents mean ± SD n=9. Representative photographs of stained wells are
shown below their corresponding graphs.
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6.4.4 Rocker culture of hE-SMP cells
Rocking was initially performed at room temperature to more closely follow
the method developed by Delaine-Smith et al. [82]. However, due to the
greater control of variables offered by rocking within an incubator, subsequent
experiments were performed using an incubator.
Influence of seeding density on osteogenic responses to FSS
To assess the influence of seeding density on osteogenesis in response to FSS
stimulation, hES-MP cells were seeded at a low and high density and subjected
to rocking in OIM. Cell metabolic activity increased from day 1 to day 21 in all
groups with no significant difference between high and low seeding densities on
day 21 (Figure 6.12). Rocking had no adverse effects on cell metabolic activity
at 0.75Hz or 1.33Hz in either low or high density seeded cells.
Although RR showed no significant differences between static and rocked
groups on day 14 of culture, day 14 DNA was higher in the static group com-
pared to the 0.75Hz rocked group (Figure 6.13). However, similarly to the RR
results, DNA was significantly lower in all low-density groups compared to
high density groups. There were no significant differences between static and
rocked groups at low-density. Total ALP activity was significantly lower in all
low-density groups compared to high density groups. There were no significant
differences between static and rocked groups at low-density. At high density
cells subjected to 0.75Hz had significantly less total ALP activity compared to
statically cultured cells. However, when normalised to total DNA there was no
difference between static and rocked groups at high density.
HES-MP cells seeded at low-density showed very faint and patchy ARS staining
(Figure 6.14). ARS staining was inconsistent in cells subjected to 1.33Hz rock-
ing with some wells showing very faint staining similar to statically cultured
cells and other wells showing more intense staining as shown in Figure 6.14.
Qualitatively there were no significant differences between statically cultured
and cells rocked at 0.75Hz at low seeding density. Cells seeded at low-density
and subjected to 1Hz had significantly higher ARS compared to statically
cultured cells. Matrix mineralisation staining at high density was more in-
tense but still patchy. Staining was more intense at the edges of rocked wells
compared to statically cultured cells where staining intensity was more even
throughout the well. Both 0.75Hz and 1Hz rocked cells had significantly
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higher ARS levels compared to statically cultured cells. Collagen staining
was patchy throughout the well plate in low seeding density groups with no
differences between static and rocked samples. In high seeding density samples
collagen staining was more intense at the edge of the wells in both static and
rocked cells and patchy in the centre. There were no significant differences
between static and rocked samples.
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Figure 6.12: Effect of FSS on hES-MP metabolic activity over 21 days of
monolayer culture. Cells were mechanically stimulated on an IKA rocking
platform for 1h, 5 days per week from day 7 at room temperature. Metabolic
activity was assessed with RR. Data represents mean ± SD n=9. Fluorescence
was measured at λex: 540nm and λem: 590nm.
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Figure 6.13: Effect of FSS on hES-MP day 14 cell number and ALP activity
in monolayer culture. Cells were mechanically stimulated on an IKA rocking
platform for 1h, 5 days per week from day 7 at room temperature. (A) Total DNA.
(B) ALP activity. (C) ALP activity normalised to total DNA. Data represents
mean ± SD n=9. * = p<0.05 compared to the static control. # = p<0.05 compared
to the high seeding density.
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Figure 6.14: Effect of FSS on hES-MP matrix formation in monolayer culture.
Cells were mechanically stimulated on an IKA rocking platform for 1h, 5 days
per week from day 7 at room temperature. (A) Day 21 matrix calcium quantified
by ARS. (B) Day 21 matrix collagen quantified by DR80. Data represents mean
± SD n=9. * = p<0.05 compared to the static control. # = p<0.05 compared
to the high seeding density. Representative photographs of stained wells are
shown below their corresponding graphs.
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Influence of temperature on osteogenic responses to FSS
To have further control of variables during mechanical stimulation, such as
media pH and temperature, rocking was performed in standard conditions in
an incubator (5% CO2, 37 ◦C). There were no differences in culture conditions
between seeding and day 7 of culture. Cell metabolic activity increased at the
same rates between day 1 and day 7 of culture in all groups (Figure 6.15). From
day 7 of culture, cells were subjected to rocking at either room temperature
or in an incubator. The differences in temperature, humidity and CO2 had no
significant effects on metabolic activity levels at day 14 or day 21.
Although there were no significant differences found in terms of metabolic
activity, day 14 total DNA was found to be significantly lower in samples sub-
jected to 0.75Hz at room temperature compared to samples cultured statically
and samples subjected to rocking at 0.75Hz in an incubator (Figure 6.16).
There were no significant differences in total DNA between static and rocked
samples when stimulated in an incubator. Samples stimulated in an incubator
had significantly higher ALP activity both in terms of total ALP activity and
when normalised to total DNA. There were no significant differences in ALP
activity between static and rocked samples at either temperature.
Under static conditions matrix mineralisation was significantly higher
in incubated samples compared to samples subjected to room temperature
conditions (Figure 6.17). In rocked samples, at both frequencies there were no
significant differences between incubated and room temperature samples. At
both room temperature and when stimulated in an incubator, only samples
subjected to 1.33Hz had significantly greater matrix mineralisation compared
to statically cultured cells. Similarly to ARS samples cultured at room temper-
ature had significantly lower collagen staining compared to cells continuously
cultured in an incubator. Staining in cells stimulated at room temperature was
less evenly distributed throughout the well and often less intense. There were
no significant differences in collagen production between static and rocked
samples at either temperature.
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Figure 6.15: Effect of FSS on hES-MP metabolic activity over 21 days of
monolayer culture. Cells were mechanically stimulated on an IKA rocking
platform for 1h, 5 days per week from day 7 in an incubator. Metabolic activity
was assessed with RR. Data represents mean ± SD n=9. Fluorescence was
measured at λex: 540nm and λem: 590nm.
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Figure 6.16: Effect of FSS on hES-MP day 14 cell number and ALP activity
in monolayer culture. Cells were mechanically stimulated on an IKA rocking
platform for 1h, 5 days per week from day 7 in an incubator. (A) Total DNA. (B)
ALP activity. (C) ALP activity normalised to total DNA. Data represents mean
± SD n=9. * = p<0.05 compared to the static control. # = p<0.05 compared to
the room temperature stimulated group.
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Figure 6.17: Effect of FSS on hES-MP matrix formation in monolayer culture.
Cells were mechanically stimulated on an IKA rocking platform for 1h, 5 days
per week from day 7 in an incubator. (A) Day 21 matrix calcium quantified by
ARS. (B) Day 21 matrix collagen quantified by DR80. Data represents mean ±
SD n=9. * = p<0.05 compared to the static control. # = p<0.05 compared to the
room temperature stimulated group. Representative photographs of stained
wells are shown below their corresponding graphs.
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Influence of stimulus duration on osteogenic responses to FSS
Longer durations of rocking at 1.33Hz had no detrimental effects on metabolic
activity over 21 days of culture (Figure 6.18). Both static and rocked samples
metabolic activity increased from day 1 to day 7 with no further significant
increase between day 7 and day 21.
Increased rocking duration had no significant effect on matrix minerali-
sation or collagen production (Figure 6.19). Samples subjected to 1, 2 or 3h
of rocking all showed significantly higher matrix mineralisation compared to
statically cultured cells. Collagen production levels were similar between static
and rocked groups at all durations tested.
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Figure 6.18: Effect of rocking duration on hES-MP metabolic activity in mono-
layer culture over 21 days of monolayer culture. Cells were mechanically
stimulated on an IKA rocking platform for 1h, 2 h or 3h 5 days per week
from day 7 in an incubator. Metabolic activity was assessed with RR. Data
represents mean ± SD n=9.
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Figure 6.19: Effect rocking duration on hES-MP matrix formation in mono-
layer culture. Cells were mechanically stimulated on an IKA rocking platform
for 1h, 5 days per week from day 7 in an incubator. (A) Day 21 matrix cal-
cium quantified by ARS. (B) Day 21 matrix collagen quantified by DR80. Data
represents mean ± SD n=9. * = p<0.05 compared to the static control.
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Influence of media composition on osteogenic responses to FSS
Withdrawal of Dex from culture media had no significant effects on metabolic
activity at any subsequent RR assay days (Figure 6.20). Cells in both DW and
OIM samples showed similar increases in metabolic activity between day 1 and
day 7 and remained at similar levels between day 7 and day 21.
Although RR showed no differences in metabolic activity between groups,
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Figure 6.20: Effect of Dex withdrawal on hES-MP metabolic activity over
21 days in response to rocking in monolayer culture. Cells were mechanically
stimulated on a rocking platform for 1h, 5 days per week from day 7 in an
incubator. Metabolic activity was assessed with RR. Data represents mean ±
SD n=9. Fluorescence was measured at λex: 540nm and λem: 590nm.
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day 14 total DNA was significantly lower in cells continually cultured in OIM
both when statically cultured and when subjected to rocking (Figure 6.21).
There were no significant differences between static and rocked samples
whether Dex was withdrawn or not. In statically cultured samples ALP ac-
tivity was significantly lower in samples that had Dex withdrawn, both when
normalised to DNA and total levels. In samples subjected to rocking and DW,
ALP activity was only significantly lower when normalised to total DNA. There
were no significant differences in total or normalised ALP activity between
static and rocked groups whether Dex was withdrawn or not.
In static conditions Dex withdrawal resulted in significantly lower matrix
mineralisation compared to OIM cultured samples (Figure 6.22). However, in
Dex withdrawn samples, rocking stimulated matrix mineralisation to similar
levels to OIM cultured samples. Matrix mineralisation was significantly higher
in both OIM and DW samples when rocked compared to statically cultured.
Samples that had Dex withdrawn had significantly higher collagen matrix
compared to OIM cultured samples. Rocking had no significant effect on
collagen production whether Dex was withdrawn or not.
Metabolic activity increased between day 1 and day 7 in all sera when
statically cultured and rocked (Figure 6.23). Serum B had the lowest increase
in metabolic activity between day 1 and day 7 and was significantly lower
than both serum A and C. On day 14 of culture rocked samples cultured
in serum B had significantly lower metabolic activity compared to all other
samples except statically cultured samples in serum A and rocked samples in
serum B. On day 21 of culture metabolic activity was similar in all serum types.
Similarly to metabolic activity there was no significant differences in to-
tal DNA on day 14 of culture between serum A and C (Figure 6.24). Total
DNA was also lower in samples cultured in serum B compared to both serum
A and C. Cells cultured in serum C also had significantly lower total and
normalised ALP activity compared to cells cultured in serum B and C. There
was no difference in ALP activity in samples cultured in serum A compared to
serum C. Additionally, rocking had no effect on ALP activity in any of the sera
tested.
Serum B cultured samples had significantly lower mineralised matrix and
collagen production compared to both serum A and C cultured samples (Fig-
ure 6.25). Rocking only had a significant effect on matrix mineralisation in
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samples cultured in serum A, where samples subjected to rocking had sig-
nificantly more mineralised matrix compared to statically cultured samples.
Collagen production was not affected by rocking in any of the tested sera.
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Figure 6.21: Effect of Dex withdrawal on hES-MP day 14 cell number and
ALP activity in monolayer culture. Cells were mechanically stimulated on an
IKA rocking platform for 1h, 5 days per week from day 7 in an incubator. (A)
Total DNA. (B) ALP activity. (C) ALP activity normalised to total DNA. Data
represents mean ± SD n=9.# = p<0.05 compared to the OIM cultured group.
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Figure 6.22: Effect of Dex withdrawal on hES-MP matrix formation in mono-
layer culture. Cells were mechanically stimulated on an IKA rocking platform
for 1h, 5 days per week from day 7 in an incubator. (A) Day 21 matrix calcium
quantified by ARS. (B) Day 21 matrix collagen quantified by DR80. Data repre-
sents mean ± SD n=9. * = p<0.05 compared to the static control. # = p<0.05
compared to the OIM cultured group. Representative photographs of stained
wells are shown below their corresponding graphs.
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Figure 6.23: Effect of different sera on hES-MPmetabolic activity over 21 days
in response to rocking inmonolayer culture. Cells weremechanically stimulated
on a rocking platform for 1h, 5 days per week from day 7 in an incubator.
Metabolic activity was assessed with RR. Data represents mean ± SD n=6.
Fluorescence was measured at λex: 540nm and λem: 590nm.
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Figure 6.24: Effect of different sera on hES-MP day 14 cell number and
ALP activity in monolayer culture. Cells were mechanically stimulated on
an IKA rocking platform for 1h, 5 days per week from day 7 in an incubator.
(A) Total DNA. (B) ALP activity. (C) ALP activity normalised to total DNA.
Data represents mean ± SD n=6. * = p<0.05 compared to the static control.
# = p<0.05 compared to serum A.
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Figure 6.25: Effect of different sera on hES-MPmatrix formation in monolayer
culture. Cells were mechanically stimulated on an IKA rocking platform for
1h, 5 days per week from day 7 in an incubator. (A) Day 21 matrix calcium
quantified by ARS. (B) Day 21 matrix collagen quantified by DR80. Data
representsmean± SDn=6. * = p<0.05 compared to the static control. # = p<0.05
compared to serum A.
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6.5 Discussion
This chapter investigated the response of osteogenic progenitors (hES-MP) and
osteoblast (MLO-A5, MC3T3-E1) cell lines to low-level FSS. Following the proto-
col developed by Delaine-Smith et al., MLO-A5 cells were not found to respond
to low-level FSS [132]. When the protocol was modified by performing the
stimulation in an incubator, cells were found to respond to the FSS. However,
the increase in mineralised matrix production was of a lesser extent to that re-
ported by Delaine-Smith et al. Another osteoblast cell line, MC3T3-E1, also did
not respond to low-level FSS. The osteogenic progenitor cell line, hES-MP was
found to respond to low-level FSS following a similar protocol to that developed
by Delaine-Smith et al. [240]. However, this was again to a lesser extent to
that reported by Delaine-Smith et al where matrix mineralisation more than
doubled. With further optimisation of the culture conditions the increase in
matrix mineralisation due to FSS was increased but was still lower than double.
MLO-A5 cells are a fast-growing osteoblast-like cell line with doubling times
of less than two days (data not shown). Initial experiments found that when
seeded at 1,000 cells cm−2 MLO-A5 cells detached resulting in cell apopto-
sis during long-term culture. The seeding density was therefore reduced to
50 cells cm−2 to prevent this cell detachment and subsequent apoptosis. Al-
though this prevented the problem it resulted in the formation of cell colonies
rather than a confluent cell sheet at the bottom of the well. Additionally, ALP
activity and matrix production were low and no apparent responses to the
application of FSS at room temperature were observed. Since cell confluence is
an important factor in matrix production and mineralisation, the low levels of
osteogenesis and lack of response to FSS observed may be due to the lack of
confluent cell sheet [343]. The issue of cell detachment may have been caused
by a change in phenotype in the cells due to the high passage number. Cell
phenotype, including osteogenic characteristics and cell growth are known to
be influenced by passage number [344]. However, the passage numbers used
(28-31) in this study were within the same 25-30 range used by Delaine-Smith
et al. As no information was available as to any passage limit for this cell line,
a new batch of MLO-A5 cells were purchased from Kerafast and used between
passage 22-25 (cells were received as passage 21).
This batch of MLO-A5 cells did not have the same issues of detachment
and death at higher density and had similar levels of ALP and matrix produc-
tion (data not shown). When rocking was repeated at room temperature at the
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higher seeding density with this batch of cells there was still no response to
FSS observed.
It was also noted that the Stuart rocker that was used to stimulate the
MLO-A5 cells did not seem to be functioning as designed. This was confirmed
by measuring the rocking cycle using an inertial measurement unit. The
Stuart rocking platform was found to have a higher tilt angle than designed
on one half of the cycle. Surprisingly, although this resulted in a higher FSS
being applied to the cells it had not resulted in any FSS stimulated osteogenic
responses. This may have been due to the higher FSS being offset by the fact
the higher tilt angle resulted in the platform passing the critical flip angle
(the angle at which media no longer covers the entirety of the bottom of the
well plate). As noted by Zhou et al., exceeding the critical flip angle results
in a FSS discontinuity at regions where the media loses contact but also in
a FSS singularity at two regions in the well plate [83]. The discontinuity of
FSS during rocking would result in a loss of stimulus to those cells affected.
Additionally, the FSS singularity may have been at a detrimentally high level
further affecting the ability of the cells to respond to the stimulus. The use
of this rocker was therefore discontinued and an IKA rocking platform was
purchased and characterised. Characterisation of this rocker showed it did
not surpass the critical flip angle and more closely adhered to its designed
characteristics. An added benefit of the IKA rocking platform was that it
was also rated for use in an incubator allowing further variables such as
temperature and media pH to be more tightly controlled.
When rocking was performed in an incubator using the IKA rocking platform,
increases in matrix mineralisation at 1.33Hz were observed with MLO-A5 cells.
This suggests that the environmental conditions provided by the incubator
were more favourable to mechanotransduction in MLO-A5 cells. Cold stress
and heat shock can be caused by a change in temperature of only a few degrees
and results in a wide array of cellular responses. Performing rocking in the
incubator thus prevented both cold stress when cells were removed from the
incubator and heat shock when cells were reintroduced to the incubator. With
hES-MP cells these changes in environmental conditions appeared to be less of
an issue. However, Puwanun found that both hES-MP cells and primary human
jaw periosteum cells mineralised differently in room temperature compared to
incubator conditions [345]. This was dependent upon the supplements added
to the media with higher mineralisation in room temperature conditions when
cultured in SM and higher in incubator conditions when cultured in OIM.
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Although metabolic activity was found to be affected, osteogenic responses were
stimulated by FSS at both room temperature and in an incubator. However,
the temperature of the room was not recorded during rocking and it was noted
that during summer months, when the hES-MP experiments were conducted,
temperatures ranged between 22-27 ◦C compared to the winter months, when
MLO-A5 experiments were conducted, where temperatures ranged between
16-24 ◦C. These lower temperatures may therefore have had a greater influence
in MLO-A5 cells. Furthermore, since the room temperatures of the rocking
performed by Delaine-Smith et al. were not reported it is not possible to directly
compare the results.
Cold stress has received little attention in the research community and to the
authors knowledge there are no studies investigating its effects on mechan-
otransduction. The majority of studies investigating heat shock focus on the
effects of increasing temperatures above the typical 37 ◦C. However, there are
studies that have shown increasing temperatures from below 37 ◦C back to
37 ◦C causes similar heat shock responses in cells [346,347]. Additionally, the
responses of cells to both cold-stress and heat shock are themselves similar,
causing reduced metabolic activity, cell cycle arrest and disassembly of the
cytoskeleton [348–350]. In this study only cold stress could have had a direct
effect on mechanotransduction since cells were stimulated after removal from
the incubator. However, heat shock upon returning the cells to the incubator
could also diminish any responses to FSS stimulation.
Although metabolic activity was not measured during room temperature
conditions, metabolic activity and therefore cell growth was lower in cells
subjected to rocking at room temperature compared to in an incubator at
multiple time-points in the culture. Lower metabolic activity and activity of
various enzymes within the cells would likely have a detrimental impact on
a number of cellular processes, including cell signalling, which is required
for mechanotransduction to occur. Many external cellular features that are
thought to be involved in mechanotransduction, such as focal adhesions and
the primary cilia are internally linked to the cytoskeleton. It is therefore not
surprising that the cytoskeleton plays a central role in mechanotransduction
or that its disruption alters mechanically induced responses [85, 351]. An-
other phenomenon that has been reported to occur with temperature shock
is disassembly of the primary cilia. Prodromou et al., showed elevated tem-
peratures in kidney, fibroblast and retinal cells resulted in rapid resorption
of their primary cilium [352]. Although this was only reported with heat
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shock this may also occur with cold stress since many other responses are
similar. Removal of primary cilia has been shown in a number of studies
to abbrogate cellular responses to mechanical stimuli [132, 139, 140, 201].
If this resorption of primary cilia also occurred here during cold-stress this
would have had a negative effect on the cells ability to sense mechanical stimuli.
The FSS experienced by cells within bone has been estimated to be between
0.8-3Pa for osteocytes and their processes and between 1-25Pa for cells in
trabecular bone marrow such as bone lining osteoblasts or osteogenic pro-
genitor cells. Some studies have suggested the lower threshold of osteoblast
mechanosensitivity to lie between 0.6-2Pa which lies roughly within the range
of FSS levels thought to occur in vivo [340,353]. The results presented here
suggest this threshold may be lower since the osteoblastic cell line MLO-A5
responded to the low-level FSS applied here (peak levels between 0.08-0.2Pa).
MC3T3-E1 cells, the other osteoblastic cell line used here, did not show differ-
ences in any of the measured osteogenic responses. MC3T3-E1 cells have been
shown to be mechanically sensitive to higher magnitudes of FSS [86,341,342].
This may suggest MLO-A5 cells are more sensitive to mechanical stimuli than
other osteoblastic cells. However, to the authors knowledge, no studies have
investigated the effects of mechanical stimulation on matrix mineralisation
in MC3T3-E1 cells. Although no mechanically induced increase in matrix
production was observed, the level of matrix mineralisation with MC3T3-E1
cells was extremely low. If any mechanically induced increases had occurred,
they would also likely have been low. Therefore, due to the sensitivity of the
ARS assay and the variability in the matrix mineralisation itself, this result
does not necessarily suggest MC3T3-E1 cells are mechanically unresponsive.
Furthermore, none of the cell lines tested showed increased ALP activity in
response to FSS. Therefore, no conclusions on MC3T3-E1 mechanosensitivity
can be drawn from these result. Other measurements that were not performed
such as calcium signalling assays or gene upregulation may have shown the
MC3T3-E1 cells to be mechanosensitive. However, since the aim of this chapter
was to optimise a mechanical stimulation method that stimulated matrix
production no further experiments with MC3T3-E1 cells were performed. Fur-
thermore, there have been other studies that have shown mechanosensitivity
to occur at similarly low FSS levels in osteoblastic cells [242, 354]. Which
gives evidence to suggest that the mechanosensitivity of MLO-A5 cells may
actually bemore representative of other osteoblastic cell lines and primary cells.
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Although both MLO-A5 cells and hES-MP cells were found to be mechan-
ically sensitive in the form of increased matrix mineralisation, neither ALP
activity or collagen production were affected. To the authors knowledge no
studies have investigated the effects of low-level FSS on ALP activity or collagen
production in MLO-A5 cells. However, other osteoblastic cell lines have been
shown to upregulate both collagen production and ALP activity in response to
low-level FSS [238,355]. This suggests the lack of sensitivity in these areas to
mechanical stimulation may be specific to MLO-A5 cells and not all osteoblastic
cells. MLO-A5 cells were originally isolated by Kato et al. and were noted to
have high ALP activity compared to other cells isolated from the same bone
fragments [269]. This inherently high ALP activity may limit further increases
in activity from mechanical stimulation.
Both collagen production and ALP activity have previously been shown by
Delaine-Smith et al. to be upregulated by low-level FSS in hES-MP cells [240].
However, neither of these osteogenic markers were found to be upregulated
in this study. A number of variables may have contributed towards these
differences. When hES-MP cells were rocked in an incubator, both ALP ac-
tivity and collagen production were higher compared to samples rocked at
room temperature. The previously discussed points with regards to effects
due to environmental conditions, such as cold and heat shock, are therefore
also relevant here and may go some way to explain the observed differences.
Additionally, serum batch variability is well known for having an influence on
cell culture reproducibility [103,356–358]. This was highlighted here where
metabolic activity, ALP activity, collagen production and matrix mineralisation
were all affected by the use of different batches of FBS.
Dex is commonly used to stimulate osteogenic differentiation in stem cells
[317,359,360]. Despite this Dex and other glucocorticoids can have detrimental
effects on cell growth, mineralisation and collagen formation [360–363]. To
avoid these detrimental effects, it would therefore be beneficial to avoid the use
of Dex. Delaine-Smith et al. found rocking without the use of Dex did not induce
osteogenic differentiation [240]. Other studies have also found FSS alone is
not a potent enough stimulator to induce osteogenic differentiation [240,364].
Therefore, Dex was initially added to media of hES-MP cells to induce os-
teogenic differentiation and was subsequently withdrawn on day 5 of culture.
Although no significant differences were observed in terms of metabolic activity,
withdrawal of Dex resulted in higher total DNA per well on day 14 of culture
suggesting greater cell growth. Dex withdrawal also beneficially increased
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collagen production. Despite this, Dex withdrawal had a detrimental impact on
both ALP activity and matrix mineralisation. However, matrix mineralisation
was only lower in DW samples cultured under static conditions and ARS stain-
ing of rocked samples was indistinguishable from rocked OIM cultured samples.
The greater increase in matrix mineralisation with loaded cells that had
Dex withdrawn could be due to Dex inhibiting mechanosensitivity. To the
authors knowledge there are no direct studies investigating the effects of
Dex withdrawal on osteogenic responses to FSS or mechanosensitivity. How-
ever, Dex treatment itself has been shown to affect multiple mechanisms
involved in mechanotransduction. Xu et al. found Dex decreased expression of
mechanosensitive micro ribonucleic acid (miRNA), which have been shown to
be important in bone formation [365,366]. Dex has also been shown to alter
both the cytoskeleton itself, actin polymerization dynamics, and Wnt signalling
which are all known to play a role in mechanotransduction. Alternatively,
mechanical loading itself may have increased the sensitivity of the cells to the
detrimental effects of Dex. Two isoenzymes of 11β-hydroxysteroid dehydroge-
nase (11β-HSD) modulate the actions of glucocorticoids such as Dex and have
been shown to be stimulated by pro inflammatory cytokines such as interleukin-
1 (IL-1) and tumor necrosis factor α (TNF-α) [367, 368]. Proinflammatory
cytokines have also been shown to be released in response to FSS in bone cells,
although this is typically at high shear levels [369]. Furthermore, FSS has also
been shown to activate the glucocorticoid receptor and its transcriptional sig-
nalling pathway which may further increase sensitivity of the cells to Dex [370].
The peak FSS profiles varied between different locations in the wells and
this was more pronounced with the Stuart rocker. Despite this variation in
peak FSS matrix production was typically consistent throughout the well in
MLO-A5 cells and MC3T3-E1 cells. In hES-MP cells matrix mineralisation
typically appeared stronger at the edges of the wells, where FSS was higher.
However, it is not thought that this is due to the higher FSS but rather due to
mineralisation progressing from the edge of the well towards the centre, as
this was also observed under static conditions. The uniform matrix production
suggests that either the different FSS profiles experienced by cells in different
areas of the well have similar effects or that there is communication between
cells. Communication between cells can either be direct, such as through
gap junctions, or indirect, such as endocrine signalling [371, 372]. FSS has
been shown to cause cell-cell signalling through gap junctions in a range of
bone cell lines [373,374]. Additionally, FSS has also been shown to cause the
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release of nitric oxide, PGE2 and other soluble signalling factors involved in
cell-cell signalling [375–377]. It is therefore likely that a combination of these
signalling pathways were stimulated by the FSS applied here.
In addition to the magnitude of the FSS, the duration of the loading and
how often it is applied has also been shown to affect osteogenic responses to
mechanical stimulation [378–380]. Other studies have shown longer durations
of mechanical loading to be more stimulatory than shorter durations. Prodanov
et al. found cells responded to 3h of fluid flow but did not respond when only 1h
of loading was applied [379]. In this studyhES-MP cells were stimulated once
per day, 5 days per week for 1, 2 or 3h. All three durations resulted in an in-
crease in matrix mineralisation but no increase in collagen production. Longer
durations of rocking did not result in further increases inmatrixmineralisation.
Extending the rocking duration further may have resulted in greater in-
creases in osteogenic responses. However, continuous loading has been shown
to decrease mechanosensitivity, although, this can be regained through the
introduction of rest periods [381, 382]. Therefore, any further increases in
loading duration would need to be split by rest periods to allow the cells to
recover their sensitivity. Although the underlying mechanism behind this
phenomenon is not entirely understood, it is thought the primary cilia plays
a role. With continuous loading primary cilia have been shown to become
shorter [195,383]. In addition, shorter cilia have also been shown to be less
mechanically sensitive [384]. It is therefore thought that primary cilia length
regulation plays an important role in regulating mechanosensitivity.
6.6 Summary
To summarise, methods of mechanically stimulating long-term osteogenic
responses in osteogenic progenitor and osteoblast cell lines was developed.
Low-level FSS enhanced osteogenesis in MLO-A5 and hES-MP cells but not in
MC3T3-E1 cells. However, enhanced osteogenic responses were only seen in
matrix mineralisation and not in collagen production or ALP activity, which
is in contrast to previously published results. In MLO-A5 cells only rocking
at 1.33Hz stimulated osteogenesis and in hES-MP cells both 0.75 and 1.33Hz
stimulated osteogenic responses. However, increasing the frequency also results
in increasing shear stress it was not possible to conclude if these results were
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due to frequency or shear stress levels. Increasing the duration of stimulation
to 3h had no effect on osteogenic responses. Seeding density and environmental
conditions during rocking (temperature, CO2 concentration) affected responses
to FSS in hES-MP cells and MLO-A5 cells. Furthermore, media conditions
(serum batch and Dex withdrawal) were also found to influence responses to
FSS in hES-MP cells. These developed methods can be taken forward to study
the effects of lithium on mechanically induced osteogenesis.
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7. Osteogenic responses to lithium
and fluid shear stress
7.1 Introduction
Mechanotransduction is a critical process in the development, maintenance
and function of a variety of tissues. During embryonic development morphogen-
esis generates mechanical cues which activate mechanotransduction pathways
involved in regulating cytoskeleton remodelling, cell differentiation and pro-
liferation [385]. In the collecting duct of kidneys epithelial cells sense and
respond to urine flow rates [386]. In bone, mechanotransduction is essential in
regulating the balance between bone formation and resorption in response to
the current levels of mechanical stimulation [387,388]. Further understanding
of the mechanisms behind how cells sense and transduce these mechanical cues
into biochemical responses would therefore be of great use in the development
of treatments for a wide variety of diseases, including skeletal disorders such
as osteoporosis.
Mechanical regulation of cells occurs through a variety of mechanisms includ-
ing, stretch activated ion channels, cytoskeletal mechanics, the glycocalyx and
the primary cilium [131,389–391]. Each of these mechanisms may have differ-
ing levels of involvement in mechanotransduction, dependent upon the type of
mechanical force that is applied, such as matrix strain or fluid shear. When
bone is loaded it has been predicted that interstitial fluid flows through the
lacunae-canaliculae network where it may stimulate osteocytes residing in the
lacunae and osteoblasts that line the bone surface [392, 393]. Additionally,
modelling of trabecular bone marrow under load has shown fluid shear within
the marrow to reach mechanostimulatory levels [340]. Fluid shear within bone
can therefore affect both mature osteogenic cells and osteogenic precursors,
where it can stimulate their differentiation towards osteogenic cells and the
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formation of new bone. In vitro primary cilia are known to be present in both
osteogenic lineage cells and precursor cells and have been shown to deflect
in response to fluid flow, highlighting their potential as a fluid flow sensor
[130, 131, 335]. Additionally, mechanically induced osteogenic responses to
fluid flow are abrogated when primary cilia are removed, further highlighting
their importance in mechanotransduction [94,132,201]. Primary cilia are also
able to modulate their responsiveness to mechanical stimuli by triggering a re-
duction in primary cilia length through disassembly in response to mechanical
stimuli [195, 383, 394]. This disassembly of primary cilia in response to me-
chanical stimuli results in a reduced mechanoresponse to the same magnitude
of stimulus, this allows cells to modulate their sensitivity, preventing over stim-
ulation [199]. This relationship between primary cilia length and magnitude
of stimulus could therefore be manipulated to increase mechanosensitivity of
cells.
As discussed in chapter 5 lithium can be used to elongate primary cilia with-
out affecting the number of ciliated cells or osteogenesis itself when applied
intermittently. Since primary cilia are thought to be mechanosensitive, with
length playing a role in controlling sensitivity, it was hypothesised that lithium
treatment may alter mechanosensitivity of cells. This chapter therefore in-
vestigates the effects of the LiCl treatment regime established in chapter 5
used in combination with the application of FSS on mechanoinduced osteogenic
responses.
7.2 Aims and objectives
The aim of this chapter was to explore the mechanoresponse of osteogenic pro-
genitor and osteoblast cells after treatment with LiCl. The following objectives
were addressed in order to achieve this:
• Evaluate the effect LiCl treatment has on FSS induced osteogenesis in
monolayer culture and in PU scaffolds.
• Evaluate the effect LiCl treatment has on FSS induced Ca2+ and cAMP
signalling
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7.3 Methods
The following materials and methods are specific to the work presented in this
chapter and expand upon the materials and methods presented in chapter 4,
chapter 6 and chapter 5. hES-MP cells were cultured in DWmedia andMLO-A5
cells were cultured in SM.
7.3.1 Application of fluid shear stimuli
Monolayer stimulation
Mechanical stimulation in combination with LiCl treatment was applied fol-
lowing the rocking protocol optimised in chapter 6 and the LiCl treatment
optimised in chapter 5, as shown in Figure 7.1.
Figure 7.1: Timeline for rocking experiments showing the days LiCl and FSS
stimulus was applied.
3D stimulation
Scaffolds were treated with LiCl and subjected to oscillatory FSS generated
by fluid flow in an Ibidi perfusion pump system (Ibidi GmbH, Germany) on
day 5, 13 and 18 for hES-MPs and day 3 and 8 for MLO-A5s (Figure 7.2). This
flow regime had previously been optimised by the author during their Master’s
degree research project. Fluid flow was applied at 8mm3 s−1 (0.63mms−1) at
1Hz. Scaffolds were placed inside silicone tubing with an inside diameter of
4mm, connected to the fluidic unit of the pump system and subjected to flow for
1 hour in an incubator. Statically cultured cells were also placed within tubing
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for 1 hour but were not subjected to flow to control for scaffold manipulation
and confinement. LiCl was applied following the the protocol optimised in
chapter 5.
Figure 7.2: Timeline for Ibidi reactor fluid shear stress experiments showing
the days LiCl and FSS stimulus was applied
cAMP measurement
cAMP levels were measured using a cAMP ELISA (cAMP XP® assay kit #4339,
Cell Signaling Technology Europe, Netherlands) following the manufacturer’s
instructions. Cells were rinsed twice with ice cold PBS, 900µL of the supplied
lysis buffer (10X lysis buffer diluted to 1X in diH2O) with 1mM phenylmethyl-
sulfonyl fluoride was added and the samples were incubated on ice for 5min.
Well plates were scraped and the lystates transferred to 1.5mL centrifuge
tubes. The tubes were centrifuged at 6700 × g to remove cell debris. 50µL of
cell lysates and 50µL of horseradish peroxidase (HRP) conjugated cAMP were
added to the supplied microplate with anti-cAMP rabbit antibody immobilised
on its surface and incubated for 3h at room temperature on an orbital shaker.
The cAMP in the cell lysates competes with the fixed amount of HRP conjugated
cAMP for binding to the antibody. The wells were washed 4 times with 200µL
of the supplied wash buffer (20X wash buffer diluted to 1X in diH2O) and
100µL of 3,3’,5,5’-tetramethylbenzidine (TMB) substrate added. After 30min
incubation at room temperature 100µL stop solution was added. The optical
density of each well was measured at λabs: 450nm. The absorbance at 570nm
was subtracted from the absorbance at 450nm to correct for optical aberra-
tions in the plate. To determine the concentration of cAMP in the samples, a
four-parameter logistic curve, fit to the absorbance of the known standards was
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used.
cAMP signalling in response to FSS
Measurement of cAMP signalling was only performed in monolayer culture.
cAMP signalling was assessed on the first application of rocking (day 7). hES-
MP cells were treated with 1mM LiCl for 24h following 24h serum free media
culture. Baseline cAMP levels were evaluated before the application of FSS for
both 1mM LiCl treated cells and untreated controls. cAMP levels were then
measured 15min, 30min and 60min after the initiation of FSS.
Adenylyl cyclase inhibition
Although LiCl is a known inhibitor of adenylyl cyclase it also affects other
pathways within the cell. Therefore, to assess the role of adenylyl cyclase
in mechanotransduction, MDL-12330A hydrochloride (MDL) (Sigma Aldrich
- M182) was employed as a more specific inhibitor of AC. To determine the
optimum MDL concentration to inhibit AC without affecting basal cAMP levels,
a dose response study of MDL was performed. MDL was dissolved in DMSO
and added to culture medium to give a final concentration of 1, 10 or 100mM
MDL and a final concentration of 0.1% DMSO. hES-MP cells were cultured
in MDL containing media or vehicle control for 60min on day 7 of culture,
matching the duration of time FSS would be applied. hES-MP cells were then
treated with 10mM MDL during the application of FSS to assess if it inhibited
an increase in cAMP due to AC activity. 10mMwas chosen as it was the highest
concentration that did not affect basal cAMP levels.
Calcium signalling
Mechanical stimulation is known to induce calcium signalling. This calcium
signalling occurs within seconds after the initiation of the stimulus. Due to this
rapid response and the inability to visualise cells on the rocking platform, a
different method to apply FSS in monolayer culture was required. For this 0.1%
gelatin coated Ibidi μ-slide VI 0.4 (Ibidi GmbH, Germany) were used as they
allowed simultaneous application of FSS and microscopic imaging. Cells were
seeded at 10,000 cells cm−2 and cultured to day 6 following the culture regime
outlined in Figure 7.1. On day 7 of culture cells were subjected to FSS using
an Ibidi perfusion pump and calcium signalling observed through the use of a
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fluorogenic calcium-sensitive dye Fluo-4 acetoxymethyl ester (Fluo-4) (Thermo
Fisher Scientific, UK). The acetoxymethyl ester of the Fluo-4 is membrane-
permeant, once inside a cell esterases cleave the acetoxymethyl group which
renders the Fluo-4 membrane-impermeant. Fluo-4 exhibits an increase in
fluorescence upon Ca2+ binding and can therefore be used to monitor changes
in intracellular Ca2+ concentrations. On day 7 of culture hES-MP cells were
rinsed with hanks balanced salt solution (HBSS) and incubated with 5µM
Fluo-4 in serum free BM containing 0.02% Pluronic F-127 and 25mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) for 30min at 37 ◦C.
After loading cells were rinsed twice with HBSS to remove any extracellular dye.
Oscillatory FSS was applied for 1min at 1.33Hz with a shear stress of 0.3Pa
or 1.5Pa. Fluorescent images were captured every second, with 10 images
captured before the initiation of flow. ImageJ was used for post-processing of
the captured images. 25 cells were randomly selected per field of view and the
baseline intensity calculated by measuring the average intensity of each cell
over the 10 images captured before flow initiation. The maximum fluorescence
intensity of each of the cells during flow was measured and the relative change
in intensity was calculated by subtracting the baseline intensity from the
maximum intensity. Peaks in fluorescence caused by floating cell debris were
excluded from analysis.
7.4 Results
7.4.1 Effects of lithium chloride on hES-MP flow induced
osteogenesis in monolayer
hES-MP cells were mechanically stimulated after treatment with LiCl. 1mM
LiCl was applied on day 6 and day 13 for 24h and rocking was performed at
1.33Hz for 1h 5 days per week from day 7. Cell viability was measured on
day 1, 7, 14 and 21 with RR (Figure 7.3). Metabolic activity increased from
day 1 to day 7 in all groups with no significant differences between groups.
There was no significant increase in metabolic activity between day 7 and
day 21 in any group. There were also no significant differences in metabolic
activity at any time point between groups. Total DNA and ALP activity was
measured on day 14 (Figure 7.4). Similarly to the day 14 RR results, there
was no significant difference in total DNA between any of the groups. In
static culture, LiCl had no effect on ALP activity. Additionally, rocking alone
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without LiCl treatment had no effect on ALP activity. However, when rocking
was performed after LiCl treatment, ALP activity was significantly higher
compared to both the static control and the untreated rocked group. The
amount of mineralised matrix and collagen produced was analysed on day 21
of culture by ARS and DR80 respectively (Figure 7.5). Despite no increase in
day 14 ALP activity with rocking alone, there was a significant increase in the
amount of mineralised matrix produced by day 21 of culture compared to the
static control. LiCl treatment in statically cultured cells had no significant effect
on matrix mineralisation. However, when rocking was performed after LiCl
treatment, the amount of mineralised matrix produced over 21 days of culture
was significantly higher compared to both statically cultured controls and rocked
cells without LiCl treatment. The amount of collagen produced over 21 days of
culture was not significantly different between any of the experimental groups.
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Figure 7.3: Effect of FSS and LiCl exposure on hES-MP metabolic activity
over 21 days of monolayer culture. LiCl was applied on day 6 and day 13 for
24 hours and cells were mechanically stimulated on a rocking platform for 1h,
5 days per week from day 7. Metabolic activity was assessed with RR. Data
represents mean ± SD n=9. Fluorescence was measured at λex: 540nm and
λem: 590nm.
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Figure 7.4: Effect of FSS and LiCl exposure on hES-MP day 14 cell number
and ALP activity in monolayer culture. LiCl was applied on day 6 and day 13
for 24 hours and cells were mechanically stimulated on a rocking platform for
1h, 5 days per week from day 7. (B) Total DNA. (A) ALP activity. (C) ALP
activity normalised to total DNA. Data represents mean ± SD n=9. * = p<0.05
compared to the static control. # = p<0.05 compared to 0mM LiCl.
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Figure 7.5: Effect of FSS and LiCl exposure on hES-MP matrix formation in
monolayer culture. LiCl was applied on day 6 and day 13 for 24 hours and cells
were mechanically stimulated on a rocking platform for 1h, 5 days per week
from day 7. (A) Day 21 matrix calcium quantified by ARS. (B) Day 21 matrix
collagen quantified by DR80. Data represents mean ± SD n=9. * = p<0.05 com-
pared to the static control. # = p<0.05 compared to 0mM LiCl. Representative
photographs of stained wells are shown below their corresponding graphs.
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7.4.2 Effects of lithium chloride on MLO-A5 flow induced
osteogenesis in 2D
MLO-A5 cells were mechanically stimulated after LiCl treatment. 1mM LiCl
was applied on day 2 and day 7 for 24h and rocking was performed at 1.33Hz
for 1h 5 days per week from day 7. Cell viability was measured on day 1, 7
and 14 with RR (Figure 7.6). Metabolic activity increased from day 1 to day 7
in all groups with no significant differences between groups. There was no
significant increase in metabolic activity between day 7 and day 14 in any
group. There were also no significant differences in metabolic activity at any
time point between groups. Total DNA and ALP activity was measured on
day 7 (Figure 7.7). Similarly to the day 7 RR results, there was no significant
difference in total DNA between any of the groups. In static culture, LiCl had
no effect on ALP activity. Additionally, rocking alone without LiCl treatment
had no effect on ALP activity. However, when rocking was performed after LiCl
treatment, ALP activity was significantly higher compared to both the static
control and the untreated rocked group. The amount of mineralised matrix
and collagen produced was analysed on day 14 of culture by ARS and DR80
respectively (Figure 7.8). Despite no increase in day 7 ALP activity with rocking
alone, there was a significant increase in the amount of mineralised matrix
produced by day 14 of culture compared to the static control. LiCl treatment
in statically cultured cells had no significant effect on matrix mineralisation.
However, when rocking was performed after LiCl treatment, the amount of
mineralised matrix produced over 14 days of culture was significantly higher
compared to both statically cultured controls and rocked cells without LiCl
treatment. The amount of collagen produced over 14 days of culture was not
significantly different between any of the experimental groups.
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Figure 7.6: Effect of FSS and LiCl exposure on MLO-A5 metabolic activity
over 14 days of monolayer culture. LiCl was applied on day 2 and day 7 for 24
hours and cells were mechanically stimulated on a rocking platform for 1h,
5 days per week from day 3. Metabolic activity was assessed with RR. Data
represents mean ± SD n=9. Fluorescence was measured at λex: 540nm and
λem: 590nm.
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Figure 7.7: Effect of FSS and LiCl exposure on MLO-A5 day 7 cell number
and ALP activity in monolayer culture. LiCl was applied on day 2 for 24 hours
and cells were mechanically stimulated on a rocking platform for 1h, 5 days per
week from day 3. (A) Total DNA. (B) ALP activity. (C) ALP activity normalised
to total DNA. Data represents mean ± SD n=9. * = p<0.05 compared to the
static control. # = p<0.05 compared to 0mM LiCl.
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Figure 7.8: Effect of FSS and LiCl exposure on MLO-A5 matrix formation
in monolayer culture. LiCl was applied on day 2 for 24 hours and cells were
mechanically stimulated on a rocking platform for 1h, 5 days per week from
day 3. (A) Day 14 matrix calcium quantified by ARS. (B) Day 14 matrix collagen
quantified by DR80. Data represents mean ± SD n=9. * = p<0.05 compared
to the static control. # = p<0.05 compared to 0mM LiCl. Representative
photographs of stained wells are shown below their corresponding graphs.
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7.4.3 Effects of lithium chloride on hES-MP flow induced
osteogenesis in 3D
To assess if the increased osteogenic responses found when mechanically stim-
ulating cells after LiCl treatment in 2D culture translates to 3D culture, hES-
MPs were cultured in DW media in PU scaffolds and mechanically stimulated
after LiCl treatment. 1mM LiCl was applied following the intermittent treat-
ment regime, as this regime was shown to not affect osteogenesis itself, and
the cells were subjected to FSS in an Ibidi bioreactor (Figure 7.2). Cell viability
was measured on day 1, 7, 14 and 21 with RR (Figure 7.9), ALP and total DNA
was measured on day 14 (Figure 7.10) and total matrix calcium and collagen
production was assessed with ARS and DR80 staining respectively on day 21
(Figure 7.11). DR80 stained samples were also imaged with light-sheet mi-
croscopy to visualise the collagen matrix (Figure 7.12).
Cell viability was higher in all groups on day day 21 compared to day 1. Between
day 14 and day 21 viability decreased in the LiCl treated cells subjected to flow.
However, despite this reduction viability remained higher than the control on
day 21. Additionally, all other groups had significantly higher viability com-
pared to the control on day 21. FSS stimulus alone did not have an osteogenic
effect, showing no significant changes in ALP activity or total mineralised
matrix or collagen production. However, when FSS was applied after using
LiCl, there was an osteogenic effect. ALP activity and total mineralised matrix
production was significantly higher compared to the static controls. Total DNA
was also significantly higher in the LiCl treated cells subjected to flow compared
to the untreated static control. No other treatment had an effect on total DNA.
Collagen production was not affected by LiCl treatment or FSS in terms of the
amount of collagen produced. However, light-sheet microscopy images of DR80
stained samples show the collagen in samples not treated with LiCl to be more
fibrous compared to the LiCl treated samples.
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Figure 7.9: Effect of FSS and LiCl exposure on hES-MP metabolic activity
over 21 days of 3D culture. LiCl was applied on day 4, day 12 and day 17 for 24
hours and cells were mechanically stimulated for 1h using an Ibidi perfusion
pump on day 5, day 13 and day 18. Metabolic activity was assessed with RR.
Data represents mean ± SD n=9. Fluorescence was measured at λex: 540nm
and λem: 590nm.
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Figure 7.10: Effect of FSS and LiCl exposure on hES-MP day 14 cell number
and ALP activity in 3D culture. LiCl was applied on day 4, day 12 and day 17
for 24 hours and cells were mechanically stimulated for 1h using an Ibidi
perfusion pump on day 5, day 13 and day 18. (A) ALP activity. (B) Total DNA.
(C) ALP activity normalised to total DNA. Data represents mean ± SD n=9.
* = p<0.05 compared to the static control. # = p<0.05 compared to 0mM LiCl.
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Figure 7.11: Effect of FSS and LiCl exposure on hES-MP matrix formation
in 3D culture. LiCl was applied on day 4, day 12 and day 17 for 24 hours
and cells were mechanically stimulated for 1h using an Ibidi perfusion pump
on day 5, day 13 and day 18. (A) Day 21 matrix calcium quantified by ARS.
(B) Day 21 matrix collagen quantified by DR80. Data represents mean ± SD
n=9. * = p<0.05 compared to the static control. Representative photographs of
stained scaffolds are shown below their corresponding graphs. (left to right)
0 Hz 0 mM, 0 Hz 1 mM, 1 Hz 0 mM and 1 Hz 1 mM.
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Figure 7.12: Day 21 Light-sheet images of DR80 (red) and DAPI (blue) stained
scaffolds showing collagen matrix formation in response to LiCl exposure and
FSS on hES-MPs. (A) 0 Hz 0 mM LiCl (B) 0 Hz 1 mM LiCl (C) 1 Hz 0 mM LiCl
and (D) 1 Hz 1 mM LiCl.
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7.4.4 Effects of lithium chloride on MLO-A5 flow induced
osteogenesis in 3D
MLO-A5s were mechanically stimulated after treatment with LiCl. 1mM LiCl
was applied following the intermittent treatment regime and the cells were
subjected to FSS in an Ibidi bioreactor (Figure 7.2). The intermittent treat-
ment regime was used as it did not affect osteogenesis itself. Cell viability
was measured on day 1, 7 and 14 with RR (Figure 7.13), ALP and total DNA
was measured on day 7 (Figure 7.14) and total matrix calcium and collagen
production was assessed with ARS and DR80 staining respectively on day 14
(Figure 7.15). DR80 stained samples were also imaged with light-sheet mi-
croscopy to visualise the collagen matrix (Figure 7.16). Cell viability increased
in all groups between day 1 and day 14. Day 7 viability was significantly lower
in LiCl treated cells subjected to FSS compared to the control. However, this
was still significantly greater than day 1 viability and by day 14 all groups
showed similar viability. FSS significantly increased ALP activity compared
to the static controls. With the addition of LiCl treatment the FSS induced
increase in ALP activity was increased further. However, when normalised to
total DNA, FSS alone was not significantly different to the static control but
FSS in conjunction with LiCl treatment was. LiCl treatment alone did not affect
ALP activity. FSS and LiCl treatment alone or in combination did not have an
effect on total DNA. FSS significantly increased mineralised matrix deposition
compared to the static controls, which similarly to ALP activity was further
increased with the addition of LiCl treatment. Total collagen production was
not affected by FSS and LiCl treatment alone or in combination.
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Figure 7.13: Effect of FSS and LiCl exposure on MLO-A5 metabolic activity
over 14 days of 3D culture. LiCl was applied on day 2 and day 7 for 24h and
cells were mechanically stimulated for 1h using an Ibidi perfusion pump on
day 3 and day 8. Metabolic activity was assessed with RR. Data represents
mean ± SD n=9. Fluorescence was measured at λex: 540nm and λem: 590nm.
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Figure 7.14: Effect of FSS and LiCl exposure on MLO-A5 day 7 cell number
and ALP activity in 3D culture. LiCl was applied on day 2 and day 7 for 24h
and cells were mechanically stimulated for 1 h using an Ibidi perfusion pump on
day 3 and day 8. (A) Total DNA. (B) ALP activity. (C) ALP activity normalised
to total DNA. Data represents mean ± SD n=9. * = p<0.05 compared to the
static control. # = p<0.05 compared to 0mM LiCl.
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Figure 7.15: Effect of FSS and LiCl exposure on MLO-A5 matrix formation
in 3D culture. LiCl was applied on day 2 and day 7 for 24h and cells were
mechanically stimulated for 1h using an Ibidi perfusion pump on day 3 and
day 8. (A) Day 14 matrix calcium quantified by ARS. (B) Day 14 matrix collagen
quantified by DR80. Data represents mean ± SD n=9. * = p<0.05 compared
to the static control. # = p<0.05 compared to 0mM LiCl. Representative
photographs of stained scaffolds are shown below their corresponding graphs.
(left to right) 0 Hz 0 mM, 0 Hz 1 mM, 1 Hz 0 mM and 1 Hz 1 mM
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Figure 7.16: Day 21 Light-sheet images of DR80 (red) and DAPI (blue) stained
scaffolds showing collagen matrix formation in response to LiCl exposure and
FSS on MLO-A5s. (A) 0 Hz 0 mM LiCl (B) 0 Hz 1 mM LiCl (C) 1 Hz 0 mM LiCl
and (D) 1 Hz 1 mM LiCl
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7.4.5 Adenylyl cyclase activity is required for mechan-
otransduction
LiCl is a known inhibitor of AC, a key enzyme in the production of cAMP.
cAMP is an important second messenger involved in many biological processes
including mechanotransduction, although its role in mechanotransduction is
not well understood. Therefore, to determine if cAMP signalling is utilised as a
second messenger in hES-MP cells and how LiCl affects this, cAMP levels were
measured after cells were exposed to FSS with and without LiCl treatment.
Basal levels of cAMP were higher in cells treated with LiCl (Figure 7.17). cAMP
levels peaked after 15min of FSS exposure in both untreated and LiCl treated
cells. However, the peak cAMP levels were significantly higher in untreated
cells compared to the LiCl treated cells. After the initial peak in cAMP levels
at 15min, cAMP levels in cells not treated with LiCl decreased between 15 and
30min but was not different between 30 and 60min. In the LiCl treated cells
this reduction in cAMP levels after the initial peak was not observed and at 15
and 30min of FSS cAMP levels were not significantly different to the non-LiCl
treated cells. cAMP levels remained higher than the static basal levels at all
time points after the initiation of FSS in both LiCl treated and untreated cells.
Since LiCl treated cells had previously shown increased osteogenic responses
but had shown a reduced response in terms of peak cAMP levels, a general
adenylyl cyclase inhibitor, MDL, was employed to asses if adenylyl cyclase
activity and cAMP signalling is required for osteogenic responses to mechanical
stimulation. MDLwas applied at 1, 10 and 100µMto determine a concentration
that did not affect basal cAMP levels. 100mM MDL resulted in a significant
decrease in cAMP levels compared to the vehicle control (Figure 7.17). Neither
1 nor 10µM MDL affected basal cAMP levels.
To assess whether MDL inhibited the mechanically induced increase in cAMP
10µM MDL was applied during the application of FSS and cAMP levels were
measured at 15min. 10µM MDL blocked the mechanically induced increase in
cAMP levels in both LiCl treated and untreated cells (Figure 7.17). To assess if
this AC dependant cAMP increase was required for the mechanically induced
osteogenic responses observed, rocking with and without LiCl treatment was
performed in conjunction with 10µM MDL. When cAMP signalling was inhib-
ited with MDL there was no longer a mechanically induced increase in ALP
activity as there was when cAMP signalling was not inhibited (Figure 7.18).
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Figure 7.17: cAMP signalling in response to FSS and LiCl exposure. (A) Effect
of FSS and LiCl exposure on hES-MP cAMP signalling at 15, 30 and 60 minutes
after flow initiation in monolayer culture. (B) Dose response of the adenylyl
cyclase inhibitor MDL on cAMP signalling at 15min. (C) cAMP signalling in
response to FSS and LiCl when adenylyl cyclase is inhibited with 10µM MDL.
Data represents mean ± SD n=4. * = p<0.05 compared to the untreated control.
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Figure 7.18: Day 14 ALP activity and total DNA in response to FSS and LiCl
treatment when adenylyl cyclase activity is inhibited with MDL. LiCl was
applied on day 6 and day 13 for 24h and cells were mechanically stimulated
on a rocking platform for 1h 5 days per week from day 7. 10µM MDL was
added to culture media for the 1h of rocking. (A) Total DNA. (B) ALP activity.
(C) ALP activity normalised to total DNA. Data represents mean ± SD n=6.
* = p<0.05 compared to the 0mM control.
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7.4.6 Mechanically induced calcium signalling is
increased with LiCl treatment
Ca2+ signalling in response to oscillatory FSS at 1.33Hz was assessed at a
low (0.3Pa) and a high (1Pa) shear stress in monolayer culture (Figure 7.19).
A higher percentage of cells responded to the high fluid shear stress (1Pa)
compared to low fluid shear stress (0.3Pa) in both LiCl treated and untreated
hES-MP cells. At low fluid shear stress, a higher percentage of cells responded
when treated with LiCl compared to untreated. However, at high fluid shear
stress there was no difference. The maximum response was detected between
15 and 20 s after the initiation of flow at high fluid shear stress. At low fluid
shear stress, the maximum response was detected between 15 and 20 s for
LiCl treated cells but between 30 and 50 s for untreated cells. The increase in
fluorescence intensity from the baseline was greater in LiCl treated cells at
both fluid shear stress levels compared to untreated cells. However, this was
less pronounced at the high fluid shear stress. The increase in fluorescence
was also greater in both high fluid shear stress groups compared to low fluid
shear stress groups.
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Figure 7.19: Ca2+ signalling in response to fluid shear stress and LiCl expo-
sure. Data represents mean ± SD n=55. * = p<0.05 compared to the 0.3Pa
stimulated control. # = p<0.05 compared to 0mM LiCl control. (A) Percentage
of cells responding to FSS. (B) Fold increase in calcium at first peak following
application of FSS. Data represents mean ± SD n¾9). (C) Basal and peak
intensity fluorescence images of hES-MP cells subjected to 1Pa FSS.
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7.5 Discussion
This chapter investigates the effects of FSS on osteogenesis when used in com-
bination with LiCl treatment. This chapter highlights the potential of LiCl for
use as a drug to stimulate bone formation in both monolayer culture and tissue
engineered constructs. The LiCl treatment regime developed in chapter 5 was
used in combination with FSS to evaluate if mechanically induced osteogenesis
can be pharmacologically manipulated.
Promoting osteogenic differentiation in progenitor cells and promoting new
bone matrix formation in mature bone cells would be highly beneficial in the
treatment of osteoporosis. The traditional approach for treating osteoporosis
has been through the use of pharmaceuticals that are either inhibitors of bone
resorption, such as bisphosphonates, hormone replacement therapy or selective
oestrogen receptor modulators, or stimulate bone formation directly, such as
strontium renelate or parathyroid hormone (PTH) [395–398]. However, the
majority of these treatments come with increased risks of developing other
diseases. Bisphosphonates can result in bisphosphate-related necrosis of the
jaw, hormone replacement therapy, selective oestrogen receptor modulators and
strontium renelate can increase the risk of venous thromboembolisms and PTH
may increase the risk of developing osteosarcoma, although this has not been
observed in humans [399–403]. Since bone is a mechanically sensitive organ
that upregulates bone formation in response to bone loading, an alternative
method of treatment could be through targeting mechanotransduction. The
primary cilia, a hair like protrusion present on bone cells, is thought to play a
mechanotrandsuctory role and could therefore be a target for manipulating
mechanotransduction in bone.
The effects LiCl treatment onmechanotransduction was first evaluated inmono-
layer culture as a proof-of-concept due to its simplicity and higher throughput
compared to 3D culture. However, it was important to conduct the experiments
in 3D culture due to differences in 3D culture compared to monolayer culture
that may influence any responses.
Metabolic activity of hES-MP and MLO-A5 cells was not influenced by the
application of fluid shear stress with or without LiCl treatment in monolayer
culture. In 3D culture, MLO-A5 cells treated with LiCl and subjected to fluid
shear stress had significantly lower metabolic activity on day 7 compared
to the controls. LiCl can downregulate E-cadherin and integrins through
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GSK3-β inhibition and the subsequent β-catenin accumulation [404, 405].
Downregulation of these cell adhesion molecules may cause reduced cell-cell
and cell-matrix attachment which could result in an increase in cell detachment
cause by fluid shear. However, in 3D culture hES-MP cells treated with LiCl
and subjected to fluid shear stress had higher metabolic activity on day 14
and day 21 suggesting higher cells numbers were present. Additionally, the
concentration used by studies investigating the effects of LiCl on cell adhesion
molecules used 10-fold higher concentrations compared to the 1mM LiCl used
here. The influence of LiCl on cell attachment is therefore either different in
stem cells compared to mature bone cells or at the 1mM concentration used, is
likely to be minimal. The differences between monolayer and 3D culture may
be due to differences in the applied shear stress. Although in 3D culture the
shear stress was not calculated it is likely to be higher than the low magnitude
applied in monolayer culture and could therefore have a greater effect on cell
attachment.
In monolayer culture, both early and late stage indicators of osteogenesis
were increased when treated with LiCl and mechanically stimulated compared
to both statically cultured cells treated with LiCl and untreated mechanically
stimulated cells. As progenitor cells differentiate towards an osteogenic lin-
eage, ALP levels increase and it is therefore often used as a marker of early
osteogenic differentiation. With mechanical stimulation alone ALP activity was
not affected, however with LiCl treatment and mechanical stimulation ALP
activity was higher compared to all other groups. Of the late stage osteogenic
differentiation indicators only matrix calcium was affected. Similarly, other
studies have found no changes in collagen matrix formation in response to
mechanical stimulation and this suggests mechanical stimulation may prefer-
entially upregulate mineralisation of the existing collagen matrix, rather than
stimulating collagen matrix formation [250]. Although mechanical stimulation
alone did enhance osteogenic differentiation, as indicated by increased matrix
mineralisation, it did so at a delayed rate, or less prominently compared to
mechanical stimulation in cells treated with LiCl. The earlier osteogenic differ-
entiation with LiCl treatment could be due to a combinatorial effect of LiCl
and mechanical stimulation upregulating osteogenic pathways or may be due
to enhanced mechanotransduction due to LiCl with primary cilia elongation
being one potential mechanism behind this.
It is theorised that primary cilia mediated mechanotransduction involves
bending of primary cilia and this has been shown to occur in kidney epithelial
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cells [130, 139]. However, it is not known if this occurs in bone cells in vivo
and in osteocytes in particular, the available space within lacunae may limit
primary cilia length, potentially making primary cilia bending unlikely at the
shear levels experienced by the cells. In order for primary cilia to bend in
vitro they must be exposed to fluid flow. The majority of primary cilia of both
hES-MP and MLO-A5 cells presented themselves on the apical surface of the
cells, meaning primary cilia would be presented to the fluid flow. However,
this is complicated by the fact that the experiments performed were long term
experiments and both cell types produce high levels of extracellular matrix
over this time. It was observed that in monolayer culture this matrix was pro-
duced primarily at the apical surface of the cells, which could have resulted in
primary cilia becoming covered and potentially embedded in matrix. Collagen
matrix production was measurable by day 10 in hES-MP cells and day 5 in
MLO-A5 cells. By the end time point for each cell type collagen matrix covered
the majority of the well plate area. This would undoubtedly alter the shear
stress the cells and therefore the primary cilia and other mechanotransducers
are exposed to and could possible prevent primary cilia from bending, either
through spatially constraining them or by completely blocking them from being
exposed to fluid flow. Therefore, the forces applied to the cells by rocking in
monolayer culture are likely to vary from the calculated 0.05Pa and over the
course of the culture may change from predominantly fluid shear forces to
varying levels of matrix strain and fluid shear.
If primary cilia and other mechanotransducers were shielded from fluid
flow at later time points, this would suggest the enhanced matrix production
stimulated by fluid shear is a result of mechanical stimulation at earlier time
points. The importance of earlier time points of mechanical loading has been
highlighted by Delaine-Smith, where applying mechanical loading in the first
half of culture was more stimulatory than in the second half of culture [82].
The production of matrix and resultant shielding of primary cilia and other
mechanotransducers from fluid flow may explain the reduction in stimulatory
responses seen by Delaine-Smith. When cells were not treated with LiCl, early
osteogenic responses, measured through ALP activity, were not observed in
response to fluid shear. However, when cells were treated with LiCl, ALP
activity was upregulated in response to loading. This indicates whatever
mechanism is behind the lithium induced increase in sensitivity occurs before
day 7 and day 14 for MLO-A5 and hES-MP cells respectively.
An alternative mechanism to direct detection of shear stress could be through
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the detection of matrix strain. Cells embedded in extracellular matrix would
be subjected to matrix strain from matrix deformation caused by fluid shear
forces acting upon it. However, any matrix strain resulting from rocking
induced shear stress would be minimal due to the low level of shear stress
applied (0.05Pa). It would therefore be unlikely that any matrix deformation
caused would be a high enough magnitude to be stimulatory. In 3D culture
the production of matrix over the duration of culture would have different
effects to that in monolayer culture. Firstly, in 3D culture the cells were not
confined to a monolayer, they were able to bridge pores and grow on top of
each other and the produced matrix. Therefore, at any given time there could
be cells present on the surface that could be exposed to fluid flow. Secondly,
as the cells produce more matrix the pore sizes would decrease and since the
volumetric flow rate was kept constant, the shear stress applied to cells would
increase. For these reasons, in 3D culture the earlier applications of fluid flow
may be be less important than in monolayer and each application of loading
over the culture period may have been as stimulatory or more stimulatory
than the previous due to increased shear stress resulting from reduced pore size.
In 3D culture, cells were treated with LiCl before each fluid flow application.
However, in monolayer culture 1 application of LiCl preceded 5 applications
of fluid flow. Although the duration that primary cilia remained elongated
was not investigated thoroughly, observations suggested that it was less than
24h. Therefore, any increase in mechanosensitivity caused by primary cilia
elongation in monolayer culture would potentially be limited to the single
application of fluid flow directly following LiCl treatment. In 3D culture
however, increased mechanosensitivity would have occurred with all fluid flow
applications. The observed upregulation of osteogenic responses are therefore
due to as little as 1h of enhanced mechanosensitivity to fluid shear stress
with regards to ALP activity or 2h for matrix calcium. Enhanced osteogenic
responses from this limited duration of LiCl exposure would be beneficial if
translatable to an in vivo treatment. Treatment of mental disorders with
lithium salts require continuous dosing that can result in adverse effects
such as impaired concentration and vision, polyuria and with extended use
can result in renal failure [411–413]. Since only short and intermittent LiCl
exposure was required to enhance mechanosensitivity this is beneficial for its
potential application in vivo for enhancing bone matrix deposition in response
to mechanical loading.
In 3D culture primary cilia were of a more representative length to those
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observed by Coughline et al. in vivo in bone [335]. Coughlin et al. attributed
the shorter lengths compared to those typical observed in vitro to the spatial
constraints within lacunae. However, the cells cultured here did not have these
same spatial constraints applied to them yet had similar length primary cilia.
Therefore, these shorter lengths may not be due to spatial constraints as has
been suggested, and may instead be due to other environmental differences
between monolayer culture and 3D. Due to the more representative primary
cilia lengths with 3D culture the 3D culture results may more accurately
reflect what may occur in vivo compared to monolayer culture. It may still
not accurately reflect what would occur in vivo. Despite this, the 3D culture
results do highlight the potential for using LiCl to enhance osteogenesis in
bone tissue engineered scaffolds.
There have been two other studies that have investigated the effects of chemicals
on mechanotransduction where primary cilia elongation also occurs [205,414].
Both studies utilised LiCl and fenoldopam. Spasic et al., found primary cilia
elongated with either chemical and resulted in upregulation of mechanically
induced osteogenic gene expression compared to mechanical stimulation alone.
Since the two chemicals have affect different pathways but both resulted in
primary cilia elongation and increased mechanosensitivity. It suggest the
primary cilia elongation is playing a role in the increased mechanosensitvity.
Although, Corrigan et al., found only fenoldopam induced primary cilia elonga-
tion resulted in increases in osteogenic markers with mechanical stimulation.
However, the study by Corrigan et al., used a higher concentration of LiCl
(100mM compared to 0.5mM) and was performed with a murine stem cell line
whereas the study by Spasic et al. used a murine osteocyte cell line. The use of
such a high concentration by Corrigan et al. is unusual as unsurprisingly they
found it was cytotoxic, resulted in further cell death when used in combination
with mechanical stimulation and down-regulated osteogenic gene expression
when applied alone. Conversely, the study by Spasic et al. showed no cytotox-
icity with 0.5mM LiCl application, however, it is not clear if there was any
cytotoxicity when used in combination with mechanical stimulation or if it
affected osteogenic markers itself as this was not reported. Here, cell viability,
indicated by metabolic activity, was not affected by LiCl treatment alone or
in combination with mechanical stimulation in either hES-MP or MLO-A5
cells. Since in vitro matrix formation typically requires cells to be at or near
confluence, reductions in cell viability would be likely to reduce or prevent
matrix production and mask any effects primary cilia elongation may have, as
was seen by Corrigan et al. This may explain the differences between these
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studies and the findings presented here [415].
Whether elongating primary cilia increases their mechanical sensitivity and
the mechanism that may be behind it is still not known. However, there are a
number of potential mechanisms that could be responsible. When primary cilia
are elongated, the amount of primary cilia membrane and primary cilia com-
partment size is increased. This in turn may result in increases in primary cilia
membrane proteins, as well as primary cilia specific proteins and signalling
molecules within the primary cilia microdomain [416, 417]. Many proteins
and signalling molecules that have been shown to be needed for mechanically
induced cellular responses can be found in the primary cilia. Therefore, increas-
ing the total number of ciliary proteins could enhance primary cilia mediated
signalling. Additionally, longer primary cilia may also be subjected to greater
membrane strain when fluid flow is applied as hypothesised by Schwartz et
al. [129]. This greater membrane strain could result in greater opening of
stretch-activated ion channels on the ciliary membrane and if there were more
stretch-activated ion channels present this effect could be amplified further.
Second messengers such as cAMP and Ca2+ signalling play an important
role in mechanotransduction and they were both altered with LiCl treatment,
with mechanically induced cAMP signalling being diminished and Ca2+ sig-
nalling being enhanced. For some time, the prevailing thought has been that
primary cilia are Ca2+ responsive mechanosensors. With advances in calcium
indicators, genetically encoded cilia-localised calcium indicators have been
used to show mechanically induced Ca2+ signalling to occur within primary
cilia [94,130,418]. Additionally, Resnick and Hopfer have shown the magnitude
of Ca2+ signalling is directly proportional to the length of primary cilia [199].
This would suggest the enhanced Ca2+ signalling responses observed here are
a result of increased sensitivity of the elongated primary cilia. However, most
recently, Delling et al. have used genetically encoded calcium indicators and
found no changes in ciliary calcium in response to fluid flow, which suggests
Ca2+ signalling does not originate in the primary cilia. The discrepancy be-
tween their study and others was attributed to potential imaging artefacts
resulting from the lower temporal resolution of previous studies and subsequent
errors in their examination [137]. Delling at el., only subjected the cells to 2 s
of flow, where other studies used longer durations and examined peak calcium
influx. Nevertheless, these results suggest mechanically induced calcium
signalling may not originate in the primary cilia and has raised interest in the
role of alternative second messengers in cilia mediated mechanotransduction,
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such as cAMP.
cAMP levels within the primary cilia microdomain have been found to be
fivefold higher than cytostolic levels in fibroblasts and IMCD3 cells [419].
Furthermore, cAMP levels are regulated by adenylyl cyclases and some, such
as adenylyl cyclase 6, have been shown to localise to the primary cilium and be
required for mechanically induced cellular responses [140,143,420]. However,
it is unclear exactly how mechanical stimulation affects cAMP signalling and
the role it plays in mechanotransduction. For example, there are conflicting
findings with regards to how cAMP levels are altered in response to mechanical
stimulation. Kwon et al., have shown the mechanoresponse of cAMP signalling
to be temporal, initially decreasing before increasing in osteocytes [140]. This
decrease was not observed here, cAMP levels rose with mechanical stimulation
in both control and LiCl treated cells before decreasing back towards basal
levels. Since the reduction in cAMP was seen 2min after the initiation of fluid
flow this decrease may have been missed as the earliest time point measured
was 15min. However, Johnson et al. measured cAMP levels in stem cells in
response to fluid flow at 2min and did not observe a decrease at this earlier
time point. This may suggest that the cAMP response varies between stem cells
and mature bone cells. cAMP responses have also been shown to be dependent
on the magnitude of the fluid shear applied, increasing in a dose dependant
manner, giving further evidence to support the hypothesis that cAMP levels
rise in response to mechanical stimulation [421].
A magnitude dependant cAMP response would suggest if the mechanosensi-
tivity of cells was enhanced the cAMP response would be greater for a given
magnitude of stimulation. However, the cAMP response to mechanical stimu-
lation was diminished with LiCl treatment despite the apparent increase in
mechanosensitivity indicated by increased mechanically induced osteogenic
responses. The diminished cAMP response is likely due to the inhibitory
effect LiCl is known to have on adenylyl cyclase activity and suggests peak
cAMP levels may not influence osteogenic mechanoresponses [219,422]. cAMP
signalling regulated through adenylyl cyclase activity was however required for
mechanically induced increases in osteogenesis to occur, as when mechanically
induced cAMP signalling was abrogated with MDL treatment, osteogenic
responses to mechanical stimulation no longer occurred.
Counter-intuitively, basal levels of cAMP were higher in LiCl treated cells
compared to controls, despite the fact LiCl inhibits adenylyl cyclase activity.
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Other studies have shown LiCl treatment decreases cAMP levels [423–425].
However, these studies were performed in neuronal cells which may respond
differently. Furthermore, lithium’s inhibitory effects on adenylyl cyclase that
cause the decreased cAMP have been shown to be specific to the adenylyl
cyclase V and VII isoforms in neuronal cells [426]. The increase observed
here could therefore be due to an increase in different adenylyl cyclase isoform
expression as a compensatory mechanism to LiCl’s inhibitory action as has
been observed by Colin et al. [427]. Additionally, the expression levels of
each of the different adenylyl cyclase isoforms is likely to be different between
neuronal cells and the hES-MP cells used here. Changes in cAMP levels are
known to alter primary cilia length, Besschetnova et al. have shown increased
cAMP levels result in primary cilia elongation through higher anterograde
intraflagellar transport speeds [195]. The primary cilia elongation caused by
LiCl treatment may therefore be due to this increase in basal cAMP.
Clearly both cAMP and Ca2+ signalling are important and required for me-
chotransduction to occur, since, when either of these are inhibited mechanically
induced responses are attenuated or abrogated [133,140,428]. However, nei-
ther of these work in strict isolation. Adenylyl cyclases can either be activated
by or inhibited by Ca2+ signalling and cAMP through its downstream effector,
protein kinase A (PKA), can affect Ca2+ signalling at every level from its
generation to termination [429–433]. This coupled with the fact LiCl affects
both of these pathways makes it difficult to pinpoint the role each of these
second messengers plays in the increased mechanosensitivity observed here.
7.6 Summary
To summarise, the previously optimised LiCl treatment regime and mechanical
loading regime were combined to assess the effects of LiCl on mechanosensi-
tivity. LiCl treatment resulted in increased sensitivity to FSS stimulation in
osteogenic progenitors and osteoblast cell lines. This increased mechanosen-
sitivity occurred in both monolayer culture and 3D culture. LiCl was found
to increase basal levels of cAMP but also inhibited FSS stimulated cAMP sig-
nalling. Although cAMP signalling was reduced in LiCl treated cells, cAMP
signalling was required for FSS stimulated increases in ALP activity to occur.
Ca2+ signalling in response to FSS after LiCl treatment was found to increase
the number of Ca2+ responding cells at low FSS but not at high FSS. Addition-
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ally, intracellular Ca2+ levels increased more in LiCl treated cells compared to
untreated cells in response to both levels of FSS.
202
8. General discussion and future
work
Mechanotransduction is a critical process in the development, maintenance and
function of a variety of tissues, including bone. Bone itself is a complex tissue
that contains multiple cell types, each playing an essential role in regulating
the balance between bone formation and resorption in response to the habitual
levels of mechanical stimulation [387,388]. Diseases such as osteoporosis can
cause imbalances in this bone remodelling cycle, resulting in reduced bone
density and quality and subsequent increases to the risk of bone fractures. In
order to restore the balance of resorption and deposition current therapies focus
on the inhibition of bone resorption. However, with many of these treatments
over a quarter of patients respond poorly and in rare circumstances serious
and debilitating side-effects can occur [434]. Alternatives to these treatments
would therefore be highly beneficial. High impact physical activity is well
known to increase bone deposition; however, the amount of exertion elderly and
osteoporotic patients can tolerate can be limited. Therapeutically enhancing
the sensitivity of bone cells to lower levels of physical stimuli could form an
alternative treatment.
In addition to applications for treating osteoporosis, increased mechanosensi-
tivity in osteogenic cells could be used to enhance matrix deposition in tissue
engineered bone. One method for creating tissue engineered bone involves
initial culture of the scaffold in vitro to allow cells to deposit natural matrix
onto the scaffold. This is often performed in bioreactors to increase mass
transport into the core of the scaffold but also to mechanically stimulate the
cells. Enhancing the osteogenic responses to this mechanical stimulation would
therefore be beneficial.
The main aim of this thesis was to investigate the use of lithium in enhancing
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osteogenic responses to FSS.
Lithium, in the form of lithium salts such as LiCl, have previously been
shown to elongate primary cilia [208,209,211]. Primary cilia are one organelle
thought to play a role in mechanotransduction. They have been shown to
regulate their length in response to mechanical loading, becoming shorter
in response to continuous loading leading to a subsequent decrease in me-
chanical sensitivity of the cells [195, 383, 384]. Lithium is also safe for use
in humans and has been used clinically for many years to treat psychiatric
disorders, although it is not without its side effects. Due to these reasons it
was a promising candidate for investigating its effects on mechanosensitivity.
However, lithium has also been shown to directly affect osteogenesis, although
there are also conflicting studies that have found it to have no effects [287–
290]. If the lithium treatment used to enhance mechano-induced osteogenesis
also enhanced osteogenesis itself, this would make analysis of the effects of
lithium on FSS driven osteogenesis more difficult. Therefore, in addition
to investigating the effects of lithium on mechanotransduction and primary
cilia length, it was necessary to optimise a treatment regime that did this
without affecting osteogenesis. To this end, continuous LiCl treatment, at a
therapeutically used concentration, was found to promote osteogenic markers.
When used intermittently this same concentration of LiCl was found to increase
primary cilia length without affecting primary cilia prevalence or osteogenic
markers. For this study the use of continuous LiCl treatment was therefore
excluded. Despite this, in the future it would be interesting to investigate if
these osteogenic effects are combinatorial with increased osteogenic responses
due to enhanced mechanosensitivity. If this were to be the case this would
have greater potential as a treatment for bone disorders such as osteoporosis.
Although the cells used in this study did respond to mechanical stimula-
tion, collagen production was not affected. Previous studies have shown
collagen production to be increased in response to mechanical loading in bone
cells [82,266,342]. Specifically, Delaine-Smith et al., showed increased collagen
production in response to low magnitude FSS in hES-MP cells [82]. This
cell type is therefore responsive to mechanical loading in terms of collagen
production. Different batches of serums can contain different levels and types
of hormones and other proteins, which can greatly influence the way cells
grow and respond to treatments [435–437]. This was highlighted here where
different batches of serum were found to alter cell growth, collagen production,
matrix mineralisation and responses to FSS. Although the serum composition
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may have played a role in the differences in responses observed it is not known
at which point in culture the serum influences the cellular responses. For
example, the FSS applied may have upregulated collagen type 1 α 1 (COL-
1α1) gene expression but downstream of this each different serum may alter
translation of COL-1α1 into collagen or the expression of other genes that may
alter collagen expression. Future studies should focus on the use of chemically
defined media to avoid these problems and also to allow comparison between
studies. Additionally, it would be beneficial to assess both short-term (such
as gene expression) and long-term responses in the future to gain a better
understanding of what is occurring throughout the culture period.
There is growing evidence Wnt/β-catenin signalling plays an important reg-
ulatory role in bone formation and controlling stem cell proliferation and
differentiation [292, 307, 312]. When Wnt/β-catenin signalling is inhibited
or highly stimulated it results in reduced bone formation or reduced bone
remodelling and reduced bone strength [438]. In contrast, with only a slight
activation of Wnt/β-catenin signalling, bone formation increases resulting in
improved bone strength [438]. The extent at which Wnt/β-catenin signalling is
stimulated is therefore important and may explain some of the contrasting con-
clusions from studies investigating the role of Wnt/β-catenin signalling in bone
formation. LiCl is well known to inhibit GSK3-β activity and therefore increase
β-catenin levels [321]. With regards to this it is likely the LiCl treatment
applied here altered β-catenin levels. Only continuous LiCl treatment affected
osteogenesis and this only occurred when hES-MP cells were cultured in DW
media. The LiCl treatment therefore did not stimulate osteogenic differentia-
tion alone but did enhance osteogenic differentiation through increased matrix
mineralisation when osteogenic differentiation was pre-stimulated with Dex.
It would therefore be interesting to explore how the LiCl treatments effected
β-catenin levels in non-differentiated compared to differentiated hES-MP cells
and what differences there were between continuous compared to intermittent
treatments.
In 3D culture primary cilia were found to be shorter than in monolayer
culture and of a more similar length to those reported to occur in vivo in bone.
Cells with shorter primary cilia have been shown to be less mechanically sensi-
tive [195]. This would suggest that when cultured in 3D the cells would be less
mechanically sensitive than in monolayer culture. Since the FSS magnitude
applied to the cells in monolayer and 3D culture were not matched it is not
possible to conclude this from the results presented in this study. In the future
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modelling the FSS within the PU scaffold would allow a flow regime to be used
that matches the FSS applied by the rocking platform, allowing comparisons of
osteogenic responses to the same magnitude of FSS.
The shorter primary cilia of bone cells observed in vivo has previously been
attributed to spatial constrains of bone surrounding the cells such as osteocytes
within the lacunae [335]. However, the pore size of the PU scaffold used here
was greater than 100µm and therefore the scaffold does not apply significant
spatial constraints to the cells. Furthermore, bone lining osteoblasts and
osteogenic progenitors within bone marrow have also been shown to have
similarly short primary cilia despite these cell types not being surrounded by
bone matrix and therefore not having the same spatial constraints [335].
If the elongation of primary cilia is part of the mechanism behind the increased
mechanosensitivity, it would be important to know if spatial constraints would
limit the amount of primary cilia elongation that is achievable. If primary
cilia elongation is limited by spatial constraints in vivo it could limit the
potential for the use of lithium in elongating primary cilia which may limit
any enhancement in mechnosensitivity due to increased primary cilia length
in vivo. This would be more of a limiting factor in osteocytes within lacunae
where cells are surrounded by bone matrix and less of a limiting factor in both
bone lining osteoblasts and osteogenic progenitor cells within the bone marrow
which have less spatial constraints applied to them. The work presented here
highlights lithium induced primary cilia elongation in both osteoblasts and
osteogenic progenitor cells. As these cells are less spatially constrained primary
cilia elongation in these cell types may be less limited. This suggests primary
cilia elongation may still have beneficial effects in these cell types in vivo.
To investigate if spatial constraints may limit primary cilia elongation and
whether this would prevent enhanced mechanoresponses to FSS an alternative
scaffold with smaller pores could be employed. A possible alternative scaffold
could be polyHIPE scaffolds, where median pore size can be controlled in the
range of 8-21µm diameter [439].
The mechanism by which lithium increases primary cilia length is still unclear.
Nakakura et al., proposed lithium induced primary cilia elongation occurs
through an increase in acetylated α-tubulin due to GSK3-β inhibition [208]. If
there was an increase in acetylated α-tubulin there would likely be an increase
in fluorescence intensity of the stained primary cilia here. This was not the
case as there was no increases in fluorescence intensity of anti-acetylated
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α-tubulin stained primary cilia observed. However, a more in-depth analysis
through measuring acetylated and non-acetylated α-tubulin levels by ELISA
and measuring α-tubulin N-acetyltransferase expression levels would be re-
quired to assess if this were the case.
Studies have shown LiCl as well as other GSK3-β inhibitors elongate pri-
mary cilia [208,212]. However, other studies have contradicted these findings,
suggesting primary cilia elongation, due to lithium, is independent of GSK3-β
inhibition and that other GSK3-β inhibitors did not cause primary cilia elonga-
tion [209,210]. Instead of GSK3-β inhibition Ou et al., found LiCl inhibited
adenylyl cyclase and suggested the subsequent decrease in cAMP levels caused
primary cilia elongation [209]. However, Besschetnova et al., found activation
of adenylyl cyclase and subsequent increases in cAMP levels caused primary
cilia elongation [195]. Interestingly, this study found basal levels of cAMP
were higher after LiCl treatment. It should be noted however that these
measurements were taken after the removal of LiCl from the media and by this
time-point primary cilia elongation had already occurred. Since lithium itself
affects multiple pathways, including both cAMP and Ca2+ signalling, it may be
that lithium causes primary cilia elongation through multiple mechanisms.
Furthermore, due to these many conflicting findings it is clear further work in
this area is necessary and a more specific drug to elongate primary cilia would
be more beneficial moving forwards.
Although LiCl treatment did elongate primary cilia, it may not have been
the only mechanosensitive organelle of the cell that was altered. There may
therefore be other factors involved in the increased mechanosensitivity ob-
served here. For example, the cytoskeleton is known to play an important
role in mechanotransduction and in osteoblasts lithium has been shown to
increase focal adhesions and F-actin stress fibres, altering cell spreading and
shape [316]. Other studies have also shown lithium affects focal adhesion
turnover rates which may also alter mechanotransduction [440]. Furthermore,
lithium inhibits inositol enzymes resulting in reduced Phosphatidylinositol
4,5-bisphosphate (PIP2), which are a required cofactor in many ion channels
including mechanosensitive ion channels [226]. However, since the mechanical
stimulation was applied after LiCl was removed from the media some of these
effects may have been minimised, such as the inhibition of inositol and sub-
sequent alterations in PIP2 levels. Nevertheless, it is possible the increased
mechanosensitivity observed here is due to a combination of these effects and
not due to primary cilia elongation alone or at all. To further elucidate how
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much of an impact primary cilia elongation played in the increased osteogenic
responses observed, these experiments could be repeated after primary cilia are
elongated with other chemicals or either removed through chloral hydrate treat-
ment or prevented from forming through knockdown of intraflagellar transport
(IFT) 88 with small interfering ribonucleic acid (siRNA). If enhanced responses
to stimulation still occurred this would indicate either other mechanosensors
are playing a role or that the increase is due to other effects lithium has.
Primary cilia are known to reduce their length in response to continuous
mechanical loading and these cells become less mechanically sensitive after
their primary cilia become shorter [384,441]. To the authors knowledge there
have been no studies investigating if drugs can prevent this shortening from
occurring or if their length can be quickly recovered. It is thought that this
phenomenon also occurs in vivo as cells in areas of higher loading have been
shown to have shorter primary cilia than those in areas of lower loading [383].
Future studies could apply this LiCl treatment regime developed here after
shortening primary cilia through mechanical loading and also assess if primary
cilia shortening occurs due to continuous mechanical loading while LiCl is also
applied.
One limitation of this study may be the use of only osteogenic progenitor
and osteoblast/pre-osteocyte cell lines. Osteocytes are thought to play an
important role in mechanotransduction and directing bone resorption and
deposition in response to loading. As this study focused on long term effects
such as matrix production and osteocytes themselves do not produce bone
matrix they were not used for this study. However, it would be important to
see how lithium treatment affects the function of osteocytes, including how
it alters osteoblast recruiting signalling such as PGE2 and nitric oxide (NO).
The previously discussed point on spatial constraints limiting primary cilia
elongation is also particularly relevant to osteocytes. It would therefore be
important to assess if primary cilia elongation is also possible in osteocytes
given the spatial constraints applied by the lacunae.
The FSS applied in this study through rocking was of a low magnitude and is
lower than what is theorised to occur in vivo when bones are loaded. With in-
creasing levels of loading stimulus cellular responses such as calcium signalling
also increase [442]. However, this only occurs until responses become saturated,
after which further increases in stimulus magnitude do not result in increased
responses [443–445]. This may mean that increased mechanosensitivity
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observed here is limited to low magnitudes of loading and that at higher mag-
nitudes responses may already be saturated. However, increasing responses
to low level stimuli would be beneficial in older people who are less able to
perform high impact activities such as running that stimulates bone deposition.
Lithium treatment has been shown to reduce the risk of fracture in osteoporotic
patients being treated with lithium for mental disorders [281–283]. However,
its use as a bone anabolic agent is limited by its side effects which can range
from excessive thirst and urination to mental impairment and kidney, thyroid
and parathyroid gland problems with continuous use. Previous investigations
into lithium’s bone anabolic effects have only focused on its direct effects on
bone formation and not on its potential to increase mechanosensitivity. This
study therefore highlights a second potential mechanism by which lithium
treatment may reduce bone fracture risk through increased bone density.
Furthermore, only intermittent lithium treatment was required in order to
induce increases in osteogenic responses to FSS. Only requiring intermittent
treatment could mean only taking lithium before bouts of exercise, this would
be beneficial as many of the side effects from lithium treatment occur due to
its continuous use.
The exact mechanism by which lithium caused increases in mechanoresponses
was not fully elucidated in this study. There are numerous signalling pathways
involved in mechanotransduction and second messengers such as cAMP and
Ca2+ play an important role in the transduction of mechanical stimuli to
biochemical responses. When adenylyl cyclase activity, the enzyme which
catalyses adenosine triphosphate (ATP) to cAMP, was inhibited with MDL
ALP activity was no longer increased with lithium treatment and FSS appli-
cation. This suggests adenylyl cyclase and cAMP signalling is required for
osteogenic mechanoresponses to occur. Interestingly although adenylyl cyclase
was found to be required, cAMP signalling was actually found to be lower in
LiCl treated cells subjected to FSS than control cells. Since cAMP signalling is
temporal, it may be that cAMP signalling was not lower and instead peaked at
a different time point. Certain isoforms of adenylyl cyclase have been shown
to be concentrated in or specific to primary cilia [133,140,446]. Elongation of
primary cilia could potentially also result in an increase in adenylyl cyclase
expression. Due to these reasons further work is required in both assessing the
temporal cAMP response to FSS and also whether lithium treatment alters
the distribution of adenylyl cyclase within the cell or increases or its levels or
alters the isoforms in the primary cilium.
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9. Conclusion
This thesis explored the feasibility of pharmacologically enhancing osteogenic
responses to mechano-stimulation in osteogenic progenitor and osteoblast cells.
Cells were established to be mechanically sensitive to an optimised low-level
FSS stimulus, where they showed enhanced osteogenesis in response to FSS.
Lithium, in the form of LiCl was applied to cells in monolayer culture and
in a 3D porous PU scaffold. LiCl treatment was found to increase osteoge-
nesis when applied continuously. In order to assess the effects of LiCl on
mechanoresponses, a treatment regime that did not stimulate osteogenesis in
static conditions was optimised. Osteogenic responses to FSS were found to be
enhanced with the established LiCl treatment regime compared to stimulation
without LiCl treatment. One mechanism that may have played a role in the
enhanced mechanoresponses observed is through lithium’s effects on primary
cilia. Primary cilia length is thought to play a role in regulating mechanosensi-
tivity and the LiCl treatment used here was found to elongate primary cilia.
However, this would require further work to fully elucidate whether primary
cilia elongation was involved in the increases in mechanoinduced osteogenic
responses observed here. In 3D culture primary cilia were shown to be shorter
than in monolayer culture and were found to be of similar lengths to those
reported to occur in vivo. As primary cilia were able to be elongated it suggests
the shorter lengths were not due to physical confinement.
Due to the complex and multifaceted pharmacological actions of lithium,
the exact mechanisms behind how it induced primary cilia elongation and
the exact mechanism behind the enhancement in mechanosensitivity were
not established. However, two pathways that lithium effects, namely cAMP
and Ca2+ signalling, were found to be altered in LiCl treated cells subjected
to FSS. Furthermore, when AC activity was inhibited mechanically induced
increases in ALP activity no longer occurred, suggesting AC activity and
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cAMP signalling are required for mechanotransduction to occur. Further work
should aim to elucidate the exact mechanisms behind both the LiCl induced
primary cilia elongation and the enhanced mechanosensitivity and if possible,
to find a pharmacological agent that more specifically targets this mechanism.
Despite the exact mechanisms behind these responses not being known, this
thesis highlights a novel therapeutic option that could be used to enhance
mechanosensitivity in bone cells in order to treat diseases that cause reduced
bone density, such as osteoporosis.
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